ID,Title,Authors,PublicationYearMonth,PublicationYearQuarter,DOI,PMID,Journal,DSS,DeclaredDataSharing,Individual,Aggregate,Unspeficied,RqstAuthors,RqstCommGroupUnit,RqstRepository,RepositoryName,InformationAboutDataOnRepository,DataAvailableOnRepository,RqstCompany,DataAvailableToOthers,AccessUnspecified,Embargo,EmbargoPeriodMonths,EmbargoUpTo1Y,EmbargoAbove1Yto2Y,EmbargoAbove2Y,ProductApproval,EmbargoOrProductApproval,Collaboration,NoReason,DataPrivacy,Time/Cost,OngoingTrialResearch,RegulatoryApproval,ProprietaryData,SharedAmongCoTrialistsOnly,MayBeAvailableForCollab,MayBeMadeAvailableUponRequest,FundingStatement,FunderType
1," Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.","Gordon KB, Strober B, Lebwohl M, Augustin M, Blauvelt A, Poulin Y, Papp KA, Sofen H, Puig L, Foley P, Ohtsuki M, Flack M, Geng Z, Gu Y, Valdes JM, Thompson EHZ, Bachelez H",2018-8,2018-Q3,10.1016/S0140-6736(18)31713-6,30097359,Lancet,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,AbbVie and Boehringer Ingelheim.,1_Industry
2," Intravenous remifentanil patient-controlled analgesia versus intramuscular pethidine for pain relief in labour (RESPITE): an open-label, multicentre, randomised controlled trial.","Wilson MJA, MacArthur C, Hewitt CA, Handley K, Gao F, Beeson L, Daniels J",2018-8,2018-Q3,10.1016/S0140-6736(18)31613-1,30115484,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,National Institute for Health Research Clinician Scientist Award.,3_NonIndustryNonNIH
3," Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.","ONeil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JPH",2018-8,2018-Q3,10.1016/S0140-6736(18)31773-2,30122305,Lancet,1,1,1,,,,1,,,,,1,,,1,,,,,1,1,,,,,,,,,,,Novo Nordisk A/S.,1_Industry
4, Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.,"Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Carrie D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N",2018-12,2018-Q4,10.1056/NEJMoa1805374,30145927,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by the French Ministry of Health and Research National Program and Abbott Vascular,4_Mixed
5, Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.,"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C",2018-9,2018-Q3,10.1056/NEJMoa1805689,30145929,NEJM,1,1,1,,,,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,Funded by Pfizer,1_Industry
6, Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.,"Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM",2018-9,2018-Q3,10.1056/NEJMoa1808721,30145941,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Eisai,1_Industry
7, Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.,"Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE",2018-9,2018-Q3,10.1056/NEJMoa1805090,30145946,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,,,,,1,1,,,,,,,,,,,Funded by Janssen Research and Development,1_Industry
8, One-Year Outcomes after PCI Strategies in Cardiogenic Shock.,"Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S",2018-11,2018-Q4,10.1056/NEJMoa1808788,30145971,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,"Trial funding was provided by the European Union Seventh Framework Program, the German Heart Research Foundation, and the German Cardiac Society. Additional support was provided by the German Center for Cardiovascular Research. These institutions had no involvement in the conduct of the trial, as reported previously. ",3_NonIndustryNonNIH
9, Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.,"Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, Murphy K, Aung T, Haynes R, Cox J, Murawska A, Young A, Lay M, Chen F, Sammons E, Waters E, Adler A, Bodansky J, Farmer A, McPherson R, Neil A, Simpson D, Peto R, Baigent C, Collins R, Parish S, Armitage J",2018-10,2018-Q4,10.1056/NEJMoa1804988,30146931,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,"The trial was funded by the British Heart Foundation. The aspirin and matching placebo (along with funding for packaging) were provided by Bayer (Germany), and Solvay, Abbott, and Mylan provided the n−3 fatty acid and placebo capsules and some funding for packaging. Bayer (Germany) commented on the design of the trial, and both Bayer and Mylan commented on the draft of the manuscript but had no part in the collection, handling, analysis, or interpretation of the data or in the decision to submit the manuscript for publication. ",4_Mixed
10, Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.,"Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, Murphy K, Aung T, Haynes R, Cox J, Murawska A, Young A, Lay M, Chen F, Sammons E, Waters E, Adler A, Bodansky J, Farmer A, McPherson R, Neil A, Simpson D, Peto R, Baigent C, Collins R, Parish S, Armitage J",2018-10,2018-Q4,10.1056/NEJMoa1804989,30146932,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,"The trial was funded by the British Heart Foundation. Capsules containing the n−3 fatty acids and matching placebo (along with funding for packaging) were provided by Mylan (and formerly by Solvay and Abbott), and Bayer provided the aspirin and placebo. Mylan, Solvay, and Abbott had nonvoting representation at meetings of the steering committee and provided comments regarding the trial design and draft manuscript but otherwise had no role in data collection or analysis or in the decision to submit the manuscript for publication.",4_Mixed
11," Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.","Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B",2018-10,2018-Q4,10.1056/NEJMoa1808848,30146935,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,,,,,1,1,,,,,,,,,,,Funded by Janssen Research and Development,1_Industry
12, Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.,"Mazer CD, Whitlock RP, Fergusson DA, Belley-Cote E, Connolly K, Khanykin B, Gregory AJ, de Medicis E, Carrier FM, McGuinness S, Young PJ, Byrne K, Villar JC, Royse A, Grocott HP, Seeberger MD, Mehta C, Lellouche F, Hare GMT, Painter TW, Fremes S, Syed S, Bagshaw SM, Hwang NC, Royse C, Hall J, Dai D, Mistry N, Thorpe K, Verma S, Juni P, Shehata N",2018-9,2018-Q3,10.1056/NEJMoa1808561,30146969,NEJM,1,1,1,,,1,,,,,,,,,1,18,,1,,,1,,,,,,,,,,,"Supported by grants (232416 and 301852) from the Canadian Institutes of Health Research (CIHR), by a grant (Kenneth J. Fyke Award, to Dr. Shehata) from the Canadian Blood Services–Health Canada, by a grant (1085942) from the National Health and Medical Research Council of Australia, by a grant (16/353) from the Health Research Council of New Zealand, and by a Tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases (to Dr. Jüni) from the CIHR Canada Research Chairs Programme.",3_NonIndustryNonNIH
13, Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.,"Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, Bruun NE, Hofsten DE, Fursted K, Christensen JJ, Schultz M, Klein CF, Fosboll EL, Rosenvinge F, Schonheyder HC, Kober L, Torp-Pedersen C, Helweg-Larsen J, Tonder N, Moser C, Bundgaard H",2019-1,2019-Q1,10.1056/NEJMoa1808312,30152252,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Supported by unrestricted grants from the Danish Heart Foundation, the Capital Regions Research Council, the Hartmann's Foundation, Svend Aage Andersens Foundation, and the Novo Nordisk Foundation (Borregaard Clinical Scientist Fellowship in translational research; grant no. NNF17OC0025074).",4_Mixed
14," Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.","Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbuhler M, Tebaldi M, Varbella F, Calabro P, Garducci S, Rubartelli P, Briguori C, Ando G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van t Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Juni P",2018-9,2018-Q3,10.1016/S0140-6736(18)31714-8,30153988,Lancet,1,1,1,,,,1,1,Clinical Trials Unit University of Bern,0,0,,,,1,48,,,1,,1,,,,,,,,,,,"Italian Society of Invasive Cardiology, The Medicines Company, Terumo, amd Canada Research Chairs Programme.",4_Mixed
15," Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.","Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G",2018-9,2018-Q3,10.1016/S0140-6736(18)31924-X,30158069,Lancet,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,,,,,1,1,,,,,,,,,,,Bayer,1_Industry
16," Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.","Vranckx P, Valgimigli M, Juni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Mollmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S",2018-9,2018-Q3,10.1016/S0140-6736(18)31858-0,30166073,Lancet,1,1,,,1,,1,,,,,,,,1,60,,,1,,1,,,,,,,,,,,"AstraZeneca, Biosensors, and The Medicines Company.",1_Industry
17," Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.","Pilgrim T, Piccolo R, Heg D, Roffi M, Tuller D, Muller O, Moarof I, Siontis GCM, Cook S, Weilenmann D, Kaiser C, Cuculi F, Hunziker L, Eberli FR, Juni P, Windecker S",2018-9,2018-Q3,10.1016/S0140-6736(18)31715-X,30170848,Lancet,1,1,,,1,,1,1,Bern Open Repository and Information System (BORIS),0,0,,,,1,24,,1,,,1,,,,,,,,,,,Clinical Trials Unit of the University of Bern and Biotronik.,4_Mixed
18," High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.","Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, Sandeman D, Stables CL, Adamson PD, Andrews JPM, Anwar MS, Hung J, Moss AJ, OBrien R, Berry C, Findlay I, Walker S, Cruickshank A, Reid A, Gray A, Collinson PO, Apple FS, McAllister DA, Maguire D, Fox KAA, Newby DE, Tuck C, Harkess R, Parker RA, Keerie C, Weir CJ, Mills NL",2018-9,2018-Q3,10.1016/S0140-6736(18)31923-8,30170853,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,The British Heart Foundation.,3_NonIndustryNonNIH
19, Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.,"Jeger RV, Farah A, Ohlow MA, Mangner N, Mobius-Winkler S, Leibundgut G, Weilenmann D, Wohrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N, Osswald S, Kaiser C, Scheller B",2018-9,2018-Q3,10.1016/S0140-6736(18)31719-7,30170854,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Basel Cardiovascular Research Foundation, and B Braun Medical AG.",4_Mixed
20," Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.","Lansky A, Wijns W, Xu B, Kelbaek H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schachinger V, Baumbach A",2018-9,2018-Q3,10.1016/S0140-6736(18)31649-0,30190206,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Shanghai Microport Medical.,1_Industry
21, Mandatory Medicare Bundled Payment Program for Lower Extremity Joint Replacement and Discharge to Institutional Postacute Care: Interim Analysis of the First Year of a 5-Year Randomized Trial.,"Finkelstein A, Ji Y, Mahoney N, Skinner J",2018-9,2018-Q3,10.1001/jama.2018.12346,30193277,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,J-PAL North America and the National Institute on Aging (grant P01AG019783-15) provided research support.,3_NonIndustryNonNIH
22, Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.,"Papp K, Gordon K, Thaci D, Morita A, Gooderham M, Foley P, Girgis IG, Kundu S, Banerjee S",2018-10,2018-Q4,10.1056/NEJMoa1806382,30205746,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Funded by Bristol-Myers Squibb,1_Industry
23, Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.,"Kolb M, Raghu G, Wells AU, Behr J, Richeldi L, Schinzel B, Quaresma M, Stowasser S, Martinez FJ",2018-11,2018-Q4,10.1056/NEJMoa1811737,30220235,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,Funded by Boehringer Ingelheim,1_Industry
24, Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.,"McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, Kirpach B, Shah RC, Ives DG, Storey E, Ryan J, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Radziszewska B, Grimm R, Murray AM",2018-10,2018-Q4,10.1056/NEJMoa1803955,30221595,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Supported by a grant (U01AG029824) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the National Health and Medical Research Council of Australia, and by Monash University and the Victorian Cancer Agency.",4_Mixed
25, Effect of Aspirin on Disability-free Survival in the Healthy Elderly.,"McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Ryan J, Radziszewska B, Grimm R, Murray AM",2018-10,2018-Q4,10.1056/NEJMoa1800722,30221596,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Supported by a grant (U01AG029824) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the National Health and Medical Research Council of Australia, and by Monash University and the Victorian Cancer Agency.",4_Mixed
26, Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.,"McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Storey E, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM",2018-10,2018-Q4,10.1056/NEJMoa1805819,30221597,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Supported by a grant (U01AG029824) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the National Health and Medical Research Council of Australia, and by Monash University and the Victorian Cancer Agency.",4_Mixed
27," Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study.","van Vollenhoven RF, Hahn BH, Tsokos GC, Wagner CL, Lipsky P, Touma Z, Werth VP, Gordon RM, Zhou B, Hsu B, Chevrier M, Triebel M, Jordan JL, Rose S",2018-10,2018-Q4,10.1016/S0140-6736(18)32167-6,30249507,Lancet,1,1,,,1,,,1,The Yale Open Data Access (YODA) Project,0,0,,,,,,,,,,,,,,,,,,,,,"Janssen Research & Development, LLC.",1_Industry
28," A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.","Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Muller-Hulsbeck S",2018-10,2018-Q4,10.1016/S0140-6736(18)32262-1,30262332,Lancet,1,1,,,1,,,,,,,1,,1,,,,,,,,,,,,,,,,,,Boston Scientific,1_Industry
29, Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.,"Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J Jr, Sims M, Wray D, Zervos M, Fowler VG Jr",2018-9,2018-Q3,10.1001/jama.2018.13155,30264119,JAMA,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,This research was funded by award HHSN272200900023C from the National Institutes of Health (NIH). Dr Fowler was supported by NIH grant K24 AI093969.,2_NonIndustryNIH
30, Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial.,"Salminen P, Tuominen R, Paajanen H, Rautio T, Nordstrom P, Aarnio M, Rantanen T, Hurme S, Mecklin JP, Sand J, Virtanen J, Jartti A, Gronroos JM",2018-9,2018-Q3,10.1001/jama.2018.13201,30264120,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"This trial was supported by the Mary and Georg C. Ehrnrooth Foundation, a government research grant (EVO Foundation) awarded to Turku University Hospital, and a Turku University research grant.",3_NonIndustryNonNIH
31, Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.,"Stone GW, Ellis SG, Gori T, Metzger DC, Stein B, Erickson M, Torzewski J, Williams J Jr, Lawson W, Broderick TM, Kabour A, Piegari G, Cavendish J, Bertolet B, Choi JW, Marx SO, Genereux P, Kereiakes DJ",2018-10,2018-Q4,10.1016/S0140-6736(18)32283-9,30266412,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,Abbott Vascular.,1_Industry
32, Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.,"Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gumus M, Mazieres J, Hermes B, Cay Senler F, Csoszi T, Fulop A, Rodriguez-Cid J, Wilson J, Sugawara S, Kato T, Lee KH, Cheng Y, Novello S, Halmos B, Li X, Lubiniecki GM, Piperdi B, Kowalski DM",2018-11,2018-Q4,10.1056/NEJMoa1810865,30280635,NEJM,1,1,1,,,,,,,,,1,,,1,,,,,1,1,,,,,,,,,,,Funded by Merck Sharp & Dohme,1_Industry
33, Transcatheter Mitral-Valve Repair in Patients with Heart Failure.,"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ",2018-12,2018-Q4,10.1056/NEJMoa1806640,30280640,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,Funded by Abbott,1_Industry
34, First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.,"Horn L, Mansfield AS, Szczesna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV",2018-12,2018-Q4,10.1056/NEJMoa1809064,30280641,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,,,,,,,,,,,,,,,,,,Funded by F. Hoffmann-La Roche/Genentech,1_Industry
35, Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.,"Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E, Ayles HM, Henostroza G, Thienemann F, Scriba TJ, Diacon A, Blatner GL, Demoitie MA, Tameris M, Malahleha M, Innes JC, Hellstrom E, Martinson N, Singh T, Akite EJ, Khatoon Azam A, Bollaerts A, Ginsberg AM, Evans TG, Gillard P, Tait DR",2018-10,2018-Q4,10.1056/NEJMoa1803484,30280651,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),1,1,,,,1,6,1,,,,1,,,,,,,,,,,Funded by GlaxoSmithKline Biologicals and Aeras,1_Industry
36, Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.,"Camidge DR, Kim HR, Ahn MJ, Yang JC, Han JY, Lee JS, Hochmair MJ, Li JY, Chang GC, Lee KH, Gridelli C, Delmonte A, Garcia Campelo R, Kim DW, Bearz A, Griesinger F, Morabito A, Felip E, Califano R, Ghosh S, Spira A, Gettinger SN, Tiseo M, Gupta N, Haney J, Kerstein D, Popat S",2018-11,2018-Q4,10.1056/NEJMoa1810171,30280657,NEJM,1,1,1,,,,,,,,,1,,,1,,,,,1,1,,,,,,,,,,,Funded by Ariad Pharmaceuticals,1_Industry
37, Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.,"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeno J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Ozguroglu M",2018-12,2018-Q4,10.1056/NEJMoa1809697,30280658,NEJM,1,1,1,,,,,,,,,1,,,1,12,1,,,,1,,,,,,,,,,,Funded by AstraZeneca,1_Industry
38, Effect of Early Surgery vs Physical Therapy on Knee Function Among Patients With Nonobstructive Meniscal Tears: The ESCAPE Randomized Clinical Trial.,"van de Graaf VA, Noorduyn JCA, Willigenburg NW, Butter IK, de Gast A, Mol BW, Saris DBF, Twisk JWR, Poolman RW",2018-10,2018-Q4,10.1001/jama.2018.13308,30285177,JAMA,1,1,1,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,"This study was funded by the Netherlands Organization for Health Research and Development (in Dutch: ZonMw; grant 837002009), Zilverenkruis Health Insurance (grant Z436), and the Foundation of Medical Research of the OLVG, Amsterdam (grant 15u.025).",3_NonIndustryNonNIH
39," Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.","Hernandez AF, Green JB, Janmohamed S, DAgostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S",2018-10,2018-Q4,10.1016/S0140-6736(18)32261-X,30291013,Lancet,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),1,1,,,,,,,,,,,,,,,,,,,,,GlaxoSmithKline,1_Industry
40," Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.","Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R",2018-10,2018-Q4,10.1016/S0140-6736(18)31947-0,30292578,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"JDRF, NIHR, and Wellcome Trust.",3_NonIndustryNonNIH
41," Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.","Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C, Urva S, Gimeno RE, Milicevic Z, Robins D, Haupt A",2018-11,2018-Q4,10.1016/S0140-6736(18)32260-8,30293770,Lancet,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,1,,,,,1,1,,,,,,,,,,,Eli Lilly and Company,1_Industry
42," Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.","Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, Ray KK, Ruda M, Spinar J, Patel T, Miao W, Perdomo C, Francis B, Dhadda S, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD",2018-11,2018-Q4,10.1016/S0140-6736(18)32328-6,30293771,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,Eisai,1_Industry
43, Effect of Immediate vs Delayed Pushing on Rates of Spontaneous Vaginal Delivery Among Nulliparous Women Receiving Neuraxial Analgesia: A Randomized Clinical Trial.,"Cahill AG, Srinivas SK, Tita ATN, Caughey AB, Richter HE, Gregory WT, Liu J, Woolfolk C, Weinstein DL, Mathur AM, Macones GA, Tuuli MG",2018-10,2018-Q4,10.1001/jama.2018.13986,30304425,JAMA,1,1,1,,,1,,,,,,,,,1,50,,,1,,1,,,,,,,,,,,"This work was supported by grant U01HD077384 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (awarded to Drs Cahill and Tuuli) and by funding from the Department of Obstetrics and Gynecology, School of Medicine, Washington University in St Louis.",4_Mixed
44, Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.,"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, Walker PM",2018-10,2018-Q4,10.1001/jama.2018.14618,30304428,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,This study was supported by Spectral Medical Inc.,1_Industry
45, Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.,"Devereux G, Cotton S, Fielding S, McMeekin N, Barnes PJ, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Gompertz S, Haughney J, Innes K, Kaniewska J, Lee A, Morice A, Norrie J, Sullivan A, Wilson A, Price D",2018-10,2018-Q4,10.1001/jama.2018.14432,30326124,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,The study was funded by the NIHR HTA program (project number 11/58/15). The study was cosponsored by the University of Aberdeen and NHS Grampian.,3_NonIndustryNonNIH
46, VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.,"Keating D, Marigowda G, Burr L, Daines C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Sass LA, Tullis E, McKee CM, Moskowitz SM, Robertson S, Savage J, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Taylor-Cousar JL",2018-10,2018-Q4,10.1056/NEJMoa1807120,30334692,NEJM,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,Funded by Vertex Pharmaceuticals,1_Industry
47, VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.,"Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM",2018-10,2018-Q4,10.1056/NEJMoa1807119,30334693,NEJM,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,Funded by Vertex Pharmaceuticals,1_Industry
48, Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.,"Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, Barclay C, Doherty S, Duley L, Hatton R, Rees F, Stevenson M, Zhang W",2018-10,2018-Q4,10.1016/S0140-6736(18)32158-5,30343856,Lancet,1,1,1,,,1,,,,,,,,,1,9,1,,,,1,,,,,,,,,,,Arthritis Research UK.,3_NonIndustryNonNIH
49, Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.,"Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, Gonzalez-Martin A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P",2018-12,2018-Q4,10.1056/NEJMoa1810858,30345884,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Funded by AstraZeneca and Merck,1_Industry
50, Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.,"Turner NC, Slamon DJ, Ro J, Bondarenko I, Im SA, Masuda N, Colleoni M, DeMichele A, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, Andre F, Puyana Theall K, Huang X, Giorgetti C, Huang Bartlett C, Cristofanilli M",2018-11,2018-Q4,10.1056/NEJMoa1810527,30345905,NEJM,1,1,1,,,,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,Funded by Pfizer,1_Industry
51, Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.,"Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Dieras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA",2018-11,2018-Q4,10.1056/NEJMoa1809615,30345906,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,1,,,,,,1,,,,,,,,,,,Funded by F. Hoffmann-La Roche/Genentech,1_Industry
52, Energy-Dense versus Routine Enteral Nutrition in the Critically Ill.,"Chapman M, Peake SL, Bellomo R, Davies A, Deane A, Horowitz M, Hurford S, Lange K, Little L, Mackle D, OConnor S, Presneill J, Ridley E, Williams P, Young P",2018-11,2018-Q4,10.1056/NEJMoa1811687,30346225,NEJM,1,1,,,1,1,,,,,,,,,1,36,,,1,,1,,,,,,,,,,,Funded by National Health and Medical Research Institute of Australia and the Health Research Council of New Zealand,3_NonIndustryNonNIH
53, Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.,"Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, Douglas IS, Malhotra A, Owens RL, Feinstein DJ, Khan B, Pisani MA, Hyzy RC, Schmidt GA, Schweickert WD, Hite RD, Bowton DL, Masica AL, Thompson JL, Chandrasekhar R, Pun BT, Strength C, Boehm LM, Jackson JC, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Bernard GR, Dittus RS, Ely EW",2018-12,2018-Q4,10.1056/NEJMoa1808217,30346242,NEJM,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the National Institutes of Health and the VA Geriatric Research Education and Clinical Center,4_Mixed
54, Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.,"Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, Wise MP, Morgan MPG, Depuydt P, Boelens J, Dugernier T, Verbelen V, Jorens PG, Verbrugghe W, Malhotra-Kumar S, Damas P, Meex C, Leleu K, van den Abeele AM, Gomes Pimenta de Matos AF, Fernandez Mendez S, Vergara Gomez A, Tomic V, Sifrer F, Villarreal Tello E, Ruiz Ramos J, Aragao I, Santos C, Sperning RHM, Coppadoro P, Nardi G, Brun-Buisson C, Bonten MJM",2018-11,2018-Q4,10.1001/jama.2018.13765,30347072,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,"This study was funded by the European Commission under the Seventh Framework Programme (FP7-HEALTH-2011-single-stage, grant agreement number 282512).",3_NonIndustryNonNIH
55, Effect of Protocolized Weaning With Early Extubation to Noninvasive Ventilation vs Invasive Weaning on Time to Liberation From Mechanical Ventilation Among Patients With Respiratory Failure: The Breathe Randomized Clinical Trial.,"Perkins GD, Mistry D, Gates S, Gao F, Snelson C, Hart N, Camporota L, Varley J, Carle C, Paramasivam E, Hoddell B, McAuley DF, Walsh TS, Blackwood B, Rose L, Lamb SE, Petrou S, Young D, Lall R",2018-11,2018-Q4,10.1001/jama.2018.13763,30347090,JAMA,1,1,1,,,1,,,,,,,,,1,,,,,,1,,,,,,,,,,,This project was funded by the NIHR Health Technology Assessment Programme (project HTA 10/134) and supported by the Intensive Care Foundation. The trial was co-sponsored by the Heart of England NHS Foundation Trust and the University of Warwick.,3_NonIndustryNonNIH
56, Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial.,"Simonis FD, Serpa Neto A, Binnekade JM, Braber A, Bruin KCM, Determann RM, Goekoop GJ, Heidt J, Horn J, Innemee G, de Jonge E, Juffermans NP, Spronk PE, Steuten LM, Tuinman PR, de Wilde RBP, Vriends M, Gama de Abreu M, Pelosi P, Schultz MJ",2018-11,2018-Q4,10.1001/jama.2018.14280,30357256,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"This study was supported by a grant from ZonMW, Netherlands Organization for Health Research and Development (http://www.zonmw.nl) and the Academic Medical Center (Amsterdam, the Netherlands).",3_NonIndustryNonNIH
57, Effects of a Multimodal Program Including Simulation on Job Strain Among Nurses Working in Intensive Care Units: A Randomized Clinical Trial.,"El Khamali R, Mouaci A, Valera S, Cano-Chervel M, Pinglis C, Sanz C, Allal A, Attard V, Malardier J, Delfino M, DAnna F, Rostini P, Aguilard S, Berthias K, Cresta B, Iride F, Reynaud V, Suard J, Syja W, Vankiersbilck C, Chevalier N, Inthavong K, Forel JM, Baumstarck K, Papazian L",2018-11,2018-Q4,10.1001/jama.2018.14284,30357264,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This research was funded by grant PHRIP 14-0061 from the French Ministry of Health (Programme Hospitalier de Recherche Infirmière et Paramédicale [PHRIP]) and by funding from the Assistance Publique Hôpitaux de Marseille.,3_NonIndustryNonNIH
58, Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial.,"Cooper DJ, Nichol AD, Bailey M, Bernard S, Cameron PA, Pili-Floury S, Forbes A, Gantner D, Higgins AM, Huet O, Kasza J, Murray L, Newby L, Presneill JJ, Rashford S, Rosenfeld JV, Stephenson M, Vallance S, Varma D, Webb SAR, Trapani T, McArthur C",2018-12,2018-Q4,10.1001/jama.2018.17075,30357266,JAMA,1,1,,,1,1,,,,,,,,,1,36,,,1,,1,,,,,,,,,,,"This trial was supported by grants from the National Health and Medical Research Council of Australia (545901 and 1121037); the Victorian Neurotrauma Initiative (VNI for the Transport Accident Commission, Victoria, Australia) (VNI D162); the Teaching Hospital of Besancon, France; and Health Research Board of Ireland Clinical Trial Network Program.",3_NonIndustryNonNIH
59, Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.,"Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pene F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Berrahil-Meksen L, Louis G, Constantin JM, Mayaux J, Wallet F, Kouatchet A, Peigne V, Theodose I, Perez P, Girault C, Jaber S, Oziel J, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bige N, Raphalen JH, Papazian L, Darmon M, Chevret S, Demoule A",2018-11,2018-Q4,10.1001/jama.2018.14282,30357270,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,All financial support for this study was provided by the French Ministry of Health (P150912 HIGH). Supplies for high-flow oxygen therapy were provided by Fisher & Paykel France.,3_NonIndustryNonNIH
60, Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.,"Pickkers P, Mehta RL, Murray PT, Joannidis M, Molitoris BA, Kellum JA, Bachler M, Hoste EAJ, Hoiting O, Krell K, Ostermann M, Rozendaal W, Valkonen M, Brealey D, Beishuizen A, Meziani F, Murugan R, de Geus H, Payen D, van den Berg E, Arend J",2018-11,2018-Q4,10.1001/jama.2018.14283,30357272,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,This work was supported by AM-Pharma.,1_Industry
61, Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.,"Phelps DL, Watterberg KL, Nolen TL, Cole CA, Cotten CM, Oh W, Poindexter BB, Zaterka-Baxter KM, Das A, Lacy CB, Scorsone AM, Walsh MC, Bell EF, Kennedy KA, Schibler K, Sokol GM, Laughon MM, Lakshminrusimha S, Truog WE, Garg M, Carlo WA, Laptook AR, Van Meurs KP, Carlton DP, Graf A, DeMauro SB, Brion LP, Shankaran S, Orge FH, Olson RJ, Mintz-Hittner H, Yang MB, Haider KM, Wallace DK, Chung M, Hug D, Tsui I, Cogen MS, Donahue JP, Gaynon M, Hutchinson AK, Bremer DL, Quinn G, He YG, Lucas WR Jr, Winter TW, Kicklighter SD, Kumar K, Chess PR, Colaizy TT, Hibbs AM, Ambalavanan N, Harmon HM, McGowan EC, Higgins RD",2018-10,2018-Q4,10.1001/jama.2018.14996,30357297,JAMA,1,1,1,,,,,1,NICHD Data and Specimen Hub (DASH),1,1,,,,,,,,,,,,,,,,,,,,,"Funded by grants U10 HD36790, UG1 HD27904, UG1 HD21364, UG1 HD68284, UG1 HD27853, UG1 HD40492, UG1 HD27851, UG1 HD27856, UG1 HD87229, UG1 HD68278, UG1 HD27880, UG1 HD34216, UG1 HD68270, UG1 HD53109, UG1 HD53089, UG1 HD68244, UG1 HD68263, UG1 HD40689, and UG1 HD21385 from the National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Eye Institute and by grants UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR442, UL1 TR454, and UL1 TR1117 from the National Center for Advancing Translational Sciences. Abbott Nutrition Division (Abbott Laboratories) provided the myo-inositol.",2_NonIndustryNIH
62," Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.","Reuter U, Goadsby PJ, Lanteri-Minet M, Wen S, Hours-Zesiger P, Ferrari MD, Klatt J",2018-11,2018-Q4,10.1016/S0140-6736(18)32534-0,30360965,Lancet,1,1,,,1,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,,,,,,,,,,,,,,,,,,Novartis Pharma,1_Industry
63," Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.","Mease P, Coates LC, Helliwell PS, Stanislavchuk M, Rychlewska-Hanczewska A, Dudek A, Abi-Saab W, Tasset C, Meuleners L, Harrison P, Besuyen R, Van der Aa A, Mozaffarian N, Greer JM, Kunder R, Van den Bosch F, Gladman DD",2018-12,2018-Q4,10.1016/S0140-6736(18)32483-8,30360969,Lancet,1,1,1,,,,,,,,,1,,,1,6,1,,,1,1,,,,,,,,,,,Galapagos and Gilead Sciences.,1_Industry
64," Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.","van der Heijde D, Baraliakos X, Gensler LS, Maksymowych WP, Tseluyko V, Nadashkevich O, Abi-Saab W, Tasset C, Meuleners L, Besuyen R, Hendrikx T, Mozaffarian N, Liu K, Greer JM, Deodhar A, Landewe R",2018-12,2018-Q4,10.1016/S0140-6736(18)32463-2,30360970,Lancet,1,1,1,,,,,,,,,1,,,1,6,1,,,1,1,,,,,,,,,,,Galapagos and Gilead Sciences,1_Industry
65, Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.,"Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I",2019-1,2019-Q1,10.1056/NEJMoa1810742,30365356,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The trial was funded by Kidney Research UK, which was supported by an unrestricted grant from Vifor Fresenius Medical Care Renal Pharma (which also provided iron sucrose for the trial, free of charge). Vifor Fresenius Medical Care Renal Pharma had no input into the trial design or the data collection or analysis. However, the company was kept abreast of the progress of the trial by regular study reports and newsletters. No confidentiality agreements regarding the data were in place.",4_Mixed
66, Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.,"Borlaug BA, Anstrom KJ, Lewis GD, Shah SJ, Levine JA, Koepp GA, Givertz MM, Felker GM, LeWinter MM, Mann DL, Margulies KB, Smith AL, Tang WHW, Whellan DJ, Chen HH, Davila-Roman VG, McNulty S, Desvigne-Nickens P, Hernandez AF, Braunwald E, Redfield MM",2018-11,2018-Q4,10.1001/jama.2018.14852,30398602,JAMA,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,0,0,,,,1,24,,1,,,1,,,,,,,,,,,"This work was funded by the Heart Failure Clinical Research Network, which is supported by the NHLBI/NIH (grants U10 HL084904 [awarded to the coordinating center], U10 HL110312, U10 HL110337, U10 HL110342, U10 HL110262, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, and U10 HL110338 [awarded to the regional clinical centers]) and Savara Therapeutics.",4_Mixed
67, Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.,"Dimopoulos MA, Dytfeld D, Grosicki S, Moreau P, Takezako N, Hori M, Leleu X, LeBlanc R, Suzuki K, Raab MS, Richardson PG, Popa McKiver M, Jou YM, Shelat SG, Robbins M, Rafferty B, San-Miguel J",2018-11,2018-Q4,10.1056/NEJMoa1805762,30403938,NEJM,1,1,,,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,Funded by Bristol-Myers Squibb and AbbVie Biotherapeutics,1_Industry
68, Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.,"Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E",2019-2,2019-Q1,10.1056/NEJMoa1812851,30415601,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,,,Funded by Novartis,1_Industry
69, Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.,"Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS",2019-1,2019-Q1,10.1056/NEJMoa1812389,30415602,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,Funded by AstraZeneca,1_Industry
70, Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.,"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ",2019-2,2019-Q1,10.1056/NEJMoa1809798,30415610,NEJM,1,1,,,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,"Funded by the National Heart, Lung, and Blood Institute",2_NonIndustryNIH
71, Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.,"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM",2019-1,2019-Q1,10.1056/NEJMoa1812792,30415628,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,Funded by Amarin Pharma,1_Industry
72, Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.,"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, DAgostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE",2019-1,2019-Q1,10.1056/NEJMoa1809944,30415629,NEJM,1,1,1,,,1,,,,,,,,,1,22,,1,,,1,,,,,,,,,,,"Supported by grants (U01 CA138962 and R01 CA138962) from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the Office of Dietary Supplements, the National Institute of Neurological Disorders and Stroke, and the National Center for Complementary and Integrative Health. The ancillary studies are supported by grants from multiple institutes, including the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Mental Health, and others.",2_NonIndustryNIH
73, Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.,"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Albert CM, Gordon D, Copeland T, DAgostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE",2019-1,2019-Q1,10.1056/NEJMoa1811403,30415637,NEJM,1,1,1,,,1,,,,,,,,,1,22,,1,,,1,,,,,,,,,,,"Supported by grants (U01 CA138962 and R01 CA138962) from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the Office of Dietary Supplements, the National Institute of Neurological Disorders and Stroke, and the National Center for Complementary and Integrative Health. The ancillary studies were supported by grants from multiple institutes, including the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Mental Health, and others.",2_NonIndustryNIH
74, Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.,"Zenati MA, Bhatt DL, Bakaeen FG, Stock EM, Biswas K, Gaziano JM, Kelly RF, Tseng EE, Bitondo J, Quin JA, Almassi GH, Haime M, Hattler B, DeMatt E, Scrymgeour A, Huang GD",2019-1,2019-Q1,10.1056/NEJMoa1812390,30417737,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Funded by the Cooperative Studies Program, Office of Research and Development, Department of Veterans Affairs",3_NonIndustryNonNIH
75, Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.,"Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK",2019-1,2019-Q1,10.1001/jama.2018.18269,30418475,JAMA,1,1,,,1,1,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,This study was sponsored by Boehringer Ingelheim and Eli Lilly.,1_Industry
76, Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.,"Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA",2018-12,2018-Q4,10.1001/jama.2018.17933,30419103,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,1,1,,,,,,,RETRACTED Funding was provided by the Patient-Centered Outcomes Research Institute (PCORI) (Award IHS 1304-7118).,3_NonIndustryNonNIH
77," Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.","Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K",2019-1,2019-Q1,10.1016/S0140-6736(18)32462-0,30420123,Lancet,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,,,,,,,,,,,,,,,,,,ViiV Healthcare,1_Industry
78, Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.,"Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C",2018-11,2018-Q4,10.1001/jama.2018.16131,30422193,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,This study was funded by Canadian Institutes of Health Research Grant CIHR 201303MOP-299872-KTR.,3_NonIndustryNonNIH
79, Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.,"Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, DAgnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT",2018-11,2018-Q4,10.1001/jama.2018.15870,30422235,JAMA,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,"This study is supported by grants from the Dutch Kidney Foundation (CP10.12 and CP15.01) and the Dutch Ministry of Economic Affairs (LHSM15018). In addition, IPSEN Farmaceutica BV, the Netherlands, provided an unrestricted grant.",4_Mixed
80," Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.","Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, Jackson R, Rahneva T, Wage R, Smith G, Venneri L, Tayal U, Auger D, Midwinter W, Whiffin N, Rajani R, Dungu JN, Pantazis A, Cook SA, Ware JS, Baksi AJ, Pennell DJ, Rosen SD, Cowie MR, Cleland JGF, Prasad SK",2019-1,2019-Q1,10.1016/S0140-6736(18)32484-X,30429050,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"British Heart Foundation, Alexander Jansons Foundation, Royal Brompton Hospital and Imperial College London, Imperial College Biomedical Research Centre, Wellcome Trust, and Rosetrees Trust.",3_NonIndustryNonNIH
81, AR101 Oral Immunotherapy for Peanut Allergy.,"Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibanez MD, Tilles S, Assaad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC Jr, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernandez-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW",2018-11,2018-Q4,10.1056/NEJMoa1812856,30449234,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,Funded by Aimmune Therapeutics,1_Industry
82, Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.,"Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, OToole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J",2019-1,2019-Q1,10.1016/S0140-6736(18)32752-1,30449623,Lancet,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Cancer Research UK.,3_NonIndustryNonNIH
83," Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.","Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT",2019-1,2019-Q1,10.1016/S0140-6736(18)32779-X,30449625,Lancet,1,1,,,1,,,1,NCTN/NCORP Data Archive,0,0,,,,,,,,,,,,,,,,,,,,,"National Cancer Institute USA, Eli Lilly, and The Oral Cancer Foundation.",4_Mixed
84, Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.,"Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL, Busse PJ, Anderson J, Magerl M, Martinez-Saguer I, Davis-Lorton M, Zanichelli A, Li HH, Craig T, Jacobs J, Johnston DT, Shapiro R, Yang WH, Lumry WR, Manning ME, Schwartz LB, Shennak M, Soteres D, Zaragoza-Urdaz RH, Gierer S, Smith AM, Tachdjian R, Wedner HJ, Hebert J, Rehman SM, Staubach P, Schranz J, Baptista J, Nothaft W, Maurer M",2018-11,2018-Q4,10.1001/jama.2018.16773,30480729,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This study was funded by Dyax Corp (now Shire Human Genetic Therapies).,1_Industry
85, Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.,"Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC",2018-12,2018-Q4,10.1056/NEJMoa1812836,30501481,NEJM,1,1,1,,,,,1,NCTN/NCORP Data Archive,0,0,,,,,,,,,,,,,,,,,,,,,Funded by the National Cancer Institute and Pharmacyclics,4_Mixed
86, Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.,"Tshilolo L, Tomlinson G, Williams TN, Santos B, Olupot-Olupot P, Lane A, Aygun B, Stuber SE, Latham TS, McGann PT, Ware RE",2019-1,2019-Q1,10.1056/NEJMoa1813598,30501550,NEJM,1,1,1,,,1,,,,,,,,,1,9,1,,,,1,,,,,,,,,,,"Supported by a grant (U01 HL133883, to Dr. Ware) and a Career Development Award (K23 HL128885, to Dr. McGann) from the National Heart, Lung, and Blood Institute, by the Cincinnati Children√¢¬Ä¬ôs Research Foundation, and by Senior Research Fellowships (202800 and 091758, to Dr. Williams) from the Wellcome Trust.",4_Mixed
87, Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.,"Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS",2019-2,2019-Q1,10.1056/NEJMoa1814468,30511879,NEJM,1,1,1,,,1,,,,,,,,,1,3,1,,,,1,,,,,,,,,,,Funded by the Canadian Institutes of Health Research and Bristol-Myers Squibb-Pfizer Alliance;,4_Mixed
88, Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.,"von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wulfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr",2019-2,2019-Q1,10.1056/NEJMoa1814017,30516102,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by F. Hoffmann-La Roche/Genentech,1_Industry
89," Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial.","Naslund U, Ng N, Lundgren A, Fharm E, Gronlund C, Johansson H, Lindahl B, Lindahl B, Lindvall K, Nilsson SK, Nordin M, Nordin S, Nyman E, Rocklov J, Vanoli D, Weinehall L, Wennberg P, Wester P, Norberg M",2019-1,2019-Q1,10.1016/S0140-6736(18)32818-6,30522919,Lancet,1,1,1,,,,1,,,,,,,,1,,,,,,1,1,,,,,,,,,,"Västerbotten County Council, the Swedish Research Council, the Heart and Lung Foundation, the Swedish Society of Medicine, and Carl Bennet Ltd, Sweden.",4_Mixed
90," Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.",FOCUS Trial Collaboration.,2019-1,2019-Q1,10.1016/S0140-6736(18)32823-X,30528472,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,UK Stroke Association and NIHR Health Technology Assessment Programme.,3_NonIndustryNonNIH
91, Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.,"Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y",2018-12,2018-Q4,10.1001/jama.2018.17749,30535217,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,"This study was supported by a grant from The Kidney Foundation, Japan, which received donation from Chugai Pharmaceutical.",4_Mixed
92," Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.","Sanyal A, Charles ED, Neuschwander-Tetri BA, Loomba R, Harrison SA, Abdelmalek MF, Lawitz EJ, Halegoua-DeMarzio D, Kundu S, Noviello S, Luo Y, Christian R",2019-12,2019-Q4,10.1016/S0140-6736(18)31785-9,30554783,Lancet,1,1,,,1,,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,Bristol-Myers Squibb.,1_Industry
93, FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.,"Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Chone L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, OCallaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB",2018-12,2018-Q4,10.1056/NEJMoa1809775,30575490,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"PRODIGE (Partenariat de Recherche en Oncologie Digestive) 24 was supported by R&D Unicancer (which received a grant from Chugai Pharmaceutical), by a Clinical Research Hospital Program grant (PHRC11-006) from the French Ministry of Health and the Institut National du Cancer, and by the French National League against Cancer. The Canadian Cancer Trials Group Pancreatic Adenocarcinoma (CCTG PA.6) part of the trial was supported by a Program Grant (704970) from the Canadian Cancer Society and by grants from 7 Days in May.",4_Mixed
94," The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.","Bernitz S, Dalbye R, Zhang J, Eggebo TM, Froslie KF, Olsen IC, Blix E, Oian P",2019-1,2019-Q1,10.1016/S0140-6736(18)31991-3,30581039,Lancet,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Østfold Hospital Trust,3_NonIndustryNonNIH
95, Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.,"Wang TY, Kaltenbach LA, Cannon CP, Fonarow GC, Choudhry NK, Henry TD, Cohen DJ, Bhandary D, Khan ND, Anstrom KJ, Peterson ED",2019-1,2019-Q1,10.1001/jama.2018.19791,30620370,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This study was supported by a research grant from AstraZeneca to the Duke Clinical Research Institute.,1_Industry
96, Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.,"McCartney PJ, Eteiba H, Maznyczka AM, McEntegart M, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Ford TJ, Petrie MC, Macfarlane PW, Tait RC, Welsh P, Sattar N, Weir RA, Fox KA, Ford I, McConnachie A, Berry C",2019-1,2019-Q1,10.1001/jama.2018.19802,30620371,JAMA,1,1,1,,,,,1,University of Glasgow Robertson Centre for Biostatistics,0,0,,,,,,,,,,,,,,,,,,,,,"This work was supported by grant 12/170/45 from the NIHR EME, and Boehringer-Ingelheim provided the study drugs. Dr Maznyczka was funded by a fellowship from the British Heart Foundation (FS/16/74/32573). Drs Berry, Petrie, and Sattar are supported by grant RE/18/6/34217 from the British Heart Foundation. The research was in part supported by the NIHR infrastructure at Leeds.",4_Mixed
97, Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer.,"Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, DJourno XB, Brigand C, Perniceni T, Carrere N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G",2019-1,2019-Q1,10.1056/NEJMoa1805101,30625052,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by the French National Cancer Institute,3_NonIndustryNonNIH
98, Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.,"Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM",2019-1,2019-Q1,10.1001/jama.2018.20046,30644982,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,This study was funded by the National Health and Medical Research Council and the Gutsy Foundation.,3_NonIndustryNonNIH
99, Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.,"Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB",2019-1,2019-Q1,10.1001/jama.2018.18743,30644983,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"This study was made possible by financial support from the Danhakl family, the Cumming Foundation, the McNamara Purcell Foundation, Morgan Stanley, and the National Institute for Health Research Sheffield Clinical Research Facility. There was no industry support or pharmaceutical support for the study.",3_NonIndustryNonNIH
100, Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.,"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Batista Pereira D, Espino FEJ, Mia RZ, Chuquiyauri R, Val F, Casapia M, Monteiro WM, Brito MAM, Costa MRF, Buathong N, Noedl H, Diro E, Getie S, Wubie KM, Abdissa A, Zeynudin A, Abebe C, Tada MS, Brand F, Beck HP, Angus B, Duparc S, Kleim JP, Kellam LM, Rousell VM, Jones SW, Hardaker E, Mohamed K, Clover DD, Fletcher K, Breton JJ, Ugwuegbulam CO, Green JA, Koh GCKW",2019-1,2019-Q1,10.1056/NEJMoa1710775,30650322,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),1,1,,,,1,6,1,,,,1,,,,,,,,,,,Funded by GlaxoSmithKline and Medicines for Malaria Venture,1_Industry
101, Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.,"Llanos-Cuentas A, Lacerda MVG, Hien TT, Velez ID, Namaik-Larp C, Chu CS, Villegas MF, Val F, Monteiro WM, Brito MAM, Costa MRF, Chuquiyauri R, Casapia M, Nguyen CH, Aruachan S, Papwijitsil R, Nosten FH, Bancone G, Angus B, Duparc S, Craig G, Rousell VM, Jones SW, Hardaker E, Clover DD, Kendall L, Mohamed K, Koh GCKW, Wilches VM, Breton JJ, Green JA",2019-1,2019-Q1,10.1056/NEJMoa1802537,30650326,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),1,1,,,,1,6,1,,,,1,,,,,,,,,,,Funded by GlaxoSmithKline and Medicines for Malaria Venture,1_Industry
102, Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.,"Denis F, Basch E, Septans AL, Bennouna J, Urban T, Dueck AC, Letellier C",2019-1,2019-Q1,10.1001/jama.2018.18085,30667494,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,This study was supported by SIVAN Innovation.,1_Industry
103, Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.,"Bernaudin F, Verlhac S, Peffault de Latour R, Dalle JH, Brousse V, Petras E, Thuret I, Paillard C, Neven B, Galambrun C, Divialle-Doumdo L, Pondarre C, Guitton C, Missud F, Runel C, Jubert C, Elana G, Ducros-Miralles E, Drain E, Taieb O, Arnaud C, Kamdem A, Malric A, Elmaleh-Berges M, Vasile M, Leveille E, Socie G, Chevret S",2019-1,2019-Q1,10.1001/jama.2018.20059,30667500,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This work sponsored by the Assistance Publique-Hôpitaux de Paris was supported by an institutional grant “Programme Hospitalier de Recherche Clinique” from the French Ministry of Health. Grants from the “Cordons de Vie” association allowed cognitive testing at the 3-year follow-up. Pierre Fabre Medicament provided a grant for language revision of the manuscript.,4_Mixed
104, Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.,"Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, Alazraki A, Durelle J, Knight-Scott J, Newton KP, Cleeton R, Knott C, Konomi J, Middleton MS, Travers C, Sirlin CB, Hernandez A, Sekkarie A, McCracken C, Vos MB",2019-1,2019-Q1,10.1001/jama.2018.20579,30667502,JAMA,1,1,1,,,1,,,,,,,,,,3,1,,,,,,,,,,,,,,,"This study was supported by foundational grant funding from the Nutrition Science Initiative (made possible by gifts from the Laura and John Arnold Foundation, Ambrose Monell Foundation, and individual donors); funding from the University of California, San Diego, Altman Clinical and Translational Research Institute; grants UL1TR001442 and UL1TR002378 from the National Institutes of Health; funding from the Children's Healthcare of Atlanta and Emory University's Children's Clinical and Translational Discovery Core; funding from the Children's Healthcare of Atlanta and Emory University Pediatric Biostatistics Core; and funding from the Georgia Clinical and Translational Science Alliance.",3_NonIndustryNonNIH
105, Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.,"Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA",2019-1,2019-Q1,10.1056/NEJMoa1809983,30673543,NEJM,1,1,1,,,1,,,,,,,,,,24,,1,,,,,,,,,,,,,,"Supported by unrestricted grants from the Netherlands Organization for Health Research and Development (Dutch governmental fund for health research, project number 0-82310-97-11031), Parkinson Vereniging (Dutch patient organization), Stichting Parkinsonfonds (Dutch funding organization for Parkinson's disease research), and Stichting Parkinson Nederland (Dutch funding organization for Parkinson's disease research).",3_NonIndustryNonNIH
106," Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.","Gaudinski MR, Coates EE, Novik L, Widge A, Houser KV, Burch E, Holman LA, Gordon IJ, Chen GL, Carter C, Nason M, Sitar S, Yamshchikov G, Berkowitz N, Andrews C, Vazquez S, Laurencot C, Misasi J, Arnold F, Carlton K, Lawlor H, Gall J, Bailer RT, McDermott A, Capparelli E, Koup RA, Mascola JR, Graham BS, Sullivan NJ, Ledgerwood JE",2019-3,2019-Q1,10.1016/S0140-6736(19)30036-4,30686586,Lancet,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Vaccine Research Center, US National Institute of Allergy and Infectious Diseases, and NIH",2_NonIndustryNIH
107, Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.,"Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB",2019-2,2019-Q1,10.1001/jama.2018.21442,30688979,JAMA,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,1,1,,,,,18,,1,,,,,,,,,,,,,,"SPRINT is funded with federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke, under contract numbers HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and Inter-Agency Agreement Number A-HL-13-002-001. The study is also supported in part with resources and use of facilities through the US Department of Veterans Affairs and in part by the Intramural Research Program of the National Institute on Aging. Support for the extended follow-up visits was provided by grant R01-AG055606. The SPRINT Investigators acknowledge the contribution of study medications (azilsartan and azilsartan combined with chlorthalidone) from Takeda Pharmaceuticals International Inc and additional support from the Kulynych Family Foundation and the Oristano Family Foundation. We also acknowledge support from the following Clinical and Translational Science Awards funded by the National Center for Advancing Translational Sciences: Case Western Reserve University: UL1TR000439; Ohio State University: UL1RR025755; University of Pennsylvania: UL1RR024134 and UL1TR000003; Stanford University: UL1TR000093; Tufts Medical Center: UL1RR025752; UL1TR000073, and UL1TR001064; University of Illinois: UL1TR000050; University of Pittsburgh: UL1TR000005; University of Texas Southwestern Medical Center: 9U54TR000017-06; University of Utah: UL1TR000105-05; Vanderbilt University: UL1 TR000445; George Washington University: UL1TR000075; University of California, Davis: UL1 TR000002; University of Florida: UL1 TR000064; University of Michigan: UL1TR000433; Tulane University: P30GM103337 COBRE Award NIGMS; Wake Forest Claude Pepper Center: 2P30AG021332; and Wake Forest University Alzheimer's Disease Research Center: P30 AG049638.",2_NonIndustryNIH
108, Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.,"Onland W, Cools F, Kroon A, Rademaker K, Merkus MP, Dijk PH, van Straaten HL, Te Pas AB, Mohns T, Bruneel E, van Heijst AF, Kramer BW, Debeer A, Zonnenberg I, Marechal Y, Blom H, Plaskie K, Offringa M, van Kaam AH",2019-1,2019-Q1,10.1001/jama.2018.21443,30694322,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,This trial was funded by a project grant from the Netherlands Organization for Health Research and Development (priority medicines for children grant 11-32010-02).,3_NonIndustryNonNIH
109," Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.","Hofmeyr GJ, Betran AP, Singata-Madliki M, Cormick G, Munjanja SP, Fawcus S, Mose S, Hall D, Ciganda A, Seuc AH, Lawrie TA, Bergel E, Roberts JM, von Dadelszen P, Belizan JM",2019-1,2019-Q1,10.1016/S0140-6736(18)31818-X,30696573,Lancet,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"The University of British Columbia, a grantee of the Bill & Melinda Gates Foundation; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, WHO; the Argentina Fund for Horizontal Cooperation of the Argentinean Ministry of Foreign Affairs; and the Centre for Intervention Science in Maternal and Child Health.",3_NonIndustryNonNIH
110, A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy.,"Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, Li J, Parrott S, Sasieni P, Dawkins L, Ross L, Goniewicz M, Wu Q, McRobbie HJ",2019-2,2019-Q1,10.1056/NEJMoa1808779,30699054,NEJM,1,1,1,,,1,,,,,,,,,1,,,,,,1,,,,,,,,,,,Funded by the National Institute for Health Research and Cancer Research UK,3_NonIndustryNonNIH
111, Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.,"Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B, Gaudino M, Zamvar V, Bochenek A, Buxton B, Choong C, Clark S, Deja M, Desai J, Hasan R, Jasinski M, OKeefe P, Moraes F, Pepper J, Seevanayagam S, Sudarshan C, Trivedi U, Wos S, Puskas J, Flather M",2019-1,2019-Q1,10.1056/NEJMoa1808783,30699314,NEJM,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,"Supported by grants from the British Heart Foundation (SP/03/001), the U.K. Medical Research Council (G0200390), and the National Institute of Health Research (NIHR) Efficacy and Mechanistic Evaluation Program (09/800/29) and by a grant (to Dr. Benedetto) from the NIHR Bristol Biomedical Research Centre Cardiovascular Theme.",3_NonIndustryNonNIH
112," Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.","Miller D, Pavitt S, Sharma V, Forbes G, Hooper R, Bhattacharya S, Kirkman-Brown J, Coomarasamy A, Lewis S, Cutting R, Brison D, Pacey A, West R, Brian K, Griffin D, Khalaf Y",2019-2,2019-Q1,10.1016/S0140-6736(18)32989-1,30712901,Lancet,1,1,,1,,1,,,,,,,,,1,,,,,,1,,,,,,,,,,,National Institute for Health Research Efficacy and Mechanism Evaluation Programme,3_NonIndustryNonNIH
113, Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.,"Moller-Bisgaard S, Horslev-Petersen K, Ejbjerg B, Hetland ML, Ornbjerg LM, Glinatsi D, Moller J, Boesen M, Christensen R, Stengaard-Pedersen K, Madsen OR, Jensen B, Villadsen JA, Hauge EM, Bennett P, Hendricks O, Asmussen K, Kowalski M, Lindegaard H, Nielsen SM, Bliddal H, Krogh NS, Ellingsen T, Nielsen AH, Balding L, Jurik AG, Thomsen HS, Ostergaard M",2019-2,2019-Q1,10.1001/jama.2018.21362,30721294,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The study was supported by AbbVie. The Parker Institute, Bispebjerg and Frederiksberg Hospital (Drs Christensen, Nielsen, and Bliddal), is supported by a core grant from the Oak Foundation (OCAY-13-309).",4_Mixed
114, Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial.,"Wildes TS, Mickle AM, Ben Abdallah A, Maybrier HR, Oberhaus J, Budelier TP, Kronzer A, McKinnon SL, Park D, Torres BA, Graetz TJ, Emmert DA, Palanca BJ, Goswami S, Jordan K, Lin N, Fritz BA, Stevens TW, Jacobsohn E, Schmitt EM, Inouye SK, Stark S, Lenze EJ, Avidan MS",2019-2,2019-Q1,10.1001/jama.2018.22005,30721296,JAMA,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,"This study was funded by a National Institutes of Health grant to support pragmatic trials (1 UH2 HL125141, 5 UH3 AG050312). This study was also funded by the National Institutes of Health NIDUS Grant (NIA R24AG054259) and the Dr Seymour and Rose T. Brown Endowed Chair at Washington University.",2_NonIndustryNIH
115," Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.",RIGHT-2 Investigators.,2019-3,2019-Q1,10.1016/S0140-6736(19)30194-1,30738649,Lancet,1,1,1,,,1,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,British Heart Foundation.,3_NonIndustryNonNIH
116," Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.","Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG",2019-3,2019-Q1,10.1016/S0140-6736(19)30038-8,30739745,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"National Health and Medical Research Council of Australia; UK Stroke Association; Ministry of Health and the National Council for Scientific and Technological Development of Brazil; Ministry for Health, Welfare, and Family Affairs of South Korea; Takeda.",3_NonIndustryNonNIH
117," Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.","Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, Ullman N, Ali H, Carhuapoma JR, Kase CS, Lees KR, Dawson J, Wilson A, Betz JF, Sugar EA, Hao Y, Avadhani R, Caron JL, Harrigan MR, Carlson AP, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine MR, Patel H, Dodd R, Camarata PJ, Wolfe S, Stadnik A, Money PL, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum JS, Wang W, Anderson CS, Mendelow AD, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad IA",2019-3,2019-Q1,10.1016/S0140-6736(19)30195-3,30739747,Lancet,1,1,1,,,,,1,NINDS Archived Clinical Research Datasets,1,1,,,,1,3,1,,,,1,,,,,,,,,,,National Institute of Neurological Disorders and Stroke and Genentech.,4_Mixed
118, Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty: The PANSAID Randomized Clinical Trial.,"Thybo KH, Hagi-Pedersen D, Dahl JB, Wetterslev J, Nersesjan M, Jakobsen JC, Pedersen NA, Overgaard S, Schroder HM, Schmidt H, Bjorck JG, Skovmand K, Frederiksen R, Buus-Nielsen M, Sorensen CV, Kruuse LS, Lindholm P, Mathiesen O",2019-2,2019-Q1,10.1001/jama.2018.22039,30747964,JAMA,1,1,1,,,,,,,,,,,,1,5,1,,,,1,1,,,,,,,,,,"Funding was provided by DASAIM, Sophus Johansens Fond, Region Zealand Health Scientific Research Foundation, the local research foundation at Næstved-Slagelse-Ringsted Hospitals, the A.P. Møller Foundation for the Advancement of Medical Science, Aase og Ejnar Danielsens Fond, and the Grosserer Christian Andersen og Hustru Ingeborg Andersen, f. Schmidts legat (fund).",3_NonIndustryNonNIH
119," Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.","Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR",2019-3,2019-Q1,10.1056/NEJMoa1815671,30763142,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,1,1,,,,,,,,,,,Funded by Bayer HealthCare and Orion Pharma,1_Industry
120, Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.,"Hernandez G, Ospina-Tascon GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegria L, Teboul JL, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernandez P, Barahona D, Granda-Luna V, Cavalcanti AB, Bakker J, Hernandez G, Ospina-Tascon G, Petri Damiani L, Estenssoro E, Dubin A, Hurtado J, Friedman G, Castro R, Alegria L, Teboul JL, Cecconi M, Cecconi M, Ferri G, Jibaja M, Pairumani R, Fernandez P, Barahona D, Cavalcanti AB, Bakker J, Hernandez G, Alegria L, Ferri G, Rodriguez N, Holger P, Soto N, Pozo M, Bakker J, Cook D, Vincent JL, Rhodes A, Kavanagh BP, Dellinger P, Rietdijk W, Carpio D, Pavez N, Henriquez E, Bravo S, Valenzuela ED, Vera M, Dreyse J, Oviedo V, Cid MA, Larroulet M, Petruska E, Sarabia C, Gallardo D, Sanchez JE, Gonzalez H, Arancibia JM, Munoz A, Ramirez G, Aravena F, Aquevedo A, Zambrano F, Bozinovic M, Valle F, Ramirez M, Rossel V, Munoz P, Ceballos C, Esveile C, Carmona C, Candia E, Mendoza D, Sanchez A, Ponce D, Ponce D, Lastra J, Nahuelpan B, Fasce F, Luengo C, Medel N, Cortes C, Campassi L, Rubatto P, Horna N, Furche M, Pendino JC, Bettini L, Lovesio C, Gonzalez MC, Rodruguez J, Canales H, Caminos F, Galletti C, Minoldo E, Aramburu MJ, Olmos D, Nin N, Tenzi J, Quiroga C, Lacuesta P, Gaudin A, Pais R, Silvestre A, Olivera G, Rieppi G, Berrutti D, Ochoa M, Cobos P, Vintimilla F, Ramirez V, Tobar M, Garcia F, Picoita F, Remache N, Granda V, Paredes F, Barzallo E, Garces P, Guerrero F, Salazar S, Torres G, Tana C, Calahorrano J, Solis F, Torres P, Herrera L, Ornes A, Perez V, Delgado G, Lopez A, Espinosa E, Moreira J, Salcedo B, Villacres I, Suing J, Lopez M, Gomez L, Toctaquiza G, Cadena Zapata M, Orazabal MA, Pardo Espejo R, Jimenez J, Calderon A, Paredes G, Barberan JL, Moya T, Atehortua H, Sabogal R, Ortiz G, Lara A, Sanchez F, Hernan Portilla A, Davila H, Mora JA, Calderon LE, Alvarez I, Escobar E, Bejarano A, Bustamante LA, Aldana JL",2019-2,2019-Q1,10.1001/jama.2019.0071,30772908,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,This study received logistic support from the Pontificia Universidad Católica of Chile.,3_NonIndustryNonNIH
121, Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.,"Beitler JR, Sarge T, Banner-Goodspeed VM, Gong MN, Cook D, Novack V, Loring SH, Talmor D",2019-3,2019-Q1,10.1001/jama.2019.0555,30776290,JAMA,1,1,1,,,1,,,,,,,,,1,10,1,,,,1,,,,,,,,,,,"This study was funded by the US National Heart, Lung, and Blood Institute (grant UM1-HL108724).",2_NonIndustryNIH
122, Effect of a Nurse-Led Preventive Psychological Intervention on Symptoms of Posttraumatic Stress Disorder Among Critically Ill Patients: A Randomized Clinical Trial.,"Wade DM, Mouncey PR, Richards-Belle A, Wulff J, Harrison DA, Sadique MZ, Grieve RD, Emerson LM, Mason AJ, Aaronovitch D, Als N, Brewin CR, Harvey SE, Howell DCJ, Hudson N, Mythen MG, Smyth D, Weinman J, Welch J, Whitman C, Rowan KM",2019-2,2019-Q1,10.1001/jama.2019.0073,30776295,JAMA,1,1,1,,,1,,,,,,,,,1,22,,1,,,1,,,,,,,,,,,This project was funded by the NIHR Health Services and Delivery Research (HS&DR) Programme (project No.: 12/64/124).,3_NonIndustryNonNIH
123, Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery: The DEXACET Randomized Clinical Trial.,"Subramaniam B, Shankar P, Shaefi S, Mueller A, OGara B, Banner-Goodspeed V, Gallagher J, Gasangwa D, Patxot M, Packiasabapathy S, Mathur P, Eikermann M, Talmor D, Marcantonio ER",2019-2,2019-Q1,10.1001/jama.2019.0234,30778597,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"The study was funded by Mallinckrodt Pharmaceuticals: funds were allotted to support time and effort of study personnel, sample acquisition, processing, storage, and regulatory compliance and to assist in paying for the study drugs and placebo.",1_Industry
124, Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults.,"Casey JD, Janz DR, Russell DW, Vonderhaar DJ, Joffe AM, Dischert KM, Brown RM, Zouk AN, Gulati S, Heideman BE, Lester MG, Toporek AH, Bentov I, Self WH, Rice TW, Semler MW",2019-2,2019-Q1,10.1056/NEJMoa1812405,30779528,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Supported by grants (UL1 TR000445 and UL1TR002243) from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), to the Vanderbilt Institute for Clinical and Translational Research. Dr. Casey was supported, in part, by a grant (2T32HL087738-12) from the NIH; Dr. Semler, by grants (K12HL133117 and K23HL143053) from the National Heart, Lung, and Blood Institute (NHLBI); Dr. Russell, by a grant (T32HL105346-07) from the NHLBI; and Dr. Rice, by a grant (R34HL105869) from the NIH.",2_NonIndustryNIH
125, Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.,"Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulieres D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T",2019-3,2019-Q1,10.1056/NEJMoa1816714,30779529,NEJM,1,1,1,,,,,,,,,1,,,1,,,,,1,1,,,,,,,,,,,Funded by Merck Sharp & Dohme,1_Industry
126, Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis.,"Arabi YM, Al-Hameed F, Burns KEA, Mehta S, Alsolamy SJ, Alshahrani MS, Mandourah Y, Almekhlafi GA, Almaani M, Al Bshabshe A, Finfer S, Arshad Z, Khalid I, Mehta Y, Gaur A, Hawa H, Buscher H, Lababidi H, Al Aithan A, Abdukahil SAI, Jose J, Afesh LY, Al-Dawood A",2019-4,2019-Q2,10.1056/NEJMoa1816150,30779530,NEJM,1,1,1,,,1,,,,,,,,,1,,,,,,1,,,,,,,,,,,Funded by King Abdulaziz City for Science and Technology and King Abdullah International Medical Research Center,3_NonIndustryNonNIH
127, Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.,"Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, Lee JL, Vasiliev A, Miller WH Jr, Gurney H, Schmidinger M, Larkin J, Atkins MB, Bedke J, Alekseev B, Wang J, Mariani M, Robbins PB, Chudnovsky A, Fowst C, Hariharan S, Huang B, di Pietro A, Choueiri TK",2019-3,2019-Q1,10.1056/NEJMoa1816047,30779531,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,Funded by Pfizer and Merck,1_Industry
128," Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial.","McCann ME, de Graaff JC, Dorris L, Disma N, Withington D, Bell G, Grobler A, Stargatt R, Hunt RW, Sheppard SJ, Marmor J, Giribaldi G, Bellinger DC, Hartmann PL, Hardy P, Frawley G, Izzo F, von Ungern Sternberg BS, Lynn A, Wilton N, Mueller M, Polaner DM, Absalom AR, Szmuk P, Morton N, Berde C, Soriano S, Davidson AJ",2019-2,2019-Q1,10.1016/S0140-6736(18)32485-1,30782342,Lancet,1,1,1,,,1,1,,,,,,,,1,6,1,,,,1,,,,,,,,,,,"US National Institutes of Health, US Food and Drug Administration, Thrasher Research Fund, Australian National Health and Medical Research Council, Health Technologies Assessment-National Institute for Health Research (UK), Australian and New Zealand College of Anaesthetists, Murdoch Children's Research Institute, Canadian Institutes of Health Research, Canadian Anesthesiologists Society, Pfizer Canada, Italian Ministry of Health, Fonds NutsOhra, UK Clinical Research Network, Perth Children's Hospital Foundation, the Stan Perron Charitable Trust, and the Callahan Estate",4_Mixed
129, Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.,"Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, OReilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH",2019-2,2019-Q1,10.1056/NEJMoa1814630,30786186,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,,,,,,,,,,,,,,,,,,"Supported by Janssen, Bayer, and the Sondra and Stephen Hardis Chair in Oncology Research (to Dr. Khorana), by grants (U01HL143402 and R34 HL127156, to Dr. Khorana) from the National Heart, Lung, and Blood Institute, and by the Cleveland Clinic Center of Excellence for Cancer-Associated Thrombosis (to Dr. Khorana) and the Porter Family Fund (to Dr. Khorana).",4_Mixed
130, Once-Daily Plazomicin for Complicated Urinary Tract Infections.,"Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP",2019-2,2019-Q1,10.1056/NEJMoa1801467,30786187,NEJM,1,1,1,,,,,,,,,1,,,1,12,1,,,,1,,,,,,,,,,,Funded by Achaogen and the Biomedical Advanced Research and Development Authority,4_Mixed
131, Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.,"Bardia A, Mayer IA, Vahdat LT, Tolaney SM, Isakoff SJ, Diamond JR, OShaughnessy J, Moroose RL, Santin AD, Abramson VG, Shah NC, Rugo HS, Goldenberg DM, Sweidan AM, Iannone R, Washkowitz S, Sharkey RM, Wegener WA, Kalinsky K",2019-2,2019-Q1,10.1056/NEJMoa1814213,30786188,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Immunomedics,1_Industry
132," Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","Haight BR, Learned SM, Laffont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Ling W, Heidbreder C",2019-2,2019-Q1,10.1016/S0140-6736(18)32259-1,30792007,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Indivior,1_Industry
133, Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.,"Fleischer DM, Greenhawt M, Sussman G, Begin P, Nowak-Wegrzyn A, Petroni D, Beyer K, Brown-Whitehorn T, Hebert J, Hourihane JO, Campbell DE, Leonard S, Chinthrajah RS, Pongracic JA, Jones SM, Lange L, Chong H, Green TD, Wood R, Cheema A, Prescott SL, Smith P, Yang W, Chan ES, Byrne A, Assaad A, Bird JA, Kim EH, Schneider L, Davis CM, Lanser BJ, Lambert R, Shreffler W",2019-3,2019-Q1,10.1001/jama.2019.1113,30794314,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,The study was sponsored by DBV Technologies and conducted under an Investigational New Drug application to the US FDA and Clinical Trial Approvals in Canada and European countries.,1_Industry
134, Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial.,"Van Spall HGC, Lee SF, Xie F, Oz UE, Perez R, Mitoff PR, Maingi M, Tjandrawidjaja MC, Heffernan M, Zia MI, Porepa L, Panju M, Thabane L, Graham ID, Haynes RB, Haughton D, Simek KD, Ko DT, Connolly SJ",2019-2,2019-Q1,10.1001/jama.2019.0710,30806695,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,"This study was funded by peer-reviewed grants held by Dr Van Spall from the Canadian Institutes of Health Research (135917) and Ontario Ministry of Health and Long Term Care (MOHLTC) Health System Research Fund (6686), as well as in-kind support from the participating hospitals and Community Care Access Centers and from Roche Diagnostics.",3_NonIndustryNonNIH
135," Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.","Bergenstal RM, Johnson M, Passi R, Bhargava A, Young N, Kruger DF, Bashan E, Bisgaier SG, Isaman DJM, Hodish I",2019-3,2019-Q1,10.1016/S0140-6736(19)30368-X,30808512,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"US National Institutes of Health, National Institute of Digestive and Kidney Diseases.",2_NonIndustryNIH
136, A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.,"Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, Kim JW, Raspagliesi F, Lampe B, Aletti G, Meier W, Cibula D, Mustea A, Mahner S, Runnebaum IB, Schmalfeldt B, Burges A, Kimmig R, Scambia G, Greggi S, Hilpert F, Hasenburg A, Hillemanns P, Giorda G, von Leffern I, Schade-Brittinger C, Wagner U, du Bois A",2019-2,2019-Q1,10.1056/NEJMoa1808424,30811909,NEJM,1,1,1,,,,1,,,,,,,,1,6,1,,,,1,,,,,,,,,,,Funded by Deutsche Forschungsgemeinschaft and the Austrian Science Fund;,3_NonIndustryNonNIH
137, Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.,"Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E, Tonino P, Hofma S, Zurakowski A, Smits PC, Prokopczuk J, Moreno R, Choudhury A, Petrov I, Cequier A, Kukreja N, Hoye A, Iniguez A, Ungi I, Serra A, Gil RJ, Walsh S, Tonev G, Mathur A, Merkely B, Colombo A, Ijsselmuiden S, Soliman O, Kaul U, Onuma Y, Serruys PW",2019-3,2019-Q1,10.1016/S0140-6736(18)32467-X,30827782,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The trial was designed by the principal investigators, sponsored by the European Cardiovascular Research Institute (ECRI), and supported with an unrestricted grant from SMT (India).",4_Mixed
138," Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.","Wei D, Liu JY, Sun Y, Shi Y, Zhang B, Liu JQ, Tan J, Liang X, Cao Y, Wang Z, Qin Y, Zhao H, Zhou Y, Ren H, Hao G, Ling X, Zhao J, Zhang Y, Qi X, Zhang L, Deng X, Chen X, Zhu Y, Wang X, Tian LF, Lv Q, Ma X, Zhang H, Legro RS, Chen ZJ",2019-3,2019-Q1,10.1016/S0140-6736(18)32843-5,30827784,Lancet,1,1,1,,,1,1,,,,,,,,,,,,,,,1,,,,,,,,,,The National Key Research and Development Program of China.,3_NonIndustryNonNIH
139, Effect of Multinutrient Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive Symptoms: The MooDFOOD Randomized Clinical Trial.,"Bot M, Brouwer IA, Roca M, Kohls E, Penninx BWJH, Watkins E, van Grootheest G, Cabout M, Hegerl U, Gili M, Owens M, Visser M",2019-3,2019-Q1,10.1001/jama.2019.0556,30835307,JAMA,1,1,,,1,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Funding for this article was provided by the European Union FP7 MooDFOOD Project Multi-country Collaborative Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression (grant agreement 613598). This work is supported in the United Kingdom by the National Institute for Health Research (NIHR), through the Primary Care Research Network and the NIHR Exeter Clinical Research Facility.",3_NonIndustryNonNIH
140, Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: The RAINBOW Randomized Clinical Trial.,"Ma J, Rosas LG, Lv N, Xiao L, Snowden MB, Venditti EM, Lewis MA, Goldhaber-Fiebert JD, Lavori PW",2019-3,2019-Q1,10.1001/jama.2019.0557,30835308,JAMA,1,1,1,,,,,,,,,,,1,1,9,1,,,,1,,,,,,,,,,,"This research was supported by award R01HL119453 from the National Heart, Lung, and Blood Institute and internal funding from the Palo Alto Medical Foundation Research Institute and the University of Illinois, Chicago.",4_Mixed
141, Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.,"Balducci S, DErrico V, Haxhi J, Sacchetti M, Orlando G, Cardelli P, Vitale M, Bollanti L, Conti F, Zanuso S, Lucisano G, Nicolucci A, Pugliese G",2019-3,2019-Q1,10.1001/jama.2019.0922,30835309,JAMA,1,1,1,,,1,,,,,,,,,1,9,1,,,,1,,,,,,,,,,,"This work was supported by the Metabolic Fitness Association, Monterotondo, Rome, Italy.",3_NonIndustryNonNIH
142, Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.,"Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Heim L, Gombosev A, Avery TR, Haffenreffer K, Shimelman L, Hayden MK, Weinstein RA, Spencer-Smith C, Kaganov RE, Murphy MV, Forehand T, Lankiewicz J, Coady MH, Portillo L, Sarup-Patel J, Jernigan JA, Perlin JB, Platt R",2019-3,2019-Q1,10.1016/S0140-6736(18)32593-5,30850112,Lancet,1,1,1,,,,,1,HCA Healthcare data enclave,1,1,,,,1,36,,,1,,1,,,,,,,,,,,National Institutes of Health.,2_NonIndustryNIH
143," Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.","Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L, Poghosyan T, Chevallier JM, Malherbe V, Chouillard E, Reche F, Torcivia A, Maucort-Boulch D, Bin-Dorel S, Langlois-Jacques C, Delaunay D, Pattou F, Disse E",2019-3,2019-Q1,10.1016/S0140-6736(19)30475-1,30851879,Lancet,1,1,1,,,1,,,,,,,,,1,3,1,,,,1,,,,,,,,,,,French Ministry of Health.,3_NonIndustryNonNIH
144," Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.","Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A",2019-3,2019-Q1,10.1016/S0140-6736(18)32003-8,30853151,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Japan Agency for Medical Research and Development (grant CCT-B-2503).,3_NonIndustryNonNIH
145, Patient Safety Outcomes under Flexible and Standard Resident Duty-Hour Rules.,"Silber JH, Bellini LM, Shea JA, Desai SV, Dinges DF, Basner M, Even-Shoshan O, Hill AS, Hochman LL, Katz JT, Ross RN, Shade DM, Small DS, Sternberg AL, Tonascia J, Volpp KG, Asch DA",2019-3,2019-Q1,10.1056/NEJMoa1810642,30855740,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,"Funded by the National Heart, Lung, and Blood Institute and Accreditation Council for Graduate Medical Education",4_Mixed
146, Sleep and Alertness in a Duty-Hour Flexibility Trial in Internal Medicine.,"Basner M, Asch DA, Shea JA, Bellini LM, Carlin M, Ecker AJ, Malone SK, Desai SV, Sternberg AL, Tonascia J, Shade DM, Katz JT, Bates DW, Even-Shoshan O, Silber JH, Small DS, Volpp KG, Mott CG, Coats S, Mollicone DJ, Dinges DF",2019-3,2019-Q1,10.1056/NEJMoa1810641,30855741,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,"Funded by the National Heart, Lung, and Blood Institute and American Council for Graduate Medical Education;",4_Mixed
147, Randomized Trial of Four Treatment Approaches for Actinic Keratosis.,"Jansen MHE, Kessels JPHM, Nelemans PJ, Kouloubis N, Arits AHMM, van Pelt HPA, Quaedvlieg PJF, Essers BAB, Steijlen PM, Kelleners-Smeets NWJ, Mosterd K",2019-3,2019-Q1,10.1056/NEJMoa1811850,30855743,NEJM,1,1,,,1,1,,,,,,,,,1,24,,1,,,1,,,,,,,,,,,Funded by the Netherlands Organization for Health Research and Development,3_NonIndustryNonNIH
148," Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.","Wesson DE, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E, Klaerner G, Bushinsky DA",2019-4,2019-Q2,10.1016/S0140-6736(18)32562-5,30857647,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Tricida,1_Industry
149," Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial.","Turk AS 3rd, Siddiqui A, Fifi JT, De Leacy RA, Fiorella DJ, Gu E, Levy EI, Snyder KV, Hanel RA, Aghaebrahim A, Woodward BK, Hixson HR, Chaudry MI, Spiotta AM, Rai AT, Frei D, Almandoz JED, Kelly M, Arthur A, Baxter B, English J, Linfante I, Fargen KM, Mocco J",2019-3,2019-Q1,10.1016/S0140-6736(19)30297-1,30860055,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,Penumbra,1_Industry
150, High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years.,"Brustad N, Eliasen AU, Stokholm J, Bonnelykke K, Bisgaard H, Chawes BL",2019-3,2019-Q1,10.1001/jama.2019.0052,30860552,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) is funded by private and public research funds listed on http://www.copsac.com/. The Lundbeck Foundation, Danish State Budget, Danish Council for Strategic Research, Danish Council for Independent Research, and The Capital Region Research Foundation have provided core support for COPSAC.",3_NonIndustryNonNIH
151, A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.,"Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, van Deun A, Dat PT, Lan N, Master I, Mebrahtu T, Meressa D, Moodliar R, Ngubane N, Sanders K, Squire SB, Torrea G, Tsogt B, Rusen ID",2019-3,2019-Q1,10.1056/NEJMoa1811867,30865791,NEJM,1,1,1,,,1,,,,,,,,,1,24,,1,,,1,,,,,,,,,,,"Supported by the U.S. Agency for International Development (USAID), with additional funding from the United Kingdom Medical Research Council (MRC) and the United Kingdom Department for International Development (DFID) under the MRC/DFID Concordat agreement. The MRC Clinical Trials Unit at UCL is supported by the MRC (program number MC_UU_12023/26).",3_NonIndustryNonNIH
152, A Randomized Trial of Prophylactic Antibiotics for Miscarriage Surgery.,"Lissauer D, Wilson A, Hewitt CA, Middleton L, Bishop JRB, Daniels J, Merriel A, Weeks A, Mhango C, Mataya R, Taulo F, Ngalawesa T, Chirwa A, Mphasa C, Tambala T, Chiudzu G, Mwalwanda C, Mboma A, Qureshi R, Ahmed I, Ismail H, Oladapo OT, Mbaruku G, Chibwana J, Watts G, Simon B, Ditai J, Otim Tom C, Acam J, Ekunait J, Unzia H, Iyaku M, Makiika JJ, Zamora J, Roberts T, Goranitis I, Bar-Zeev S, Desmond N, Arulkumaran S, Bhutta ZA, Gulmezoglu AM, Coomarasamy A",2019-3,2019-Q1,10.1056/NEJMoa1808817,30865795,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Supported by the Joint Global Health Trials Scheme of the Medical Research Council, the U.K. Department for International Development, and the Wellcome Trust.",3_NonIndustryNonNIH
153, Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.,"Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM",2019-3,2019-Q1,10.1056/NEJMoa1803917,30865796,NEJM,1,1,,,1,,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,Supported by Esperion Therapeutics and the NIHR Imperial Biomedical Research Centre.,4_Mixed
154, Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.,"Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, Lee KL, Packer DL",2019-4,2019-Q2,10.1001/jama.2019.0692,30874716,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,"Supported by grants U01HL89709, U01HL089786, U01HL089907 and U01HL089645 from the National Heart, Lung, and Blood Institute, St Jude Foundation and Corporation, Biosense Webster Inc, Medtronic Inc, Boston Scientific Corporation, and Mayo Clinic.",4_Mixed
155, Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.,"Blomstrom-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kenneback G, Rubulis A, Malmborg H, Raatikainen P, Lonnerholm S, Hoglund N, Mortsell D",2019-3,2019-Q1,10.1001/jama.2019.0335,30874754,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,"The study received unrestricted grants from the Swedish Heart-Lung Foundation (20150751), the Swedish Research Council (2014-36708-117759-70), and Medtronic AB.",4_Mixed
156," Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.","Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL",2019-4,2019-Q2,10.1001/jama.2019.0693,30874766,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"This research was funded by awards from the NIH. Dr Packer was supported by NIH grant U01HL089709. Dr Lee was supported by NIH grant U01HL089786. Dr Mark was supported by NIH grant U01HL089907. Dr Robb was supported by NIH grant U01HL089645. This research was also funded by St Jude Medical Foundation and Corporation, Biosense Webster Inc, Medtronic Inc, and Boston Scientific Corp.",4_Mixed
157, Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.,"Foy BD, Alout H, Seaman JA, Rao S, Magalhaes T, Wade M, Parikh S, Soma DD, Sagna AB, Fournet F, Slater HC, Bougma R, Drabo F, Diabate A, Coulidiaty AGV, Rouamba N, Dabire RK",2019-4,2019-Q2,10.1016/S0140-6736(18)32321-3,30878222,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,Bill & Melinda Gates Foundation.,3_NonIndustryNonNIH
158," Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial.","He M, Jiang Y, Huang S, Chang DS, Munoz B, Aung T, Foster PJ, Friedman DS",2019-4,2019-Q2,10.1016/S0140-6736(18)32607-2,30878226,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Fight for Sight, the Sun Yat-Sen University 5010 Project Fund, Moorfields Eye Charity, and the National Natural Science Foundation of China.",3_NonIndustryNonNIH
159, Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers.,"Bhatt DL, Pollack CV, Weitz JI, Jennings LK, Xu S, Arnold SE, Umstead BR, Mays MC, Lee JS",2019-5,2019-Q2,10.1056/NEJMoa1901778,30883047,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,Funded by PhaseBio Pharmaceuticals,1_Industry
160, Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.,"Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, Kramer N, Barasa F, Damasceno A, Dzudie A, Jones E, Mondo C, Ogah O, Ogola E, Sani MU, Shedul GL, Shedul G, Rayner B, Okpechi IG, Sliwa K, Poulter N",2019-6,2019-Q2,10.1056/NEJMoa1901113,30883050,NEJM,1,1,1,,,,1,,,,,,,,1,48,,,1,,1,,,,,,,,,,,Funded by GlaxoSmithKline Africa Noncommunicable Disease Open Lab,4_Mixed
161, A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.,"Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ",2019-4,2019-Q2,10.1056/NEJMoa1900486,30883052,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Abbott,1_Industry
162, Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.,"Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, OHair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchetche D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ",2019-5,2019-Q2,10.1056/NEJMoa1816885,30883053,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Medtronic,1_Industry
163, Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation.,"Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, Meeder JG, Lenderink T, Widdershoven J, Bucx JJJ, Rienstra M, Kamp O, Van Opstal JM, Alings M, Oomen A, Kirchhof CJ, Van Dijk VF, Ramanna H, Liem A, Dekker LR, Essers BAB, Tijssen JGP, Van Gelder IC, Crijns HJGM",2019-4,2019-Q2,10.1056/NEJMoa1900353,30883054,NEJM,1,1,1,,,1,,,,,,,,,1,9,1,,,,1,1,,,,,,,,,,Supported by a grant (837002524) from the Netherlands Organization for Health Research and Development–Health Care Efficiency Research Program and by the Maastricht University Medical Center. Boehringer Ingelheim provided some of the remote monitoring devices.,3_NonIndustryNonNIH
164, Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.,"Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH",2019-4,2019-Q2,10.1056/NEJMoa1817083,30883055,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Bristol-Myers Squibb and Pfizer,1_Industry
165, Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.,"Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL",2019-5,2019-Q2,10.1056/NEJMoa1901111,30883056,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Medtronic,1_Industry
166, Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.,"Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van de Ven PM, Oudemans-van Straaten HM, van Royen N",2019-4,2019-Q2,10.1056/NEJMoa1816897,30883057,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The trial was sponsored by the Netherlands Heart Institute, Biotronik, and AstraZeneca. The sponsors of the trial had no role in the design or monitoring of the trial; the selection of the participating centers; the enrollment of participants; the collection, recording, storage, retention, or analysis of the data; the writing of the manuscript; or the decision to submit the manuscript for publication.",4_Mixed
167, Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.,"Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR",2019-5,2019-Q2,10.1056/NEJMoa1814052,30883058,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Edwards Lifesciences,1_Industry
168, Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.,"Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N, Lembo R, Gazivoda G, Likhvantsev VV, Lei C, Lozovskiy A, Di Tomasso N, Bukamal NAR, Silva FS, Bautin AE, Ma J, Crivellari M, Farag AMGA, Uvaliev NS, Carollo C, Pieri M, Kunstyr J, Wang CY, Belletti A, Hajjar LA, Grigoryev EV, Agro FE, Riha H, El-Tahan MR, Scandroglio AM, Elnakera AM, Baiocchi M, Navalesi P, Shmyrev VA, Severi L, Hegazy MA, Crescenzi G, Ponomarev DN, Brazzi L, Arnoni R, Tarasov DG, Jovic M, Calabro MG, Bove T, Bellomo R, Zangrillo A",2019-3,2019-Q1,10.1056/NEJMoa1816476,30888743,NEJM,1,1,1,,,1,,,,,,,,,1,9,1,,,,1,,,,,,,,,,,Funded by the Italian Ministry of Health,3_NonIndustryNonNIH
169, Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.,"van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV",2019-3,2019-Q1,10.1056/NEJMoa1813865,30893534,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,Funded by Leiden University Medical Center and 17 other participating hospitals,3_NonIndustryNonNIH
170, Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.,"Rosenstock J, Allison D, Birkenfeld AL, Blicher TM, Deenadayalan S, Jacobsen JB, Serusclat P, Violante R, Watada H, Davies M",2019-4,2019-Q2,10.1001/jama.2019.2942,30903796,JAMA,1,1,1,,,,,,,,,1,,,1,105,,,1,,1,,,,,,,,,,,This trial was funded by Novo Nordisk A/S.,1_Industry
171, Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception.,"Dhillon-Smith RK, Middleton LJ, Sunner KK, Cheed V, Baker K, Farrell-Carver S, Bender-Atik R, Agrawal R, Bhatia K, Edi-Osagie E, Ghobara T, Gupta P, Jurkovic D, Khalaf Y, MacLean M, McCabe C, Mulbagal K, Nunes N, Overton C, Quenby S, Rai R, Raine-Fenning N, Robinson L, Ross J, Sizer A, Small R, Tan A, Underwood M, Kilby MD, Boelaert K, Daniels J, Thangaratinam S, Chan SY, Coomarasamy A",2019-4,2019-Q2,10.1056/NEJMoa1812537,30907987,NEJM,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the United Kingdom National Institute for Health Research,3_NonIndustryNonNIH
172," Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.","Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, Opira B, Ochokoru H, Ategeka J, Nayebare P, Clark TD, Havlir DV, Kamya MR, Dorsey G",2019-4,2019-Q2,10.1016/S0140-6736(18)32224-4,30910321,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Bill & Melinda Gates Foundation.",4_Mixed
173, Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.,"Kirpalani H, Ratcliffe SJ, Keszler M, Davis PG, Foglia EE, Te Pas A, Fernando M, Chaudhary A, Localio R, van Kaam AH, Onland W, Owen LS, Schmolzer GM, Katheria A, Hummler H, Lista G, Abbasi S, Klotz D, Simma B, Nadkarni V, Poulain FR, Donn SM, Kim HS, Park WS, Cadet C, Kong JY, Smith A, Guillen U, Liley HG, Hopper AO, Tamura M",2019-3,2019-Q1,10.1001/jama.2019.1660,30912836,JAMA,1,1,1,,,1,1,,,,,,,,1,22,,1,,,1,1,,,,,,,,,,"The trial was funded by the NICHD (grant 1-U01-HD072906-01A1). Fisher & Paykel Healthcare (Auckland, New Zealand) donated masks for the study at some sites.",2_NonIndustryNIH
174, Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.,"Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ, Acker MA, Selzman CH, Soltesz EG, Kern JA, Maltais S, Charbonneau E, Pan S, Marks ME, Moquete EG, OSullivan KL, Taddei-Peters WC, McGowan LK, Green C, Rose EA, Jeffries N, Parides MK, Weisel RD, Miller MA, Hung J, OGara PT, Moskowitz AJ, Gelijns AC, Bagiella E, Milano CA",2019-3,2019-Q1,10.1001/jama.2019.2341,30912838,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,"The trial was supported by a cooperative agreement (U01 HL088942) funded by the National Heart, Lung, and Blood Institute and the National Institutes of Neurological Disorders and Stroke, of the National Institutes of Health (NIH), and the Canadian Institutes for Health Research. Mesoblast provided no financial support but did provide study product (MPCs and control).",4_Mixed
175, Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.,"Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Linden HH, Livingston RB, Hortobagyi GN",2019-3,2019-Q1,10.1056/NEJMoa1811714,30917258,NEJM,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,Funded by the National Cancer Institute and AstraZeneca,4_Mixed
176," Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study.","Ye BD, Pesegova M, Alexeeva O, Osipenko M, Lahat A, Dorofeyev A, Fishman S, Levchenko O, Cheon JH, Scribano ML, Mateescu RB, Lee KM, Eun CS, Lee SJ, Lee SY, Kim H, Schreiber S, Fowler H, Cheung R, Kim YH",2019-4,2019-Q2,10.1016/S0140-6736(18)32196-2,30929895,Lancet,1,1,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Celltrion, Pfizer.",1_Industry
177, Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.,"Hyams JS, Davis Thomas S, Gotman N, Haberman Y, Karns R, Schirmer M, Mo A, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo PA, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis MA, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Saul B, Wang J, Serrano J, Hommel K, Marigorta UM, Gibson G, Xavier RJ, Kugathasan S, Walters T, Denson LA",2019-4,2019-Q2,10.1016/S0140-6736(18)32592-3,30935734,Lancet,1,1,,,1,,,1,NIDDK Central Repository,1,1,,,,,,,,,,,,,,,,,,,,,US National Institutes of Health,2_NonIndustryNIH
178," Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.","Masa JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, Sanchez-Quiroga MA, Romero A, Caballero-Eraso C, Teran-Santos J, Alonso-Alvarez ML, Troncoso MF, Gonzalez M, Lopez-Martin S, Marin JM, Marti S, Diaz-Cambriles T, Chiner E, Egea C, Barca J, Vazquez-Polo FJ, Negrin MA, Martel-Escobar M, Barbe F, Corral J",2019-4,2019-Q2,10.1016/S0140-6736(18)32978-7,30935737,Lancet,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Instituto de Salud Carlos III, Spanish Respiratory Foundation, and Air Liquide Spain.",4_Mixed
179, Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.,"Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, Magee T, Piligian B, Yoon P, Ellis JH, Sun X, Panch SR, Powers A, Alao H, Kumar S, Quezado M, Yan L, Lee N, Kolbeck R, Newbold P, Goldman M, Fay MP, Khoury P, Maric I, Klion AD",2019-4,2019-Q2,10.1056/NEJMoa1812185,30943337,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by the National Institute of Allergy and Infectious Diseases,2_NonIndustryNIH
180, Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.,"Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, Coppolino A, Kusztos AE, Johnson ME, Chen K, Haddad EA, Fanikos J, Harrington DP, Camp PC, Baden LR",2019-4,2019-Q2,10.1056/NEJMoa1812406,30946553,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Supported in part by the Mendez National Institute of Transplantation Foundation, Brigham and Women's Hospital, and a grant (no. 1UL1TR002541-01) from the National Center for Advancing Translational Sciences to the Harvard Clinical and Translational Science Center.",3_NonIndustryNonNIH
181," Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.","Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, Shennan AH, Chappell LC",2019-5,2019-Q2,10.1016/S0140-6736(18)33212-4,30948284,Lancet,1,1,,,1,1,,,,,,,,,1,,,,,,1,,,,,,,,,,,National Institute for Health Research.,3_NonIndustryNonNIH
182," Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.","Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G",2019-5,2019-Q2,10.1016/S0140-6736(18)32409-7,30955977,Lancet,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme,1_Industry
183, Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.,"Urashima M, Ohdaira H, Akutsu T, Okada S, Yoshida M, Kitajima M, Suzuki Y",2019-4,2019-Q2,10.1001/jama.2019.2210,30964526,JAMA,1,1,1,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,"This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities, funding from the International University of Health and Welfare Hospital, and Jikei University School of Medicine.",3_NonIndustryNonNIH
184, Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.,"Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, Rubinson DA, Schrag D, Miksad R, Bullock AJ, Allen J, Zuckerman D, Chan E, Chan JA, Wolpin BM, Constantine M, Weckstein DJ, Faggen MA, Thomas CA, Kournioti C, Yuan C, Ganser C, Wilkinson B, Mackintosh C, Zheng H, Hollis BW, Meyerhardt JA, Fuchs CS",2019-4,2019-Q2,10.1001/jama.2019.2402,30964527,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,1,"This study was supported by grants P50CA127003, R01CA205406, R01CA118553 from the National Institutes of Health, National Cancer Institute. Additional funding was provided by the Gloria Spivak Faculty Advancement Award, Friends of Dana-Farber Cancer Institute Award, Project P Fund, Consano, Pharmavite LLC, and Genentech. Pharmavite provided the vitamin D3 and placebo capsules for the study.",4_Mixed
185, Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.,"Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, Mo Y, Sur C, Michelson D",2019-4,2019-Q2,10.1056/NEJMoa1812840,30970186,NEJM,1,1,1,,,,,,,,,1,,,1,,,,,1,1,,,,,,,,,,,Funded by Merck Sharp & Dohme,1_Industry
186," Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.","Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, Lindig U, Schmiegel W, Pohl M, Stoehlmacher J, Folprecht G, Probst S, Prasnikar N, Fischbach W, Mahlberg R, Trojan J, Koenigsmann M, Martens UM, Thuss-Patience P, Egger M, Block A, Heinemann V, Illerhaus G, Moehler M, Schenk M, Kullmann F, Behringer DM, Heike M, Pink D, Teschendorf C, Lohr C, Bernhard H, Schuch G, Rethwisch V, von Weikersthal LF, Hartmann JT, Kneba M, Daum S, Schulmann K, Weniger J, Belle S, Gaiser T, Oduncu FS, Guntner M, Hozaeel W, Reichart A, Jager E, Kraus T, Monig S, Bechstein WO, Schuler M, Schmalenberg H, Hofheinz RD",2019-5,2019-Q2,10.1016/S0140-6736(18)32557-1,30982686,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The German Cancer Aid (Deutsche Krebshilfe), Sanofi-Aventis, Chugai, and Stiftung Leben mit Krebs Foundation.",4_Mixed
187," Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.","Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman GS, Warner A, Senan S",2019-5,2019-Q2,10.1016/S0140-6736(18)32487-5,30982687,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,Ontario Institute for Cancer Research and London Regional Cancer Program Catalyst Grant.,3_NonIndustryNonNIH
188, Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.,"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW",2019-6,2019-Q2,10.1056/NEJMoa1811744,30990260,NEJM,1,1,1,,,,,1,The Yale Open Data Access (YODA) Project,0,0,,,,1,,,,,1,1,,,,,,,,,,,Funded by Janssen Research and Development,1_Industry
189, Effect of a Workplace Wellness Program on Employee Health and Economic Outcomes: A Randomized Clinical Trial.,"Song Z, Baicker K",2019-4,2019-Q2,10.1001/jama.2019.3307,30990549,JAMA,1,1,,,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,"This work was supported by the National Institute on Aging (R01 AG050329; P30 AG012810 through the National Bureau of Economic Research), Robert Wood Johnson Foundation (grant 72611), and Abdul Latif Jameel Poverty Action Lab North America. BJ's Wholesale Club provided in-kind logistical and personnel support for the fielding of the wellness program.",4_Mixed
190, Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical Trial.,"Sio TT, Le-Rademacher JG, Leenstra JL, Loprinzi CL, Rine G, Curtis A, Singh AK, Martenson JA Jr, Novotny PJ, Tan AD, Qin R, Ko SJ, Reiter PL, Miller RC",2019-4,2019-Q2,10.1001/jama.2019.3504,30990550,JAMA,1,1,1,,,,1,1,NCTN/NCORP Data Archive,0,0,,,,,,,,,,,,,,,,,,,,,"This study was supported by grants UG1CA189823 (Alliance for Clinical Trials in Oncology National Cancer Institute Community Oncology Research Program), U10CA180790, U10CA180850, U10CA180866, UG1CA189858, and UG1CA189808 from the National Cancer Institute, National Institutes of Health, and by funding from the Mayo Clinic Symptom Intervention Program.",4_Mixed
191," Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.","Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D",2019-5,2019-Q2,10.1016/S0140-6736(19)30772-X,30995972,Lancet,1,1,,,1,1,,,,,,1,,,,,,,,,,,,,,,,,,,,AbbVie,1_Industry
192," Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.","Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, Woolfall K, Roper L, Noblet J, Lee ED, Potter S, Tate P, Iyer A, Evans V, Appleton RE",2019-5,2019-Q2,10.1016/S0140-6736(19)30724-X,31005385,Lancet,1,1,1,,,,,1,Clinical Trial Research Centre (CTRC) University of Liverpool,1,0,,,,,,,,,,,,,,,,,,,,,National Institute for Health Research Health Technology Assessment programme.,3_NonIndustryNonNIH
193," Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.","Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, Francis KL, Sharpe C, Harvey AS, Davidson A, Craig S, Phillips N, George S, Rao A, Cheng N, Zhang M, Kochar A, Brabyn C, Oakley E, Babl FE",2019-5,2019-Q2,10.1016/S0140-6736(19)30722-6,31005386,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Health Research Council of New Zealand, A+ Trust, Emergency Medicine Foundation, Townsville Hospital Private Practice Fund, Eric Ormond Baker Charitable Fund, and Princess Margaret Hospital Foundation.",3_NonIndustryNonNIH
194," Effects, equity, and cost of school-based and community-wide treatment strategies for soil-transmitted helminths in Kenya: a cluster-randomised controlled trial.","Pullan RL, Halliday KE, Oswald WE, Mcharo C, Beaumont E, Kepha S, Witek-McManus S, Gichuki PM, Allen E, Drake T, Pitt C, Matendechero SH, Gwayi-Chore MC, Anderson RM, Njenga SM, Brooker SJ, Mwandawiro CS",2019-5,2019-Q2,10.1016/S0140-6736(18)32591-1,31006575,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Bill & Melinda Gates Foundation, the Joint Global Health Trials Scheme of the Medical Research Council, the UK Department for International Development, the Wellcome Trust, and the Children's Investment Fund Foundation.",3_NonIndustryNonNIH
195, Effect of Addition of an Intimate Partner Violence Intervention to a Nurse Home Visitation Program on Maternal Quality of Life: A Randomized Clinical Trial.,"Jack SM, Boyle M, McKee C, Ford-Gilboe M, Wathen CN, Scribano P, Davidov D, McNaughton D, OBrien R, Johnston C, Gasbarro M, Tanaka M, Kimber M, Coben J, Olds DL, MacMillan HL",2019-4,2019-Q2,10.1001/jama.2019.3211,31012933,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"This study was supported by grant 5R49CE001170 from the National Center for Injury Prevention and Control, CDC, to the West Virginia University Injury Control Research Center (2007-2013) and since 2014 by funds (contract 4500311097) from PHAC. This study was also funded in part by the Annie E. Casey Foundation. Dr MacMillan holds the Chedoke Health Chair in Child Psychiatry; Dr Boyle holds a Canada Research Chair in the Social Determinants of Child Health. Dr Ford-Gilboe's research is supported by the Women's Health Research Chair in Rural Research, Western University.",3_NonIndustryNonNIH
196, Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.,"Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva M",2019-4,2019-Q2,10.1056/NEJMoa1815105,31018069,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Stemline Therapeutics and the Leukemia and Lymphoma Society Therapy Acceleration Program,4_Mixed
197, Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial.,"Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, Kutz A, Tribolet P, Bregenzer T, Braun N, Hoess C, Pavlicek V, Schmid S, Bilz S, Sigrist S, Brandle M, Benz C, Henzen C, Mattmann S, Thomann R, Brand C, Rutishauser J, Aujesky D, Rodondi N, Donze J, Stanga Z, Mueller B",2019-6,2019-Q2,10.1016/S0140-6736(18)32776-4,31030981,Lancet,1,1,1,,,1,1,,,,,,,,1,,,,,,1,,,,,,,,,,,"The Swiss National Science Foundation and the Research Council of the Kantonsspital Aarau, Switzerland.",3_NonIndustryNonNIH
198, Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial.,"Peden CJ, Stephens T, Martin G, Kahan BC, Thomson A, Rivett K, Wells D, Richardson G, Kerry S, Bion J, Pearse RM",2019-6,2019-Q2,10.1016/S0140-6736(18)32521-2,31030986,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,National Institute for Health Research Health Services and Delivery Research Programme.,3_NonIndustryNonNIH
199, Liraglutide in Children and Adolescents with Type 2 Diabetes.,"Tamborlane WV, Barrientos-Perez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T",2019-8,2019-Q3,10.1056/NEJMoa1903822,31034184,NEJM,1,1,,,1,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Supported by Novo Nordisk. U.K. entities, including the U.K. Medical Research Council, National Institutes of Health Research (NIHR) Translational Research Collaboration for Rare Diseases, and the NIHR Wellcome Clinical Research Facility, provided institutional grants to the trial sites, but no financial support was given to the patients.",1_Industry
200," Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-inferiority trial.","van Dijk AH, Wennmacker SZ, de Reuver PR, Latenstein CSS, Buyne O, Donkervoort SC, Eijsbouts QAJ, Heisterkamp J, Hof KI, Janssen J, Nieuwenhuijs VB, Schaap HM, Steenvoorde P, Stockmann HBAC, Boerma D, Westert GP, Drenth JPH, Dijkgraaf MGW, Boermeester MA, van Laarhoven CJHM",2019-6,2019-Q2,10.1016/S0140-6736(19)30941-9,31036336,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"The Netherlands Organization for Health Research and Development, and CZ healthcare insurance.",3_NonIndustryNonNIH
201, Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.,"Spahn DR, Schoenrath F, Spahn GH, Seifert B, Stein P, Theusinger OM, Kaserer A, Hegemann I, Hofmann A, Maisano F, Falk V",2019-6,2019-Q2,10.1016/S0140-6736(18)32555-8,31036337,Lancet,1,1,1,,,1,,,,,,,,,1,60,,,1,,1,,,,,,,,,,,Vifor Pharma and Swiss Foundation for Anaesthesia Research.,4_Mixed
202, Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.,"Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK",2019-5,2019-Q2,10.1001/jama.2019.5790,31037289,JAMA,1,1,1,,,,,1,The Jaeb Center for Health Research,1,1,,,,1,12,1,,,,1,,,,,,,,,,,Research reported in this publication was supported by the National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases under award numbers UG1EY014231 and UG1EY023207. Regeneron provided aflibercept for the study and funds to the DRCR Retina Network to defray the study's clinical site costs.,4_Mixed
203, Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.,"Raje N, Berdeja J, Lin Y, Siegel D, Jagannath S, Madduri D, Liedtke M, Rosenblatt J, Maus MV, Turka A, Lam LP, Morgan RA, Friedman K, Massaro M, Wang J, Russotti G, Yang Z, Campbell T, Hege K, Petrocca F, Quigley MT, Munshi N, Kochenderfer JN",2019-5,2019-Q2,10.1056/NEJMoa1817226,31042825,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Funded by Bluebird Bio and Celgene,1_Industry
204, Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.,"Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM",2019-8,2019-Q3,10.1056/NEJMoa1900866,31050279,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Funded by Alexion Pharmaceuticals,1_Industry
205, Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.,"Matta MK, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Florian J, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong LA, Ganley C, Michele T, Strauss DG",2019-6,2019-Q2,10.1001/jama.2019.5586,31058986,JAMA,1,1,1,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,The study was funded by the US Food and Drug Administration.,3_NonIndustryNonNIH
206, Targeting Huntingtin Expression in Patients with Huntington's Disease.,"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel SA, Paz E, Smith AV, Bennett CF, Lane RM",2019-6,2019-Q2,10.1056/NEJMoa1900907,31059641,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Ionis Pharmaceuticals and F. Hoffmann-La Roche,1_Industry
207, Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest: The PRINCESS Randomized Clinical Trial.,"Nordberg P, Taccone FS, Truhlar A, Forsberg S, Hollenberg J, Jonsson M, Cuny J, Goldstein P, Vermeersch N, Higuet A, Jimenes FC, Ortiz FR, Williams J, Desruelles D, Creteur J, Dillenbeck E, Busche C, Busch HJ, Ringh M, Konrad D, Peterson J, Vincent JL, Svensson L",2019-5,2019-Q2,10.1001/jama.2019.4149,31063573,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,The study was funded by independent research grants from the Swedish Heart-Lung Foundation and the Laerdal Foundation. The cooling devices used at each study site were provided by the company BrainCool AB at no cost.,3_NonIndustryNonNIH
208, Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial.,"Brenner H, Calderazzo S, Seufferlein T, Ludwig L, Dikopoulos N, Mangold J, Bock W, Stolz T, Eisenbach T, Block T, Kopp-Schneider A, Czock D, Tikk K",2019-5,2019-Q2,10.1001/jama.2019.4755,31063574,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The ASTER trial was conducted in the context of the German Cancer Consortium (DKTK), funded by the German Federal Ministry of Education and Research.",3_NonIndustryNonNIH
209, Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.,"Wise RA, Chapman KR, Scirica BM, Bhatt DL, Daoud SZ, Zetterstrand S, Reisner C, Gil EG",2019-5,2019-Q2,10.1001/jama.2019.4973,31063575,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,The study was initially funded by Forest Laboratories and later funded by AstraZeneca and Circassia.,1_Industry
210, Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.,"Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Christensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA",2019-5,2019-Q2,10.1056/NEJMoa1813046,31067369,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,Supported by the Australian National Health and Medical Research Council and the Commonwealth Scientific and Industrial Research Organization Flagship Program. The EXTEND trial sites in Taiwan were supported in part by a Ministry of Health and Welfare grant (MOHW108-TDU-B-212-133004) and the Ministry of Science and Technology Taiwan Clinical Trial Consortium for Stroke (MOST107-2321-B-039-004).,3_NonIndustryNonNIH
211, A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy.,"Coomarasamy A, Devall AJ, Cheed V, Harb H, Middleton LJ, Gallos ID, Williams H, Eapen AK, Roberts T, Ogwulu CC, Goranitis I, Daniels JP, Ahmed A, Bender-Atik R, Bhatia K, Bottomley C, Brewin J, Choudhary M, Crosfill F, Deb S, Duncan WC, Ewer A, Hinshaw K, Holland T, Izzat F, Johns J, Kriedt K, Lumsden MA, Manda P, Norman JE, Nunes N, Overton CE, Quenby S, Rao S, Ross J, Shahid A, Underwood M, Vaithilingam N, Watkins L, Wykes C, Horne A, Jurkovic D",2019-5,2019-Q2,10.1056/NEJMoa1813730,31067371,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the United Kingdom National Institute for Health Research Health Technology Assessment program,3_NonIndustryNonNIH
212, Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.,"Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS",2019-6,2019-Q2,10.1056/NEJMoa1901981,31075187,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,Funded by EMD Serono,1_Industry
213," Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.","Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ",2019-6,2019-Q2,10.1016/S0140-6736(19)30723-8,31079938,Lancet,1,1,1,,,,1,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,F Hoffmann-La Roche Ltd and Genentech Inc.,1_Industry
214, Effect of Restriction of the Number of Concurrently Open Records in an Electronic Health Record on Wrong-Patient Order Errors: A Randomized Clinical Trial.,"Adelman JS, Applebaum JR, Schechter CB, Berger MA, Reissman SH, Thota R, Racine AD, Vawdrey DK, Green RA, Salmasian H, Schiff GD, Wright A, Landman A, Bates DW, Koppel R, Galanter WL, Lambert BL, Paparella S, Southern WN",2019-5,2019-Q2,10.1001/jama.2019.3698,31087021,JAMA,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,This project was supported by grant R01HS023704 from the Agency for Healthcare Research and Quality.,3_NonIndustryNonNIH
215, Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.,"Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmunzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K",2019-5,2019-Q2,10.1056/NEJMoa1813959,31091372,NEJM,1,1,1,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,Funded by Boehringer Ingelheim,1_Industry
216," Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.","Andre F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Papai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D",2019-5,2019-Q2,10.1056/NEJMoa1813904,31091374,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Novartis Pharmaceuticals,1_Industry
217, Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.,"Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Hinshaw K, Tuffnell D, Linsell L, Juszczak E",2019-6,2019-Q2,10.1016/S0140-6736(19)30773-1,31097213,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,NIHR Health Technology Assessment programme.,3_NonIndustryNonNIH
218, Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial.,"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, Pettila V, Wittebole X, Meziani F, Mercier E, Lobo SM, Barie PS, Crowther M, Esmon CT, Fareed J, Gando S, Gorelick KJ, Levi M, Mira JP, Opal SM, Parrillo J, Russell JA, Saito H, Tsuruta K, Sakai T, Fineberg D",2019-5,2019-Q2,10.1001/jama.2019.5358,31104069,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,1,,1,,,,,,This work was supported by Asahi-Kasei Pharma America Corporation.,1_Industry
219," Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.","Snider CJ, Zaman K, Estivariz CF, Yunus M, Weldon WC, Wannemuehler KA, Oberste MS, Pallansch MA, Wassilak SG, Bari TIA, Anand A",2019-6,2019-Q2,10.1016/S0140-6736(19)30503-3,31104832,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,US Centers for Disease Control and Prevention.,3_NonIndustryNonNIH
220," Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.","Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Hogler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA",2019-6,2019-Q2,10.1016/S0140-6736(19)30654-3,31104833,Lancet,1,1,1,,,,,,,,,1,,,1,12,1,,,,1,,,,,,,,,,,Ultragenyx Pharmaceutical and Kyowa Kirin International.,1_Industry
221, Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.,"Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM",2019-6,2019-Q2,10.1056/NEJMoa1903076,31112379,NEJM,1,1,,,1,,1,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,Funded by Boehringer Ingelheim,1_Industry
222, Early Sedation with Dexmedetomidine in Critically Ill Patients.,"Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, Bin Kadiman S, McArthur CJ, Murray L, Reade MC, Seppelt IM, Takala J, Wise MP, Webb SA",2019-6,2019-Q2,10.1056/NEJMoa1904710,31112380,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,"The National Health and Medical Research Council of Australia, the Health Research Council of New Zealand, and the Institut Jantung Negara Foundation of Malaysia funded the trial. Pfizer and Orion Pharma supplied dexmedetomidine but had no role in the design or conduct of the trial, analysis of the data, or writing or review of the manuscript.",3_NonIndustryNonNIH
223, Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.,"Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, Grissom CK, Gundel S, Hayden D, Hite RD, Hou PC, Hough CL, Iwashyna TJ, Khan A, Liu KD, Talmor D, Thompson BT, Ulysse CA, Yealy DM, Angus DC",2019-5,2019-Q2,10.1056/NEJMoa1901686,31112383,NEJM,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,0,0,,,,1,24,,1,,,1,,,,,,,,,,,"Funded by the National Heart, Lung, and Blood Institute",2_NonIndustryNIH
224, Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.,"Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, Dyer AM, Boushey HA, Fahy JV, Woodruff PG, Bacharier LB, Cabana MD, Cardet JC, Castro M, Chmiel J, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Hastie A, Holguin F, Israel E, Jackson D, Kraft M, LaForce C, Lemanske RF Jr, Martinez FD, Moore W, Morgan WJ, Moy JN, Myers R, Peters SP, Phipatanakul W, Pongracic JA, Que L, Ross K, Smith L, Szefler SJ, Wechsler ME, Sorkness CA",2019-5,2019-Q2,10.1056/NEJMoa1814917,31112384,NEJM,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,1,1,,,,,,,,,,,,,,,,,,,,,"Funded by the National Heart, Lung, and Blood Institute",2_NonIndustryNIH
225, Benralizumab for the Prevention of COPD Exacerbations.,"Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramirez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, OQuinn S, Makulova N, Newbold P, Goldman M, Martin UJ",2019-9,2019-Q3,10.1056/NEJMoa1905248,31112385,NEJM,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,Funded by AstraZeneca [GALATHEA and TERRANOVA] and Kyowa Hakko Kirin [GALATHEA],1_Industry
226, Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.,"Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M",2019-5,2019-Q2,10.1056/NEJMoa1901963,31112386,NEJM,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by AstraZeneca and the Health Research Council of New Zealand,4_Mixed
227, Nasal High-Flow Therapy for Newborn Infants in Special Care Nurseries.,"Manley BJ, Arnolda GRB, Wright IMR, Owen LS, Foster JP, Huang L, Roberts CT, Clark TL, Fan WQ, Fang AYW, Marshall IR, Pszczola RJ, Davis PG, Buckmaster AG",2019-5,2019-Q2,10.1056/NEJMoa1812077,31116919,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by the Australian National Health and Medical Research Council and Monash University,3_NonIndustryNonNIH
228," Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.",RESTART Collaboration.,2019-6,2019-Q2,10.1016/S0140-6736(19)30840-2,31128924,Lancet,1,1,1,,,,1,,,,,,,,1,12,1,,,,1,,,,,,,,,,,British Heart Foundation.,3_NonIndustryNonNIH
229, Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.,"Rodgers H, Bosomworth H, Krebs HI, van Wijck F, Howel D, Wilson N, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Fernandez-Garcia C, Finch T, Ford GA, Francis R, Hogg S, Hughes N, Price CI, Ternent L, Turner DL, Vale L, Wilkes S, Shaw L",2019-7,2019-Q3,10.1016/S0140-6736(19)31055-4,31128926,Lancet,1,1,1,,,1,1,,,,,,,,1,,,,,,1,,,,,,,,,,,National Institute for Health Research Health Technology Assessment Programme.,3_NonIndustryNonNIH
230," Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.","Smolen JS, Pangan AL, Emery P, Rigby W, Tanaka Y, Vargas JI, Zhang Y, Damjanov N, Friedman A, Othman AA, Camp HS, Cohen S",2019-6,2019-Q2,10.1016/S0140-6736(19)30419-2,31130260,Lancet,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,"AbbVie Inc, USA",1_Industry
231," An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.","Bornstein NM, Saver JL, Diener HC, Gorelick PB, Shuaib A, Solberg Y, Thackeray L, Savic M, Janelidze T, Zarqua N, Yarnitsky D, Molina CA",2019-7,2019-Q3,10.1016/S0140-6736(19)31192-4,31133406,Lancet,1,1,1,,,,,1,"Virtual Trials Archives, VISTA",0,0,,,,1,12,1,,,,1,,,,,,,,,,,BrainsGate Ltd,1_Industry
232, Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.,"Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Hu Y, Liu H, Zheng C, Li P, Xie J, Liu F, Li Z, Zhao G, Yang K, Liu C, Li H, Chen P, Ji J, Li G",2019-5,2019-Q2,10.1001/jama.2019.5359,31135850,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,"Funding was provided by the Guangdong Provincial Science and Technology Key Project (2012A030400012), the National High Technology R&D Program from the Ministry of Science and Technology of China (201300000087), the National Key Technology R&D Program (2017YFC0108300), the Major Program of Science and Technology Program of Guangzhou (201300000087), National Project of Improvement of Complex Diseases Diagnosis and Treatment from National Development and Reform Commission, the Public Welfare in Health Industry Programfrom the National Health and Family Planning Commission of China (201402015), the Key Clinical Specialty Discipline Construction Program from the National Health and Family Planning Commission of China, and the Program of Global Medical Affairs Department of Johnson & Johnson Medical Ltd (IIS2012-100236).",4_Mixed
233, Ibrutinib and Venetoclax for First-Line Treatment of CLL.,"Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W",2019-5,2019-Q2,10.1056/NEJMoa1900574,31141631,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Supported by AbbVie, a grant from the University of Texas M.D. Anderson Cancer Center (MDACC) Chronic Lymphocytic Leukemia Moon Shot program (to Drs. Jain and Gandhi), a grant from the Andrew Sabin Family Foundation (to Drs. Jain and Gandhi), a grant from the CLL Global Research Foundation (to Dr. Gandhi), and MDACC Support Grant P30 CA016672.",4_Mixed
234, Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.,"Facon T, Kumar S, Plesner T, Orlowski RZ, Moreau P, Bahlis N, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, ODwyer M, Perrot A, Venner CP, Weisel K, Mace JR, Raje N, Attal M, Tiab M, Macro M, Frenzel L, Leleu X, Ahmadi T, Chiu C, Wang J, Van Rampelbergh R, Uhlar CM, Kobos R, Qi M, Usmani SZ",2019-5,2019-Q2,10.1056/NEJMoa1817249,31141632,NEJM,1,1,1,,,,,1,The Yale Open Data Access (YODA) Project,1,1,,,,,,,,,,,,,,,,,,,,,Funded by Janssen Research and Development,1_Industry
235, Open versus Endovascular Repair of Abdominal Aortic Aneurysm.,"Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT Jr, Matsumura JS, Huo Z, Johnson GR",2019-5,2019-Q2,10.1056/NEJMoa1715955,31141634,NEJM,1,1,,,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,Funded by the Department of Veteran Affairs Office of Research and Development,3_NonIndustryNonNIH
236, Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.,"Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Tang LL, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Chua MLK, Xie FY, Sun Y, Ma J",2019-9,2019-Q3,10.1056/NEJMoa1905287,31150573,NEJM,1,1,1,,,1,,,,,,,,,1,3,1,,,,1,,,,,,,,,,,"Supported by grants from the Innovation Team Development Plan of the Ministry of Education (IRT_17R110), the Natural Science Foundation of Guangdong Province (2017A030312003), the Planned Science and Technology Project of Guangdong Province (2019B020230002), the Health and Medical Collaborative Innovation Project of Guangzhou City, China (201803040003), the Sun Yat-Sen University Clinical Research 5010 Program (2014009), and the Overseas Expertise Introduction Project for Discipline Innovation (111 Project, B14035) and by a National Medical Research Council Singapore Clinician-Scientist Award (NMRC/CSA/0027/2018) and the Duke-NUS Oncology Academic Program Proton Research Program (EX/42-A92) (both to Dr. Chua).",3_NonIndustryNonNIH
237," Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.","Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juarez Soto A, Merseburger AS, Ozguroglu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S",2019-7,2019-Q3,10.1056/NEJMoa1903307,31150574,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by Janssen Research and Development,1_Industry
238, Effect of Intraoperative High Positive End-Expiratory Pressure (PEEP) With Recruitment Maneuvers vs Low PEEP on Postoperative Pulmonary Complications in Obese Patients: A Randomized Clinical Trial.,"Bluth T, Serpa Neto A, Schultz MJ, Pelosi P, Gama de Abreu M, Bluth T, Bobek I, Canet JC, Cinnella G, de Baerdemaeker L, Gama de Abreu M, Gregoretti C, Hedenstierna G, Hemmes SNT, Hiesmayr M, Hollmann MW, Jaber S, Laffey J, Licker MJ, Markstaller K, Matot I, Mills GH, Mulier JP, Pelosi P, Putensen C, Rossaint R, Schmitt J, Schultz MJ, Senturk M, Serpa Neto A, Severgnini P, Sprung J, Vidal Melo MF, Wrigge H",2019-6,2019-Q2,10.1001/jama.2019.7505,31157366,JAMA,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,"The Clinical Trials Network of the European Society of Anaesthesiology provided financial support for the steering committee meetings, onsite visits to participating sites, for the building of the electronic data capture system, and for the advertising of the study. The Technische Universität Dresden provided logistical support for the coordinating site. The Conselho Nacional de Desenvolvimento Científico e Tecnológico provided financial support for insurance in Brazil. The Association of Anaesthetists of Great Britain and Ireland and the Northern Ireland Society of Anaesthetists provided financial support for the participating sites in the United Kingdom.",3_NonIndustryNonNIH
239, Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.,"Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr",2019-6,2019-Q2,10.1056/NEJMoa1904819,31157962,NEJM,1,1,1,,,,,1,NCTN/NCORP Data Archive,1,1,,,,,,,,,,,,,,,,,,,,,"Supported by the National Cancer Institute (NCI) of the National Institutes of Health (award numbers CA180820, CA180794, CA180790, CA180795, CA180799, C180801, CA180816, CA180821, CA180838, CA180822, CA180844, CA180847, CA180857, CA189867, CA180868, CA189869, CA180888, CA189808, CA189859, and CA190140), the Canadian Cancer Society Research Institute (grants 015469 and 021039), the Breast Cancer Research Foundation, the Komen Foundation, the Breast Cancer Research Stamp issued by the U.S. Postal Service, and Genomic Health.",4_Mixed
240, Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.,"Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, OReilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL",2019-7,2019-Q3,10.1056/NEJMoa1903387,31157963,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,"Supported by AstraZeneca (as part of an alliance between AstraZeneca and Merck Sharp & Dohme, a subsidiary of Merck) and by a grant (P30-17 CA008748) from the National Institutes of Health National Cancer Institute Cancer Center.",4_Mixed
241, Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.,"Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ",2019-7,2019-Q3,10.1056/NEJMoa1903835,31157964,NEJM,1,1,1,,,1,1,,,,,,,,1,3,1,,,,1,,,,,,,,,,,"Supported by Astellas Scientific and Medical Affairs, a grant (704970) from the Canadian Cancer Society, the Support for Cancer Clinical Trials Program of Cancer Australia, and a practitioner fellowship (APP1102604) and program grants (1037786 and 1150467) from the National Health and Medical Research Council of the Australian Government Department of Health.",4_Mixed
242, Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.,"Shah SJ, Voors AA, McMurray JJV, Kitzman DW, Viethen T, Bomfim Wirtz A, Huang E, Pap AF, Solomon SD",2019-6,2019-Q2,10.1001/jama.2019.6717,31162568,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,This study was funded by Bayer AG.,1_Industry
243, Effect of a Home-Based Exercise Program on Subsequent Falls Among Community-Dwelling High-Risk Older Adults After a Fall: A Randomized Clinical Trial.,"Liu-Ambrose T, Davis JC, Best JR, Dian L, Madden K, Cook W, Hsu CL, Khan KM",2019-6,2019-Q2,10.1001/jama.2019.5795,31162569,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,"This study was funded by the Canadian Institutes for Health Research (MOP-110954 and MAT-92025). Dr Liu-Ambrose is a Canada Research Chair (Tier 2) in Physical Activity, Mobility, and Cognitive Neuroscience, Department of Physical Therapy, University of British Columbia. Dr Madden is the Allan M. McGavin Chair in Geriatric Medicine, Department of Medicine, University of British Columbia.",3_NonIndustryNonNIH
244, Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.,"Im SA, Lu YS, Bardia A, Harbeck N, Colleoni M, Franke F, Chow L, Sohn J, Lee KS, Campos-Gomez S, Villanueva-Vazquez R, Jung KH, Chakravartty A, Hughes G, Gounaris I, Rodriguez-Lorenc K, Taran T, Hurvitz S, Tripathy D",2019-7,2019-Q3,10.1056/NEJMoa1903765,31166679,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Novartis,1_Industry
245, Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.,"Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, Chiarion Sileni V, Schachter J, Garbe C, Bondarenko I, Gogas H, Mandala M, Haanen JBAG, Lebbe C, Mackiewicz A, Rutkowski P, Nathan PD, Ribas A, Davies MA, Flaherty KT, Burgess P, Tan M, Gasal E, Voi M, Schadendorf D, Long GV",2019-8,2019-Q3,10.1056/NEJMoa1904059,31166680,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by GlaxoSmithKline and Novartis; ,1_Industry
246," Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.","Moreau P, Attal M, Hulin C, Arnulf B, Belhadj K, Benboubker L, Bene MC, Broijl A, Caillon H, Caillot D, Corre J, Delforge M, Dejoie T, Doyen C, Facon T, Sonntag C, Fontan J, Garderet L, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Lenain P, Macro M, Mathiot C, Orsini-Piocelle F, Perrot A, Stoppa AM, van de Donk NW, Wuilleme S, Zweegman S, Kolb B, Touzeau C, Roussel M, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Fermand JP, Escoffre-Barbe M, Eveillard JR, Garidi R, Ahmadi T, Zhuang S, Chiu C, Pei L, de Boer C, Smith E, Deraedt W, Kampfenkel T, Schecter J, Vermeulen J, Avet-Loiseau H, Sonneveld P",2019-7,2019-Q3,10.1016/S0140-6736(19)31240-1,31171419,Lancet,1,1,,,1,,,1,The Yale Open Data Access (YODA) Project,0,0,,,,,,,,,,,,,,,,,,,,,The Intergroupe Francophone du Myélome and Dutch-Belgian Cooperative Trial Group for Hematology Oncology.,3_NonIndustryNonNIH
247, Vitamin D Supplementation and Prevention of Type 2 Diabetes.,"Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, ONeil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M",2019-8,2019-Q3,10.1056/NEJMoa1900906,31173679,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others,2_NonIndustryNIH
248," The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.","Van Damme P, De Coster I, Bandyopadhyay AS, Revets H, Withanage K, De Smedt P, Suykens L, Oberste MS, Weldon WC, Costa-Clemens SA, Clemens R, Modlin J, Weiner AJ, Macadam AJ, Andino R, Kew OM, Konopka-Anstadt JL, Burns CC, Konz J, Wahid R, Gast C",2019-7,2019-Q3,10.1016/S0140-6736(19)31279-6,31174831,Lancet,1,1,,,1,,1,,,,,,,,1,,,,,,1,,,,,,,,,,,Bill & Melinda Gates Foundation.,3_NonIndustryNonNIH
249, 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.,"Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA",2019-6,2019-Q2,10.1016/S0140-6736(19)30650-6,31178152,Lancet,1,1,,,1,,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,"UK National Institute for Health Research, Health Technology Assessment Programme.",3_NonIndustryNonNIH
250," 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.","Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espie M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporte I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM",2019-6,2019-Q2,10.1016/S0140-6736(19)30653-1,31178155,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,The French National Cancer Institute.,3_NonIndustryNonNIH
251," An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.","Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ",2019-8,2019-Q3,10.1056/NEJMoa1902226,31180194,NEJM,1,1,1,,,,,1,NIDDK Central Repository,1,1,,,,,,,,,,,,,,,,,,,,,"Supported by the National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, through cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085453, U01 DK085461, U01 DK085465, U01 DK085466, U01 DK085476, U01 DK085499, U01 DK085504, U01 DK085509, U01 DK103153, U01 DK103180, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK097835, and UC4 DK106993; the Juvenile Diabetes Research Foundation; and the American Diabetes Association. Additional support for clinical studies was provided by the National Center for Research Resources through Clinical Translational Science Awards UL1TR000142, UL1TR002366, UL1TR000445, UL1TR000064, UL1TR002537, UL1TR001082, UL1TR000114, UL1TR001857, UL1TR002529, UL1TR001872 and by the Immune Tolerance Network (UM1 AI09565). MacroGenics donated the study agents and provided funds for additional site monitoring.",2_NonIndustryNIH
252, Effect of Pressure Support vs T-Piece Ventilation Strategies During Spontaneous Breathing Trials on Successful Extubation Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.,"Subira C, Hernandez G, Vazquez A, Rodriguez-Garcia R, Gonzalez-Castro A, Garcia C, Rubio O, Ventura L, Lopez A, de la Torre MC, Keough E, Arauzo V, Hermosa C, Sanchez C, Tizon A, Tenza E, Laborda C, Cabanes S, Lacueva V, Del Mar Fernandez M, Arnau A, Fernandez R",2019-6,2019-Q2,10.1001/jama.2019.7234,31184740,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This study was supported by an unrestricted grant from Societat Catalana de Medicina Intensiva i Critica (SOCMIC).,3_NonIndustryNonNIH
253, Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.,"Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsboll T, Warren ML, Bain SC",2019-8,2019-Q3,10.1056/NEJMoa1901118,31185157,NEJM,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,Funded by Novo Nordisk,1_Industry
254," Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.","Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M, Pedersen KB, Saugstrup T, Meier JJ",2019-7,2019-Q3,10.1016/S0140-6736(19)31271-1,31186120,Lancet,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,Novo Nordisk A/S,1_Industry
255, Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.,"Matei D, Filiaci V, Randall ME, Mutch D, Steinhoff MM, DiSilvestro PA, Moxley KM, Kim YM, Powell MA, OMalley DM, Spirtos NM, Small W Jr, Tewari KS, Richards WE, Nakayama J, Matulonis UA, Huang HQ, Miller DS",2019-6,2019-Q2,10.1056/NEJMoa1813181,31189035,NEJM,1,1,1,,,,,1,NCTN/NCORP Data Archive,0,0,,,,1,6,1,,,,1,,,,,,,,,,,Funded by the National Cancer Institute,2_NonIndustryNIH
256," Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.","Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Ryden L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T",2019-7,2019-Q3,10.1016/S0140-6736(19)31150-X,31189509,Lancet,1,1,,,1,,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,Eli Lilly and Company.,1_Industry
257," Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.","Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Ryden L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T",2019-7,2019-Q3,10.1016/S0140-6736(19)31149-3,31189511,Lancet,1,1,,,1,,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,Eli Lilly and Company.,1_Industry
258, A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.,"Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J",2019-8,2019-Q3,10.1056/NEJMoa1903212,31199090,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Global Blood Therapeutics,1_Industry
259," HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.",Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.,2019-7,2019-Q3,10.1016/S0140-6736(19)31288-7,31204114,Lancet,1,1,1,,,,1,,,,,,,,1,3,1,,,,1,,,,,,,,,,,"Bill & Melinda Gates Foundation, US Agency for International Development and the President's Emergency Plan for AIDS Relief, Swedish International Development Cooperation Agency, South African Medical Research Council, and UN Population Fund. Contraceptive supplies were donated by the Government of South Africa and US Agency for International Development.",3_NonIndustryNonNIH
260," Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.","Rissanen TT, Uskela S, Eranen J, Mantyla P, Olli A, Romppanen H, Siljander A, Pietila M, Minkkinen MJ, Tervo J, Karkkainen JM",2019-7,2019-Q3,10.1016/S0140-6736(19)31126-2,31204115,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,"B Braun Medical AG, AstraZeneca, and Competitive State Research Funding of the Kuopio University Hospital Catchment Area.",4_Mixed
261," Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.","Widmark A, Gunnlaugsson A, Beckman L, Thellenberg-Karlsson C, Hoyer M, Lagerlund M, Kindblom J, Ginman C, Johansson B, Bjornlinger K, Seke M, Agrup M, Fransson P, Tavelin B, Norman D, Zackrisson B, Anderson H, Kjellen E, Franzen L, Nilsson P",2019-8,2019-Q3,10.1016/S0140-6736(19)31131-6,31227373,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,"The Nordic Cancer Union, the Swedish Cancer Society, and the Swedish Research Council.",3_NonIndustryNonNIH
262," Septoplasty with or without concurrent turbinate surgery versus non-surgical management for nasal obstruction in adults with a deviated septum: a pragmatic, randomised controlled trial.","van Egmond MMHT, Rovers MM, Hannink G, Hendriks CTM, van Heerbeek N",2019-7,2019-Q3,10.1016/S0140-6736(19)30354-X,31227374,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,The Netherlands Organisation for Health Research and Development (ZonMw),3_NonIndustryNonNIH
263, Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.,"Tap WD, Gelderblom H, Palmerini E, Desai J, Bauer S, Blay JY, Alcindor T, Ganjoo K, Martin-Broto J, Ryan CW, Thomas DM, Peterfy C, Healey JH, van de Sande M, Gelhorn HL, Shuster DE, Wang Q, Yver A, Hsu HH, Lin PS, Tong-Starksen S, Stacchiotti S, Wagner AJ",2019-8,2019-Q3,10.1016/S0140-6736(19)30764-0,31229240,Lancet,1,1,1,,,,,1,Vivli Center for Global Clinical Research Data,0,0,,,,,,,,,1,1,,,,,,,,,,,Daiichi Sankyo.,1_Industry
264, Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.,"Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T",2019-6,2019-Q2,10.1001/jama.2019.8145,31237644,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Abbott Vascular funded the STOPDAPT-2 study but did not provide medications or coronary devices.,1_Industry
265, Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.,"Hahn JY, Song YB, Oh JH, Chun WJ, Park YH, Jang WJ, Im ES, Jeong JO, Cho BR, Oh SK, Yun KH, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Lee JM, Park TK, Yang JH, Choi JH, Choi SH, Lee SH, Gwon HC",2019-6,2019-Q2,10.1001/jama.2019.8146,31237645,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"This study was supported by unrestricted grants from the Korean Society of Interventional Cardiology (grant 2013-3), Abbott Vascular, Biotronik, and Boston Scientific.",4_Mixed
266," Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.","Wesson DE, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E, Klaerner G, Bushinsky DA",2019-8,2019-Q3,10.1016/S0140-6736(19)31388-1,31248662,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Tricida,1_Industry
267, A Multicenter Trial of Vena Cava Filters in Severely Injured Patients.,"Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, Holley A, Kop A, Geelhoed E, Corcoran T, Misur P, Edibam C, Baker RI, Chamberlain J, Forsdyke C, Rogers FB",2019-7,2019-Q3,10.1056/NEJMoa1806515,31259488,NEJM,1,1,1,,,1,,,,,,,,,1,24,,1,,,1,,,,,,,,,,,Supported by the Medical Research Foundation of Royal Perth Hospital and the Western Australia Department of Health. The funders provided financial support to employ the research coordinators and for the cost of ultrasonography for this trial. Dr. Ho was funded by the Western Australia Department of Health and the Raine Medical Research Foundation through the Raine Clinical Research Fellowship to initiate and conduct this trial. No financial or nonfinancial (including in-kind) support has been received from any commercial entities.,3_NonIndustryNonNIH
268," Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.","Schnitzer TJ, Easton R, Pang S, Levinson DJ, Pixton G, Viktrup L, Davignon I, Brown MT, West CR, Verburg KM",2019-7,2019-Q3,10.1001/jama.2019.8044,31265100,JAMA,1,1,1,,,,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,The study was sponsored by Pfizer Inc and Eli Lilly and Company.,1_Industry
269, Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.,"Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Juni P, Cattran DC",2019-7,2019-Q3,10.1056/NEJMoa1814427,31269364,NEJM,1,1,1,,,1,,,,,,,,,1,18,,1,,,1,,,,,,,,,,,Funded by Genentech and the Fulk Family Foundation,4_Mixed
270, C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.,"Savarirayan R, Irving M, Bacino CA, Bostwick B, Charrow J, Cormier-Daire V, Le Quan Sang KH, Dickson P, Harmatz P, Phillips J, Owen N, Cherukuri A, Jayaram K, Jeha GS, Larimore K, Chan ML, Huntsman Labed A, Day J, Hoover-Fong J",2019-7,2019-Q3,10.1056/NEJMoa1813446,31269546,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,Funded by BioMarin Pharmaceutical,1_Industry
271," 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial.","Utjes D, Malmstedt J, Teras J, Drzewiecki K, Gullestad HP, Ingvar C, Eriksson H, Gillgren P",2019-8,2019-Q3,10.1016/S0140-6736(19)31132-8,31280965,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"The Swedish Cancer Society, Stockholm Cancer Society, the Swedish Society for Medical Research, Radiumhemmet Research funds, Stockholm County Council, Wallström funds.",3_NonIndustryNonNIH
272," Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.","Reich K, Gooderham M, Thaci D, Crowley JJ, Ryan C, Krueger JG, Tsai TF, Flack M, Gu Y, Williams DA, Thompson EHZ, Paul C",2019-8,2019-Q3,10.1016/S0140-6736(19)30952-3,31280967,Lancet,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,AbbVie and Boehringer Ingelheim.,1_Industry
273, Effect of Peroral Endoscopic Myotomy vs Pneumatic Dilation on Symptom Severity and Treatment Outcomes Among Treatment-Naive Patients With Achalasia: A Randomized Clinical Trial.,"Ponds FA, Fockens P, Lei A, Neuhaus H, Beyna T, Kandler J, Frieling T, Chiu PWY, Wu JCY, Wong VWY, Costamagna G, Familiari P, Kahrilas PJ, Pandolfino JE, Smout AJPM, Bredenoord AJ",2019-7,2019-Q3,10.1001/jama.2019.8859,31287522,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,This study was made possible with financial support from Fonds NutsOhra (FNO grant 1202-022) and an ESGE Research Grant.,3_NonIndustryNonNIH
274, Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.,"Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, Lopez-Jimenez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM",2019-7,2019-Q3,10.1001/jama.2019.9053,31287523,JAMA,1,1,1,,,1,,1,ClinicalStudyDateRequest.com (CSDR),1,1,,,,1,6,1,,,,1,,,,,,,,,,,This study was sponsored and funded by GlaxoSmithKline Biologicals SA.,1_Industry
275, C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.,"Butler CC, Gillespie D, White P, Bates J, Lowe R, Thomas-Jones E, Wootton M, Hood K, Phillips R, Melbye H, Llor C, Cals JWL, Naik G, Kirby N, Gal M, Riga E, Francis NA",2019-7,2019-Q3,10.1056/NEJMoa1803185,31291514,NEJM,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the National Institute for Health Research Health Technology Assessment Program,3_NonIndustryNonNIH
276, Trial of Galcanezumab in Prevention of Episodic Cluster Headache.,"Goadsby PJ, Dodick DW, Leone M, Bardos JN, Oakes TM, Millen BA, Zhou C, Dowsett SA, Aurora SK, Ahn AH, Yang JY, Conley RR, Martinez JM",2019-7,2019-Q3,10.1056/NEJMoa1813440,31291515,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,1,1,,,,,,,,,,,Funded by Eli Lilly,1_Industry
277," Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.","Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, Dubowchik GM, Conway CM, Coric V, Goadsby PJ",2019-7,2019-Q3,10.1056/NEJMoa1811090,31291516,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Biohaven Pharmaceuticals,1_Industry
278, Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.,"Winzeler B, Cesana-Nigro N, Refardt J, Vogt DR, Imber C, Morin B, Popovic M, Steinmetz M, Sailer CO, Szinnai G, Chifu I, Fassnacht M, Christ-Crain M",2019-8,2019-Q3,10.1016/S0140-6736(19)31255-3,31303316,Lancet,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,Swiss National Science Foundation and University Hospital Basel.,3_NonIndustryNonNIH
279, Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit: The ICU Visits Randomized Clinical Trial.,"Rosa RG, Falavigna M, da Silva DB, Sganzerla D, Santos MMS, Kochhann R, de Moura RM, Eugenio CS, Haack TDSR, Barbosa MG, Robinson CC, Schneider D, de Oliveira DM, Jeffman RW, Cavalcanti AB, Machado FR, Azevedo LCP, Salluh JIF, Pellegrini JAS, Moraes RB, Foernges RB, Torelly AP, Ayres LO, Duarte PAD, Lovato WJ, Sampaio PHS, de Oliveira Junior LC, Paranhos JLDR, Dantas ADS, de Brito PIPGG, Paulo EAP, Gallindo MAC, Pilau J, Valentim HM, Meira Teles JM, Nobre V, Birriel DC, Correa E Castro L, Specht AM, Medeiros GS, Tonietto TF, Mesquita EC, da Silva NB, Korte JE, Hammes LS, Giannini A, Bozza FA, Teixeira C",2019-7,2019-Q3,10.1001/jama.2019.8766,31310297,JAMA,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,This study was funded by the Brazilian Ministry of Health through the Brazilian Unified Health System Institutional Development Program (PROADI-SUS).,3_NonIndustryNonNIH
280, Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.,"Garrouste-Orgeas M, Flahault C, Vinatier I, Rigaud JP, Thieulot-Rolin N, Mercier E, Rouget A, Grand H, Lesieur O, Tamion F, Hamidfar R, Renault A, Parmentier-Decrucq E, Monseau Y, Argaud L, Bretonniere C, Lautrette A, Badie J, Boulet E, Floccard B, Forceville X, Kipnis E, Soufir L, Valade S, Bige N, Gaffinel A, Hamzaoui O, Simon G, Thirion M, Bouadma L, Large A, Mira JP, Amdjar-Badidi N, Jourdain M, Jost PH, Maxime V, Santoli F, Ruckly S, Vioulac C, Leborgne MA, Bellalou L, Fasse L, Misset B, Bailly S, Timsit JF",2019-7,2019-Q3,10.1001/jama.2019.9058,31310299,JAMA,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,This study was funded through a grant from the Fondation de France (ENG 5032) and was sponsored by the Saint Joseph Hospital Network.,3_NonIndustryNonNIH
281," Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.","Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, Coric V, Lipton RB",2019-8,2019-Q3,10.1016/S0140-6736(19)31606-X,31311674,Lancet,1,1,1,,,,,,,,,1,,,1,9,1,,,,1,,,,,,,,,,,Biohaven Pharmaceuticals.,1_Industry
282, Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).,"Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshmane Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S",2019-7,2019-Q3,10.1056/NEJMoa1814556,31314965,NEJM,1,1,1,,,,1,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Supported by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617, and UM1-AI068613, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); the International Initiative for Impact Evaluation with support from the Bill and Melinda Gates Foundation; the NIAID, the National Institute on Drug Abuse, and the National Institute of Mental Health, all part of the National Institutes of Health; funding (MR/R010161/1, to Dr. Hayes, Ms. Floyd, and Drs. Sabapathy and Macleod) from the U.K. Medical Research Council (MRC) and the U.K. Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the second program of the European and Developing Countries Clinical Trials Partnership supported by the European Union; funding (R/R015600/1, to Dr. Hauck) from the MRC and DFID, MRC Centre for Global Infectious Disease Analysis; funding (HPRU-2012-10080, to Dr. Hauck) from the National Institute for Health Research (NIHR) Health Protection Research Unit with Public Health England; and funding (to Dr. Fidler) from the NIHR Imperial Biomedical Research Centre.",4_Mixed
283, HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.,"Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, Kabami J, Sang N, Liegler T, Chamie G, Camlin CS, Jain V, Kadede K, Atukunda M, Ruel T, Shade SB, Ssemmondo E, Byonanebye DM, Mwangwa F, Owaraganise A, Olilo W, Black D, Snyman K, Burger R, Getahun M, Achando J, Awuonda B, Nakato H, Kironde J, Okiror S, Thirumurthy H, Koss C, Brown L, Marquez C, Schwab J, Lavoy G, Plenty A, Mugoma Wafula E, Omanya P, Chen YH, Rooney JF, Bacon M, van der Laan M, Cohen CR, Bukusi E, Kamya MR, Petersen M",2019-7,2019-Q3,10.1056/NEJMoa1809866,31314966,NEJM,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Supported by the Division of AIDS, National Institute of Allergy and Infectious Diseases of the National Institutes of Health (awards U01AI099959, UM1AI068636, and R01 AI074345-06A1); the President’s Emergency Plan for AIDS Relief; and Gilead Sciences, which provided tenofovir–emtricitabine (Truvada) in kind.",2_NonIndustryNIH
284," Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.","Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Lebelonyane R, Alwano MG, Powis KM, Dryden-Peterson SL, Kgathi C, Novitsky V, Moore J, Bachanas P, Abrams W, Block L, El-Halabi S, Marukutira T, Mills LA, Sexton C, Raizes E, Gaseitsiwe S, Bussmann H, Okui L, John O, Shapiro RL, Pals S, Michael H, Roland M, DeGruttola V, Lei Q, Wang R, Tchetgen Tchetgen E, Essex M, Lockman S",2019-7,2019-Q3,10.1056/NEJMoa1812281,31314967,NEJM,1,1,1,,,,,,,,,,,1,1,12,1,,,,1,,,,,,,,,,,"Supported by the President's Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention (CDC) (cooperative agreements U01 GH000447 and U2G GH001911); the National Institutes of Health (NIH) (grant R37 AI051164, to Drs. DeGruttola, Wang, and Wirth, grant K23 AI091434, to Dr. Dryden-Peterson, grants D43 TW000004 and D43 TW009610, to Drs. Gaseitsiwe, Moyo, and Okui, grant K24 AI131928, to Dr. Lockman, grant K23 HD070774, to Dr. Powis, grant R01 CA222147, to Dr. Tchetgen Tchetgen, and grants R01 AI104459 and R01 AI127271, to Drs. Tchetgen Tchetgen and Wirth); the Oak Foundation; the Harvard University Center for AIDS Research, an NIH-funded program (grant P30 AI060354); and the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a Developing Excellence in Leadership, Training, and Science (DELTAS) Africa initiative (grant DEL-15-006, through Wellcome Trust 107752/Z/15/Z, to Drs. Moyo and Gaseitsiwe).",4_Mixed
285, The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial.,"Beard DJ, Davies LJ, Cook JA, MacLennan G, Price A, Kent S, Hudson J, Carr A, Leal J, Campbell H, Fitzpatrick R, Arden N, Murray D, Campbell MK",2019-8,2019-Q3,10.1016/S0140-6736(19)31281-4,31326135,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,National Institute for Health Research Health Technology Assessment Programme.,3_NonIndustryNonNIH
286," Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.","Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, Auburn S, Chand K, Chau NH, Cheah PY, Dong LT, Dhorda M, Degaga TS, Devine A, Ekawati LL, Fahmi F, Hailu A, Hasanzai MA, Hien TT, Khu H, Ley B, Lubell Y, Marfurt J, Mohammad H, Moore KA, Naddim MN, Pasaribu AP, Pasaribu S, Promnarate C, Rahim AG, Sirithiranont P, Solomon H, Sudoyo H, Sutanto I, Thanh NV, Tuyet-Trinh NT, Waithira N, Woyessa A, Yamin FY, Dondorp A, Simpson JA, Baird JK, White NJ, Day NP, Price RN",2019-9,2019-Q3,10.1016/S0140-6736(19)31285-1,31327563,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"UK Department for International Development, UK Medical Research Council, UK National Institute for Health Research, and the Wellcome Trust through the Joint Global Health Trials Scheme (MR/K007424/1) and the Bill & Melinda Gates Foundation (OPP1054404).",3_NonIndustryNonNIH
287, Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.,"Genovese MC, Kalunian K, Gottenberg JE, Mozaffarian N, Bartok B, Matzkies F, Gao J, Guo Y, Tasset C, Sundy JS, de Vlam K, Walker D, Takeuchi T",2019-7,2019-Q3,10.1001/jama.2019.9055,31334793,JAMA,1,1,1,,,,,,,,,1,,,1,6,1,,,1,1,,,,,,,,,,,This study was supported by Gilead Sciences Inc.,1_Industry
288, Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.,"Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL",2019-7,2019-Q3,10.1001/jama.2019.9346,31334795,JAMA,1,1,1,,,,,1,NINDS Archived Clinical Research Datasets,0,0,,,,,,,,,,,,,,,,,,,,,"This study was funded by grants U01 NS069498, U01 NS056975, and U01 NS059041 from the National Institute of Neurological Disorders and Stroke. The Medical Decision Network LLC provided the Glucostabilizer software at no cost.",2_NonIndustryNIH
289, Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.,"Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E",2019-8,2019-Q3,10.1056/NEJMoa1904340,31339676,NEJM,1,1,1,,,1,,,,,,,,,1,4,1,,,,1,,,,,,,,,,,Supported by Unitaid and the French National Agency for AIDS Research (ANRS 12313).,3_NonIndustryNonNIH
290, Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.,"Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, Serenata C, Akpomiemie G, Qavi A, Chandiwana N, Norris S, Chersich M, Clayden P, Abrams E, Arulappan N, Vos A, McCann K, Simmons B, Hill A",2019-8,2019-Q3,10.1056/NEJMoa1902824,31339677,NEJM,1,1,,,1,,,1,USAID Development Data Library (DDL),0,0,,,,1,,,,,,1,,,,,,,,,,,"Supported by the U.S. Agency for International Development, Unitaid, and the South African Medical Research Council. Investigational drugs were donated by Gilead Sciences and ViiV Healthcare.",3_NonIndustryNonNIH
291, Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.,"Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP",2019-9,2019-Q3,10.1056/NEJMoa1813599,31340089,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by FibroGen and FibroGen [China] Medical Technology Development,1_Industry
292, Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.,"Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Zhong B, Stuyckens K, Santiago-Walker A, De Porre P, OHagan A, Avadhani A, Siefker-Radtke AO",2019-7,2019-Q3,10.1056/NEJMoa1817323,31340094,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by Janssen Research and Development,1_Industry
293, Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.,"Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP",2019-9,2019-Q3,10.1056/NEJMoa1901713,31340116,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by FibroGen and FibroGen [China] Medical Technology Development,1_Industry
294, Immediate Transfusion in African Children with Uncomplicated Severe Anemia.,"Maitland K, Kiguli S, Olupot-Olupot P, Engoru C, Mallewa M, Saramago Goncalves P, Opoka RO, Mpoya A, Alaroker F, Nteziyaremye J, Chagaluka G, Kennedy N, Nabawanuka E, Nakuya M, Namayanja C, Uyoga S, Kyeyune Byabazaire D, Mbaya B, Wabwire B, Frost G, Bates I, Evans JA, Williams TN, George EC, Gibb DM, Walker AS",2019-8,2019-Q3,10.1056/NEJMoa1900105,31365799,NEJM,1,1,,,1,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the Medical Research Council and Department for International Development,3_NonIndustryNonNIH
295, Transfusion Volume for Children with Severe Anemia in Africa.,"Maitland K, Olupot-Olupot P, Kiguli S, Chagaluka G, Alaroker F, Opoka RO, Mpoya A, Engoru C, Nteziyaremye J, Mallewa M, Kennedy N, Nakuya M, Namayanja C, Kayaga J, Uyoga S, Kyeyune Byabazaire D, Mbaya B, Wabwire B, Frost G, Bates I, Evans JA, Williams TN, Saramago Goncalves P, George EC, Gibb DM, Walker AS",2019-8,2019-Q3,10.1056/NEJMoa1900100,31365800,NEJM,1,1,,,1,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Funded by the Medical Research Council and Department for International Development, United Kingdom",3_NonIndustryNonNIH
296, Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.,"Shanafelt TD, Wang XV, Kay NE, Hanson CA, OBrien S, Barrientos J, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba H, Stone RM, Litzow M, Tallman M",2019-8,2019-Q3,10.1056/NEJMoa1817073,31365801,NEJM,1,1,,,1,,,1,NCTN/NCORP Data Archive,0,0,,,,,,,,,,,,,,,,,,,,,"Supported by the National Cancer Institute of the NIH (award numbers, CA193541, CA180820, CA180794, CA189828, CA180790, CA180791, CA180816, CA180833, CA189863, CA190140, CA180821, CA180888, CA189821, CA180816, CA180867, and CA180855) and in part by Pharmacyclics (a subsidiary of AbbVie).",4_Mixed
297," Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.","Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, von Dadelszen P, Shochet T, Winikoff B",2019-9,2019-Q3,10.1016/S0140-6736(19)31282-6,31378394,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"PREEMPT (University of British Columbia, Vancouver, BC, Canada; grantee of Bill & Melinda Gates Foundation)",3_NonIndustryNonNIH
298, Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.,"Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG",2019-9,2019-Q3,10.1016/S0140-6736(19)31270-X,31378395,Lancet,1,1,,,1,1,,,,,,,,,1,,,,,,1,,,,,,,,,,,National Institute for Health Research Efficacy and Mechanism Evaluation Programme.,3_NonIndustryNonNIH
299, Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.,"Witztum JL, Gaudet D, Freedman SD, Alexander VJ, Digenio A, Williams KR, Yang Q, Hughes SG, Geary RS, Arca M, Stroes ESG, Bergeron J, Soran H, Civeira F, Hemphill L, Tsimikas S, Blom DJ, ODea L, Bruckert E",2019-8,2019-Q3,10.1056/NEJMoa1715944,31390500,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Ionis Pharmaceuticals and Akcea Therapeutics,1_Industry
300," Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial.","Koskenvuo L, Lehtonen T, Koskensalo S, Rasilainen S, Klintrup K, Ehrlich A, Pinta T, Scheinin T, Sallinen V",2019-9,2019-Q3,10.1016/S0140-6736(19)31269-3,31402112,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Vatsatautien Tutkimussäätiö Foundation, Mary and Georg Ehrnrooth's Foundation, and Helsinki University Hospital research funds.",3_NonIndustryNonNIH
301," Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.","Reich K, Armstrong AW, Langley RG, Flavin S, Randazzo B, Li S, Hsu MC, Branigan P, Blauvelt A",2019-9,2019-Q3,10.1016/S0140-6736(19)31773-8,31402114,Lancet,1,1,1,,,,,1,The Yale Open Data Access (YODA) Project,0,0,,,,,,,,,,,,,,,,,,,,,This study was funded by Janssen Research & Development.,1_Industry
302, Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.,"Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN",2019-8,2019-Q3,10.1001/jama.2019.10551,31408137,JAMA,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,1,1,,,,1,12,1,,,,1,,,,,,,,,,,"The Systolic Blood Pressure Intervention Trial was funded by the NIH, including the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke under contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C and interagency agreement A-HL-13-002-001. It was also supported in part with resources and use of facilities through the Department of Veterans Affairs. Azilsartan and chlorthalidone (combined with azilsartan) were provided by Takeda Pharmaceuticals International Inc. Computing resources were supported through 1S10OD023495-01, and additional support was provided through National Center for Advancing Translational Sciences clinical and translational science awards UL1TR000439 (awarded to Case Western Reserve University); UL1RR025755 (Ohio State University); UL1RR024134 and UL1TR000003 (University of Pennsylvania); UL1RR025771 (Boston University); UL1TR000093 (Stanford University); UL1RR025752, UL1TR000073, and UL1TR001064 (Tufts University); UL1TR000050 (University of Illinois); UL1TR000005 (University of Pittsburgh); 9U54TR000017-06 (University of Texas Southwestern Medical Center); UL1TR000105-05 (University of Utah); UL1 TR000445 (Vanderbilt University); UL1TR000075 (George Washington University); UL1 TR000002 (University of California, Davis); UL1 TR000064 (University of Florida); and UL1TR000433 (University of Michigan) and by National Institute of General Medical Sciences, Centers of Biomedical Research Excellence award NIGMS P30GM103337 (Tulane University).",2_NonIndustryNIH
303," Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.","Ferrari MD, Diener HC, Ning X, Galic M, Cohen JM, Yang R, Mueller M, Ahn AH, Schwartz YC, Grozinski-Wolff M, Janka L, Ashina M",2019-9,2019-Q3,10.1016/S0140-6736(19)31946-4,31427046,Lancet,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,Teva Pharmaceuticals.,1_Industry
304, Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.,"Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, Marino P, Banerjee S, Pollari CD, Wu Y, Voineskos AN, Mulsant BH",2019-8,2019-Q3,10.1001/jama.2019.10517,31429896,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"This study was funded by US Public Health Service grants MH 62446, MH 62518, MH 62565, and MH 62624 from the NIMH. Eli Lilly provided olanzapine and matching placebo pills and Pfizer provided sertraline; neither company provided funding for the study.",4_Mixed
305, Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.,"Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S",2019-8,2019-Q3,10.1056/NEJMoa1903455,31433920,NEJM,1,1,1,,,,,,,,,1,,,1,9,1,,,,1,,,,,,,,,,,Funded by Karyopharm Therapeutics,1_Industry
306," Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.","Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, Ostovaneh MR, Nateghi A, Majed M, Navabakhsh B, Merat S, Pourshams A, Nalini M, Malekzadeh F, Sadeghi M, Mohammadifard N, Sarrafzadegan N, Naemi-Tabiei M, Fazel A, Brennan P, Etemadi A, Boffetta P, Thomas N, Marshall T, Cheng KK, Malekzadeh R",2019-8,2019-Q3,10.1016/S0140-6736(19)31791-X,31448738,Lancet,1,1,1,,,,,1,GEMINI Shared Repository (GEMShare),0,0,,,,,,,,,,,,,,,,,,,,,"Tehran University of Medical Sciences, Barakat Foundation, and Alborz Darou.",4_Mixed
307," Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.","Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R",2019-9,2019-Q3,10.1016/S0140-6736(19)31948-8,31451207,Lancet,1,1,1,,,1,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,Health Research Council of New Zealand,3_NonIndustryNonNIH
308, Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.,"Park JR, Kreissman SG, London WB, Naranjo A, Cohn SL, Hogarty MD, Tenney SC, Haas-Kogan D, Shaw PJ, Kraveka JM, Roberts SS, Geiger JD, Doski JJ, Voss SD, Maris JM, Grupp SA, Diller L",2019-8,2019-Q3,10.1001/jama.2019.11642,31454045,JAMA,1,1,1,,,,,1,NCTN/NCORP Data Archive,0,0,,,,1,6,1,,,,1,,,,,,,,,,,"Supported by National Institutes of Health, National Cancer Institute (Grant No. U10 CA180899 to Children's Oncology Group Statistics and Data Center), National Clinical Trials Network Operations Center (Grant U10 CA180886), and St Baldrick's Foundation.",4_Mixed
309, Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial.,"Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK",2019-8,2019-Q3,10.1001/jama.2019.11889,31454046,JAMA,1,1,1,,,1,,,,,,,,,1,4,1,,,,1,,,,,,,,,,,Funding was provided by Pure North S'Energy Foundation in response to an investigator-initiated research grant proposal.,3_NonIndustryNonNIH
310, Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.,"Chappell LC, Brocklehurst P, Green ME, Hunter R, Hardy P, Juszczak E, Linsell L, Chiocchia V, Greenland M, Placzek A, Townend J, Marlow N, Sandall J, Shennan A",2019-9,2019-Q3,10.1016/S0140-6736(19)31963-4,31472930,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,1,,,,,,,,,,National Institute for Health Research Health Technology Assessment Programme.,3_NonIndustryNonNIH
311, Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.,"Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H",2019-9,2019-Q3,10.1056/NEJMoa1904143,31475793,NEJM,1,1,,,1,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the Japan Cardiovascular Research Foundation,3_NonIndustryNonNIH
312, Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.,"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Dungen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP",2019-10,2019-Q4,10.1056/NEJMoa1908655,31475794,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by Novartis,1_Industry
313, Complete Revascularization with Multivessel PCI for Myocardial Infarction.,"Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, Lopez-Sendon J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum A, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodes-Cabau J, Stankovic G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA",2019-10,2019-Q4,10.1056/NEJMoa1907775,31475795,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The trial was coordinated and sponsored by the Population Health Research Institute of Hamilton Health Sciences and McMaster University. The trial was funded by the Canadian Institutes of Health Research. AstraZeneca and Boston Scientific provided additional funding. These companies had no role in the trial design; collection, analysis, or interpretation of the data; or writing of the manuscript. The protocol was approved by institutional review boards at all trial centers. The authors vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol.",4_Mixed
314, Ticagrelor in Patients with Stable Coronary Disease and Diabetes.,"Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstrale W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalan R, Cornel JH, Widimsky P, Leiter LA",2019-10,2019-Q4,10.1056/NEJMoa1908077,31475798,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by AstraZeneca,1_Industry
315, Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.,"Schupke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wohrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flugel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Mollmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schuhlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tolg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A",2019-10,2019-Q4,10.1056/NEJMoa1908973,31475799,NEJM,1,1,,,1,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the German Center for Cardiovascular Research and Deutsches Herzzentrum München,3_NonIndustryNonNIH
316, N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.,"Radonovich LJ Jr, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, Los JG, Krosche AE, Gibert CL, Gorse GJ, Nyquist AC, Reich NG, Rodriguez-Barradas MC, Price CS, Perl TM",2019-9,2019-Q3,10.1001/jama.2019.11645,31479137,JAMA,1,1,1,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,"This trial was funded by the US Centers for Disease Control and Prevention, Veterans Health Administration, and the Biodefense Advanced Research and Development Agency.",3_NonIndustryNonNIH
317, Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.,"Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V, Eby CS",2019-9,2019-Q3,10.1001/jama.2019.12085,31479138,JAMA,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,0,0,,,,,,,,,,,,,,,,,,,,,Research reported in this publication was supported by grant R01 HL097036 from the NHLBI. Statistical analyses were supported by the grant UL1 TR000448 from the National Center for Advancing Translational Sciences through the Washington University Institute of Clinical and Translational Sciences. Genotyping was supported by grant CAG-00400N from the Centers for Medicare & Medicaid Services (CMS). GenMarkDx loaned the eSensor genotyping platform to the Central Genotyping Laboratory.,2_NonIndustryNIH
318, A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.,"Claassens DMF, Vos GJA, Bergmeijer TO, Hermanides RS, van t Hof AWJ, van der Harst P, Barbato E, Morisco C, Tjon Joe Gin RM, Asselbergs FW, Mosterd A, Herrman JR, Dewilde WJM, Janssen PWA, Kelder JC, Postma MJ, de Boer A, Boersma C, Deneer VHM, Ten Berg JM",2019-10,2019-Q4,10.1056/NEJMoa1907096,31479209,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the Netherlands Organization for Health Research and Development,3_NonIndustryNonNIH
319, Trial of SAGE-217 in Patients with Major Depressive Disorder.,"Gunduz-Bruce H, Silber C, Kaul I, Rothschild AJ, Riesenberg R, Sankoh AJ, Li H, Lasser R, Zorumski CF, Rubinow DR, Paul SM, Jonas J, Doherty JJ, Kanes SJ",2019-9,2019-Q3,10.1056/NEJMoa1815981,31483961,NEJM,1,1,,1,,,,,,,,,,1,,,,,,,,,,,,,,,,,,Funded by Sage Therapeutics,1_Industry
320, Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins.,"Brittenden J, Cooper D, Dimitrova M, Scotland G, Cotton SC, Elders A, MacLennan G, Ramsay CR, Norrie J, Burr JM, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, Tassie E, Francis J, Campbell MK",2019-9,2019-Q3,10.1056/NEJMoa1805186,31483962,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the National Institute for Health Research,3_NonIndustryNonNIH
321, Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.,"Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K",2019-9,2019-Q3,10.1056/NEJMoa1816216,31483963,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,"Funded by the Japan Agency for Medical Research and Development and the Ministry of Health, Labor, and Welfare of Japan",3_NonIndustryNonNIH
322, Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.,"Grace RF, Rose C, Layton DM, Galacteros F, Barcellini W, Morton DH, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM, Sheth S, Kwiatkowski JL, Barbier AJ, Bodie S, Silver B, Hua L, Kung C, Hawkins P, Jouvin MH, Bowden C, Glader B",2019-9,2019-Q3,10.1056/NEJMoa1902678,31483964,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,Funded by Agios Pharmaceuticals,1_Industry
323," Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.","Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstrale W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA",2019-9,2019-Q3,10.1016/S0140-6736(19)31887-2,31484629,Lancet,1,1,1,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,AstraZeneca,1_Industry
324, A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.,"Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S",2019-10,2019-Q4,10.1016/S0140-6736(19)31949-X,31488369,Lancet,1,1,1,,,1,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,"Canadian Institutes of Health Research; Grand Challenges Canada; Ontario SPOR Support Unit and the Ontario Ministry of Health and Long-Term Care; Boehringer Ingelheim; Department of Management of Non-Communicable Diseases, WHO; and Population Health Research Institute.",4_Mixed
325," Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.","Bauer A, Klemm M, Rizas KD, Hamm W, von Stulpnagel L, Dommasch M, Steger A, Lubinski A, Flevari P, Harden M, Friede T, Kaab S, Merkely B, Sticherling C, Willems R, Huikuri H, Malik M, Schmidt G, Zabel M",2019-10,2019-Q4,10.1016/S0140-6736(19)31996-8,31488371,Lancet,1,1,1,,,1,1,,,,,,,,1,,,,,,1,,,,,,,,,,,The European Community's 7th Framework Programme,3_NonIndustryNonNIH
326," Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.","Iglesias JF, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Stortecky S, Losdat S, Eeckhout E, Valgimigli M, Odutayo A, Zwahlen M, Juni P, Windecker S, Pilgrim T",2019-10,2019-Q4,10.1016/S0140-6736(19)31877-X,31488372,Lancet,1,1,1,,,,,1,Bern Open Repository and Information System (BORIS),1,0,,,,1,24,,1,,,1,,,,,,,,,,,Biotronik,1_Industry
327, Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.,"Thuijs DJFM, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, Holmes DR Jr, Curzen N, Davierwala P, Noack T, Milojevic M, Dawkins KD, da Costa BR, Juni P, Head SJ",2019-10,2019-Q4,10.1016/S0140-6736(19)31997-X,31488373,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"German Foundation of Heart Research (SYNTAXES study, 5-10-year follow-up) and Boston Scientific Corporation",4_Mixed
328," Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.","Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A",2019-10,2019-Q4,10.1016/S0140-6736(19)31872-0,31492505,Lancet,1,1,1,,,,,1,Vivli Center for Global Clinical Research Data,0,0,,,,1,60,,,1,,1,,,,,,,,,,,Daiichi Sankyo,1_Industry
329," Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.","Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E",2019-10,2019-Q4,10.1016/S0140-6736(19)31817-3,31495497,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,MedImmune and Viela Bio,1_Industry
330, Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.,"Hausenloy DJ, Kharbanda RK, Moller UK, Ramlall M, Aaroe J, Butler R, Bulluck H, Clayton T, Dana A, Dodd M, Engstrom T, Evans R, Lassen JF, Christensen EF, Garcia-Ruiz JM, Gorog DA, Hjort J, Houghton RF, Ibanez B, Knight R, Lippert FK, Lonborg JT, Maeng M, Milasinovic D, More R, Nicholas JM, Jensen LO, Perkins A, Radovanovic N, Rakhit RD, Ravkilde J, Ryding AD, Schmidt MR, Riddervold IS, Sorensen HT, Stankovic G, Varma M, Webb I, Terkelsen CJ, Greenwood JP, Yellon DM, Botker HE",2019-10,2019-Q4,10.1016/S0140-6736(19)32039-2,31500849,Lancet,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"British Heart Foundation, University College London Hospitals/University College London Biomedical Research Centre, Danish Innovation Foundation, Novo Nordisk Foundation, TrygFonden.",3_NonIndustryNonNIH
331, Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.,"Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR",2019-9,2019-Q3,10.1001/jama.2019.12618,31503307,JAMA,1,1,1,,,1,1,,,,,,,,1,9,1,,,,1,,,,,,,,,,,"This study was supported by NEI cooperative agreement U10 EY021125 (to Dr Acharya, primary investigator). The University of California San Francisco pharmacy provided study drugs for all sites. The Department of Ophthalmology at UCSF is supported by an unrestricted grant from the Research to Prevent Blindness Foundation, a core grant (EY06190) from the NEI, and That Man May See Foundation.",2_NonIndustryNIH
332, Effect of a Multicomponent Home-Based Physical Therapy Intervention on Ambulation After Hip Fracture in Older Adults: The CAP Randomized Clinical Trial.,"Magaziner J, Mangione KK, Orwig D, Baumgarten M, Magder L, Terrin M, Fortinsky RH, Gruber-Baldini AL, Beamer BA, Tosteson ANA, Kenny AM, Shardell M, Binder EF, Koval K, Resnick B, Miller R, Forman S, McBride R, Craik RL",2019-9,2019-Q3,10.1001/jama.2019.12964,31503309,JAMA,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"This work was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute on Aging at the National Institutes of Health (R01 AG035009, R21 HD043269, R37 AG09901, T32 AG00262, and P30 AG028747). We also acknowledge support from the University of Maryland, Baltimore, Institute for Clinical and Translational Research. This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System and Baltimore VA Medical Center.",2_NonIndustryNIH
333, A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery.,"Makrides M, Best K, Yelland L, McPhee A, Zhou S, Quinlivan J, Dodd J, Atkinson E, Safa H, van Dam J, Khot N, Dekker G, Skubisz M, Anderson A, Kean B, Bowman A, McCallum C, Cashman K, Gibson R",2019-9,2019-Q3,10.1056/NEJMoa1816832,31509674,NEJM,1,1,1,,,1,1,,,,,,,,1,3,1,,,,1,,,,,,,,,,,Funded by the Australian National Health and Medical Research Council and the Thyne Reid Foundation,3_NonIndustryNonNIH
334," Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.","Mallucci CL, Jenkinson MD, Conroy EJ, Hartley JC, Brown M, Dalton J, Kearns T, Moitt T, Griffiths MJ, Culeddu G, Solomon T, Hughes D, Gamble C",2019-10,2019-Q4,10.1016/S0140-6736(19)31603-4,31522843,Lancet,1,1,1,,,1,,,,,,,,,1,9,1,,,,1,,,,,,,,,,,UK National Institute for Health Research Health Technology Assessment programme.,3_NonIndustryNonNIH
335, Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.,"Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, Li J, Liew M, Maier R, Zhu Q, Marlow N",2019-10,2019-Q4,10.1016/S0140-6736(19)31344-3,31522845,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Novartis,1_Industry
336," Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial.","Cooper K, Breeman S, Scott NW, Scotland G, Clark J, Hawe J, Hawthorn R, Phillips K, MacLennan G, Wileman S, McCormack K, Hernandez R, Norrie J, Bhattacharya S",2019-10,2019-Q4,10.1016/S0140-6736(19)31790-8,31522846,Lancet,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,UK National Institute for Health Research Health Technology Assessment Programme,3_NonIndustryNonNIH
337," Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.","Chinthrajah RS, Purington N, Andorf S, Long A, OLaughlin KL, Lyu SC, Manohar M, Boyd SD, Tibshirani R, Maecker H, Plaut M, Mukai K, Tsai M, Desai M, Galli SJ, Nadeau KC",2019-10,2019-Q4,10.1016/S0140-6736(19)31793-3,31522849,Lancet,1,1,,,1,1,,,,,,,,,1,,,,,,1,1,,,,,,,,,,National Institute of Allergy and Infectious Diseases,2_NonIndustryNIH
338, Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial.,"Sung VW, Borello-France D, Newman DK, Richter HE, Lukacz ES, Moalli P, Weidner AC, Smith AL, Dunivan G, Ridgeway B, Nguyen JN, Mazloomdoost D, Carper B, Gantz MG",2019-9,2019-Q3,10.1001/jama.2019.12467,31529007,JAMA,1,1,1,,,,,1,NICHD Data and Specimen Hub (DASH),0,0,,,,,,,,,,,,,,,,,,,,,"Supported by grants from the NICHD and NIH Office of Research on Women's Health (U10 HD041261, U10 HD069013, U10 HD054214, U10 HD054215, U10 HD041267, U10 HD069025, U10 HD069010, U10 HD069006, and U01 HD069031).",2_NonIndustryNIH
339, Effect of Vaginal Mesh Hysteropexy vs Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial.,"Nager CW, Visco AG, Richter HE, Rardin CR, Rogers RG, Harvie HS, Zyczynski HM, Paraiso MFR, Mazloomdoost D, Grey S, Sridhar A, Wallace D",2019-9,2019-Q3,10.1001/jama.2019.12812,31529008,JAMA,1,1,1,,,,,1,NICHD Data and Specimen Hub (DASH),0,0,,,,1,27,,,1,,1,,,,,,,,,,,"The study was conducted by the Eunice Kennedy Shriver National Institute of Child Health and Development√¢¬Ä¬ö√É¬Ñ√É¬¨sponsored Pelvic Floor Disorders Network (grant numbers U10 HD054214, U10 HD041267, U10 HD041261, U10 HD069013, U10 HD069025, U10 HD069010, U10 HD069006, U10 HD054215, and U01 HD069031). The project was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health. Boston Scientific Corporation provided partial study support through an unrestricted grant.",4_Mixed
340, Polypill for Cardiovascular Disease Prevention in an Underserved Population.,"Munoz D, Uzoije P, Reynolds C, Miller R, Walkley D, Pappalardo S, Tousey P, Munro H, Gonzales H, Song W, White C, Blot WJ, Wang TJ",2019-9,2019-Q3,10.1056/NEJMoa1815359,31532959,NEJM,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the American Heart Association Strategically Focused Prevention Research Network and the National Institutes of Health,4_Mixed
341, Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation.,"Maertens J, Cordonnier C, Jaksch P, Poire X, Uknis M, Wu J, Wijatyk A, Saliba F, Witzke O, Villano S",2019-9,2019-Q3,10.1056/NEJMoa1714656,31532960,NEJM,1,1,1,,,,,,,,,1,,,1,3,1,,,,1,,,,,,,,,,,Funded by ViroPharma/Shire Development,1_Industry
342," Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.","Agarwal R, Rossignol P, Romero A, Garza D, Mayo MR, Warren S, Ma J, White WB, Williams B",2019-10,2019-Q4,10.1016/S0140-6736(19)32135-X,31533906,Lancet,1,1,1,,,,,,,,,1,,,1,24,,1,,,1,,,,,,,,,,,"Relypsa, a Vifor Pharma Group Company",1_Industry
343, Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.,"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, Bohm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukat A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, OMeara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjostrand M, Langkilde AM",2019-11,2019-Q4,10.1056/NEJMoa1911303,31535829,NEJM,1,1,,,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,Funded by AstraZeneca,1_Industry
344," Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial.","Matthews DR, Paldanius PM, Proot P, Chiang Y, Stumvoll M, Del Prato S",2019-10,2019-Q4,10.1016/S0140-6736(19)32131-2,31542292,Lancet,1,1,1,,,,1,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,Novartis,1_Industry
345, Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.,"Sands BE, Sandborn WJ, Panaccione R, OBrien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C",2019-9,2019-Q3,10.1056/NEJMoa1900750,31553833,NEJM,1,1,1,,,,,1,The Yale Open Data Access (YODA) Project,0,0,,,,,,,,,,,,,,,,,,,,,Funded by Janssen Research and Development,1_Industry
346, Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.,"Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Toruner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S",2019-9,2019-Q3,10.1056/NEJMoa1905725,31553834,NEJM,1,1,1,,,,,1,Vivli Center for Global Clinical Research Data,0,0,,,,,,,,,,,,,,,,,,,,,Funded by Takeda,1_Industry
347, Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.,"Wechsler ME, Szefler SJ, Ortega VE, Pongracic JA, Chinchilli V, Lima JJ, Krishnan JA, Kunselman SJ, Mauger D, Bleecker ER, Bacharier LB, Beigelman A, Benson M, Blake KV, Cabana MD, Cardet JC, Castro M, Chmiel JF, Covar R, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Grossman N, Holguin F, Jackson DJ, Kumar H, Kraft M, LaForce CF, Lang J, Lazarus SC, Lemanske RF Jr, Long D, Lugogo N, Martinez F, Meyers DA, Moore WC, Moy J, Naureckas E, Olin JT, Peters SP, Phipatanakul W, Que L, Raissy H, Robison RG, Ross K, Sheehan W, Smith LJ, Solway J, Sorkness CA, Sullivan-Vedder L, Wenzel S, White S, Israel E",2019-9,2019-Q3,10.1056/NEJMoa1905560,31553835,NEJM,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,0,0,,,,,,,,,,,,,,,,,,,,,"Funded by the National Heart, Lung, and Blood Institute",2_NonIndustryNIH
348, Ticagrelor with or without Aspirin in High-Risk Patients after PCI.,"Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Dzavik V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM",2019-11,2019-Q4,10.1056/NEJMoa1908419,31556978,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by AstraZeneca,1_Industry
349, Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture.,"Bhandari M, Einhorn TA, Guyatt G, Schemitsch EH, Zura RD, Sprague S, Frihagen F, Guerra-Farfan E, Kleinlugtenbelt YV, Poolman RW, Rangan A, Bzovsky S, Heels-Ansdell D, Thabane L, Walter SD, Devereaux PJ",2019-12,2019-Q4,10.1056/NEJMoa1906190,31557429,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Supported by grants from the Canadian Institutes of Health Research (MCT-90168), the National Institutes of Health (1UM1AR063386-01), ZorgOnderzoek Nederland-Medische Wetenschappen (ZonMw) (17088.2503), Sophies Minde Foundation for Orthopaedic Research, McMaster Surgical Associates, and Stryker Orthopaedics.",4_Mixed
350, Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.,"Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, OByrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS",2019-11,2019-Q4,10.1056/NEJMoa1910231,31562796,NEJM,1,1,1,,,,,,,,,1,,,1,24,,1,,1,1,,,,,,,,,,,Funded by Bristol-Myers Squibb and Ono Pharmaceutical,1_Industry
351, Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.,"Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hogg D, Hill A, Marquez-Rodas I, Haanen J, Guidoboni M, Maio M, Schoffski P, Carlino MS, Lebbe C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bastholt L, Rizzo JI, Balogh A, Moshyk A, Hodi FS, Wolchok JD",2019-10,2019-Q4,10.1056/NEJMoa1910836,31562797,NEJM,1,1,1,,,,,,,,,1,,,1,24,,1,,1,1,,,,,,,,,,,"Supported by Bristol-Myers Squibb, a grant (P30CA008748, to Dr. Wolchok) from the National Cancer Institute, and a grant (to Dr. Larkin) from the National Institute for Health Research Royal Marsden–Institute of Cancer Research Biomedical Research Centre.",4_Mixed
352, Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.,"Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogats G, Mansour S, Noiseux N, Sabate M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Page P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Genereux P, Crowley A, Dressler O, Serruys PW",2019-11,2019-Q4,10.1056/NEJMoa1909406,31562798,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Abbott Vascular,1_Industry
353, Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.,"Gonzalez-Martin A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, OCearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Perez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ",2019-12,2019-Q4,10.1056/NEJMoa1910962,31562799,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Funded by GlaxoSmithKline,1_Industry
354, Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.,"Coleman RL, Fleming GF, Brady MF, Swisher EM, Steffensen KD, Friedlander M, Okamoto A, Moore KN, Efrat Ben-Baruch N, Werner TL, Cloven NG, Oaknin A, DiSilvestro PA, Morgan MA, Nam JH, Leath CA 3rd, Nicum S, Hagemann AR, Littell RD, Cella D, Baron-Hay S, Garcia-Donas J, Mizuno M, Bell-McGuinn K, Sullivan DM, Bach BA, Bhattacharya S, Ratajczak CK, Ansell PJ, Dinh MH, Aghajanian C, Bookman MA",2019-12,2019-Q4,10.1056/NEJMoa1909707,31562800,NEJM,1,1,1,,,,,1,Vivli Center for Global Clinical Research Data,0,0,1,,,,,,,,,,,,,,,,,,,,Funded by AbbVie,1_Industry
355, Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.,"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK",2019-10,2019-Q4,10.1056/NEJMoa1908681,31566307,NEJM,1,1,,,1,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,Funded by Boehringer Ingelheim,1_Industry
356," Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.","Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A, Tarpgaard LS, Braun M, Gollerkeri A, Keir C, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J",2019-10,2019-Q4,10.1056/NEJMoa1908075,31566309,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Supported by Array BioPharma, Merck (for sites outside North America), ONO Pharmaceutical, and Pierre Fabre.",1_Industry
357," Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.","Waksman R, Di Mario C, Torguson R, Ali ZA, Singh V, Skinner WH, Artis AK, Cate TT, Powers E, Kim C, Regar E, Wong SC, Lewis S, Wykrzykowska J, Dube S, Kazziha S, van der Ent M, Shah P, Craig PE, Zou Q, Kolm P, Brewer HB, Garcia-Garcia HM",2019-11,2019-Q4,10.1016/S0140-6736(19)31794-5,31570255,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Infraredx,1_Industry
358, Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.,"Lanz J, Kim WK, Walther T, Burgdorf C, Mollmann H, Linke A, Redwood S, Thilo C, Hilker M, Joner M, Thiele H, Conzelmann L, Conradi L, Kerber S, Schymik G, Prendergast B, Husser O, Stortecky S, Heg D, Juni P, Windecker S, Pilgrim T",2019-11,2019-Q4,10.1016/S0140-6736(19)32220-2,31570258,Lancet,1,1,1,,,,1,1,Bern Open Repository and Information System (BORIS),1,0,,,,1,24,,1,,,1,,,,,,,,,,,Boston Scientific,1_Industry
359, Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.,"Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, Sculthorpe R, Nanchal R, Syed A, Sturgill J, Martin GS, Sevransky J, Kashiouris M, Hamman S, Egan KF, Hastings A, Spencer W, Tench S, Mehkri O, Bindas J, Duggal A, Graf J, Zellner S, Yanny L, McPolin C, Hollrith T, Kramer D, Ojielo C, Damm T, Cassity E, Wieliczko A, Halquist M",2019-10,2019-Q4,10.1001/jama.2019.11825,31573637,JAMA,1,1,1,,,1,,,,,,,,1,,,,,,,,,,,,,,,,,,"Funding/Support: The study was supported by the National Heart, Lung, and Blood Institute (UM1HL116885), National Center for Advancing Translational Sciences, VCU Wright Center for Translational Science Award (CTSA) (UL1TR000058, NIH P50 AR072000), VCU Investigational Drug Services, and McGuff Pharmaceuticals, who supplied the vitamin C at no charge. Funds from the NHLBI were distributed to the participating institutions on a per-patient-enrolled basis. The principal investigator at each site determined how the funds were distributed.",2_NonIndustryNIH
360, Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm.,"Lascarrou JB, Merdji H, Le Gouge A, Colin G, Grillet G, Girardie P, Coupez E, Dequin PF, Cariou A, Boulain T, Brule N, Frat JP, Asfar P, Pichon N, Landais M, Plantefeve G, Quenot JP, Chakarian JC, Sirodot M, Legriel S, Letheulle J, Thevenin D, Desachy A, Delahaye A, Botoc V, Vimeux S, Martino F, Giraudeau B, Reignier J",2019-12,2019-Q4,10.1056/NEJMoa1906661,31577396,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Supported by independent research grants from the French Ministry of Health, the nonprofit health care institution Centre Hospitalier Départemental Vendée, and the Laerdal Foundation.",3_NonIndustryNonNIH
361, Ligelizumab for Chronic Spontaneous Urticaria.,"Maurer M, Gimenez-Arnau AM, Sussman G, Metz M, Baker DR, Bauer A, Bernstein JA, Brehler R, Chu CY, Chung WH, Danilycheva I, Grattan C, Hebert J, Katelaris C, Makris M, Meshkova R, Savic S, Sinclair R, Sitz K, Staubach P, Wedi B, Loffler J, Barve A, Kobayashi K, Hua E, Severin T, Janocha R",2019-10,2019-Q4,10.1056/NEJMoa1900408,31577874,NEJM,1,1,1,,,,1,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,Funded by Novartis Pharma,1_Industry
362, Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.,"Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Onyango-Makumbi C, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Mave V, Rouzier V, Hesseling A, Shin K, Zimmer B, Costello D, Sterling TR, Chakhtoura N, Jean-Philippe P, Weinberg A",2019-10,2019-Q4,10.1056/NEJMoa1813060,31577875,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,Funded by the National Institutes of Health,2_NonIndustryNIH
363, Community-wide Screening for Tuberculosis in a High-Prevalence Setting.,"Marks GB, Nguyen NV, Nguyen PTB, Nguyen TA, Nguyen HB, Tran KH, Nguyen SV, Luu KB, Tran DTT, Vo QTN, Le OTT, Nguyen YH, Do VQ, Mason PH, Nguyen VT, Ho J, Sintchenko V, Nguyen LN, Britton WJ, Fox GJ",2019-10,2019-Q4,10.1056/NEJMoa1902129,31577876,NEJM,1,1,,,1,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the Australian National Health and Medical Research Council,3_NonIndustryNonNIH
364," Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.","Virchow JC, Kuna P, Paggiaro P, Papi A, Singh D, Corre S, Zuccaro F, Vele A, Kots M, Georges G, Petruzzelli S, Canonica GW",2019-11,2019-Q4,10.1016/S0140-6736(19)32215-9,31582314,Lancet,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,Chiesi Farmaceutici,1_Industry
365," Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.","Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Ozguroglu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW",2019-11,2019-Q4,10.1016/S0140-6736(19)32222-6,31590988,Lancet,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,AstraZeneca,1_Industry
366, Effect of community-initiated kangaroo mother care on survival of infants with low birthweight: a randomised controlled trial.,"Mazumder S, Taneja S, Dube B, Bhatia K, Ghosh R, Shekhar M, Sinha B, Bahl R, Martines J, Bhan MK, Sommerfelt H, Bhandari N",2019-11,2019-Q4,10.1016/S0140-6736(19)32223-8,31590989,Lancet,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,Research Council of Norway and University of Bergen.,3_NonIndustryNonNIH
367, Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.,"Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA",2019-10,2019-Q4,10.1001/jama.2019.11982,31593271,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,1,1,,,,,,,Funding was provided by PCORI (Award IHS 1304-7118).,3_NonIndustryNonNIH
368, Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.,"Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, Reinstrup Bihlet A, Byrjalsen I, Ragnar Andersen J, Eckstein F",2019-10,2019-Q4,10.1001/jama.2019.14735,31593273,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,1,The study was funded by Merck KGaA and EMD Serono Research Institute Inc (a business of Merck KGaA).,1_Industry
369, Controlled Trial of Two Incremental Milk-Feeding Rates in Preterm Infants.,"Dorling J, Abbott J, Berrington J, Bosiak B, Bowler U, Boyle E, Embleton N, Hewer O, Johnson S, Juszczak E, Leaf A, Linsell L, McCormick K, McGuire W, Omar O, Partlett C, Patel M, Roberts T, Stenson B, Townend J",2019-10,2019-Q4,10.1056/NEJMoa1816654,31597020,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,Funded by the Health Technology Assessment Programme of the National Institute for Health Research,3_NonIndustryNonNIH
370, Effect of a Nutritional and Behavioral Intervention on Energy-Reduced Mediterranean Diet Adherence Among Patients With Metabolic Syndrome: Interim Analysis of the PREDIMED-Plus Randomized Clinical Trial.,"Sayon-Orea C, Razquin C, Bullo M, Corella D, Fito M, Romaguera D, Vioque J, Alonso-Gomez AM, Warnberg J, Martinez JA, Serra-Majem L, Estruch R, Tinahones FJ, Lapetra J, Pinto X, Tur JA, Lopez-Miranda J, Bueno-Cavanillas A, Delgado-Rodriguez M, Matia-Martin P, Daimiel L, Sanchez VM, Vidal J, Vazquez C, Ros E, Ruiz-Canela M, Sorli JV, Castaner O, Fiol M, Navarrete-Munoz EM, Aros F, Gomez-Gracia E, Zulet MA, Sanchez-Villegas A, Casas R, Bernal-Lopez R, Santos-Lozano JM, Corbella E, Bouzas C, Garcia-Arellano A, Basora J, Asensio EM, Schroder H, Monino M, Garcia de la Hera M, Tojal-Sierra L, Toledo E, Diaz-Lopez A, Goday A, Salas-Salvado J, Martinez-Gonzalez MA",2019-10,2019-Q4,10.1001/jama.2019.14630,31613346,JAMA,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"This work was supported by the European Research Council (Advanced Research grant 2014-2019; agreement #340918; granted to Dr Martínez-González); the official Spanish institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and Instituto de Salud Carlos III (ISCIII) through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (coordinated FIS projects led by Drs Salas-Salvadó and Vidal, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332) and the Especial Action Project “Implementación y evaluación de una intervención intensivasobre la actividad física Cohorte PREDIMED-Plus” (Dr Salas-Salvadó); the Recercaixa (grant number 2013ACUP00194) (Dr Salas-Salvadó); the SEMERGEN grant; International Nut and Dried Fruit Council–FESNAD (Long-term effects of an energy-restricted Mediterranean diet on mortality and cardiovascular disease 2014 –2015; No. 201302) (Dr Martinez-Gonzalez); the AstraZeneca Young Investigators Award in Category of Obesity and T2D 2017 (Dr Romaguera); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013; PS0358/2016; PI0137/2018), the PROMETEO/2017/017 grant from the Generalitat Valenciana, the SEMERGEN grant; grant of support to research groups 35/2011 (Balearic Islands Gov; FEDER funds) (Drs Tur and Bouzas).",3_NonIndustryNonNIH
371, Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.,"Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo H, Sanchez VM, Dunbar KB, Pham TH, Murthy UK, Kim T, Jackson CS, Wallen JM, von Rosenvinge EC, Pearl JP, Laine L, Kim AW, Kaz AM, Tatum RP, Gellad ZF, Lagoo-Deenadayalan S, Rubenstein JH, Ghaferi AA, Lo WK, Fernando RS, Chan BS, Paski SC, Provenzale D, Castell DO, Lieberman D, Souza RF, Chey WD, Warren SR, Davis-Karim A, Melton SD, Genta RM, Serpi T, Biswas K, Huang GD",2019-10,2019-Q4,10.1056/NEJMoa1811424,31618539,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,Funded by the Department of Veterans Affairs Cooperative Studies Program,3_NonIndustryNonNIH
372," Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.","Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW",2019-10,2019-Q4,10.1056/NEJMoa1907863,31618560,NEJM,1,1,1,,,,,1,The Jaeb Center for Health Research,0,0,,,,1,36,,,1,,1,,,,,,,,,,,Funded by the National Institute of Diabetes and Digestive and Kidney Diseases,2_NonIndustryNIH
373," Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.",CRASH-3 trial collaborators.,2019-11,2019-Q4,10.1016/S0140-6736(19)32233-0,31623894,Lancet,1,1,1,,,,,1,Free Bank of Injury and Emergency Research Data (freeBIRD),0,0,,,,,,,,,,,,,,,,,,,,,"National Institute for Health Research Health Technology Assessment, JP Moulton Charitable Trust, Department of Health and Social Care, Department for International Development, Global Challenges Research Fund, Medical Research Council, and Wellcome Trust (Joint Global Health Trials scheme)",3_NonIndustryNonNIH
374, Metoprolol for the Prevention of Acute Exacerbations of COPD.,"Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoglu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE",2019-12,2019-Q4,10.1056/NEJMoa1908142,31633896,NEJM,1,1,1,,,,,1,University of Minesota Repository,0,0,,,,1,24,,1,,,1,,,,,,,,,,,Funded by the Department of Defense,3_NonIndustryNonNIH
375, Effect of Cryotherapy vs Loop Electrosurgical Excision Procedure on Cervical Disease Recurrence Among Women With HIV and High-Grade Cervical Lesions in Kenya: A Randomized Clinical Trial.,"Greene SA, De Vuyst H, John-Stewart GC, Richardson BA, McGrath CJ, Marson KG, Trinh TT, Yatich N, Kiptinness C, Cagle A, Nyongesa-Malava E, Sakr SR, Mugo NR, Chung MH",2019-10,2019-Q4,10.1001/jama.2019.14969,31638680,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,This research has been supported by the President's Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention under the terms of cooperative agreements GH002036 and GH002001.,3_NonIndustryNonNIH
376, Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.,"Reddihough DS, Marraffa C, Mouti A, OSullivan M, Lee KJ, Orsini F, Hazell P, Granich J, Whitehouse AJO, Wray J, Dossetor D, Santosh P, Silove N, Kohn M",2019-10,2019-Q4,10.1001/jama.2019.14685,31638682,JAMA,1,1,1,,,1,,,,,,,,,1,3,1,,,,1,,,,,,,,,,,"The study was funded by the NHMRC (NHMRC project grant 607332) (Drs Reddihough, Marraffa, Hazell, Lee, Kohn, and Wray) and the Royal Children's Hospital Foundation, Melbourne, Australia (Dr Reddihough). Infrastructure support was provided by the Victorian government's Operational Infrastructure Support Program. The Murdoch Children's Research Institute, Melbourne, was the sponsor for this study.",3_NonIndustryNonNIH
377," Anaesthetic depth and complications after major surgery: an international, randomised controlled trial.","Short TG, Campbell D, Frampton C, Chan MTV, Myles PS, Corcoran TB, Sessler DI, Mills GH, Cata JP, Painter T, Byrne K, Han R, Chu MHM, McAllister DJ, Leslie K",2019-11,2019-Q4,10.1016/S0140-6736(19)32315-3,31645286,Lancet,1,1,1,,,,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,"Health Research Council of New Zealand; National Health and Medical Research Council, Australia; Research Grant Council of Hong Kong; National Institute for Health and Research, UK; and National Institutes of Health, USA.",3_NonIndustryNonNIH
378, Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial.,"Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, Mayers DB, Meyer-Treschan TA, Grady M, Tan EY, Ayad S, Mascha EJ, Buggy DJ",2019-11,2019-Q4,10.1016/S0140-6736(19)32313-X,31645288,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,1,,,,,,,,,,"Sisk Healthcare Foundation (Ireland), Eccles Breast Cancer Research Fund, British Journal of Anaesthesia International, College of Anaesthetists of Ireland, Peking Union Medical College Hospital, Science Fund for Junior Faculty 2016, Central Bank of Austria, and National Healthcare Group.",3_NonIndustryNonNIH
379, Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.,"Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, Van Brakel E, Salaun B, Scriba TJ, Akite EJ, Ayles HM, Bollaerts A, Demoitie MA, Diacon A, Evans TG, Gillard P, Hellstrom E, Innes JC, Lempicki M, Malahleha M, Martinson N, Mesia Vela D, Muyoyeta M, Nduba V, Pascal TG, Tameris M, Thienemann F, Wilkinson RJ, Roman F",2019-12,2019-Q4,10.1056/NEJMoa1909953,31661198,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),1,1,1,,,,,,,,,,,,,,,,,,,,Funded by GlaxoSmithKline Biologicals and Aeras,1_Industry
380, Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.,"Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, Montesinos P, Baer MR, Larson RA, Ustun C, Fabbiano F, Erba HP, Di Stasi A, Stuart R, Olin R, Kasner M, Ciceri F, Chou WC, Podoltsev N, Recher C, Yokoyama H, Hosono N, Yoon SS, Lee JH, Pardee T, Fathi AT, Liu C, Hasabou N, Liu X, Bahceci E, Levis MJ",2019-10,2019-Q4,10.1056/NEJMoa1902688,31665578,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,1,1,,,,,,,,,,,Funded by Astellas Pharma,1_Industry
381," Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.","Burtness B, Harrington KJ, Greil R, Soulieres D, Tahara M, de Castro G Jr, Psyrri A, Baste N, Neupane P, Bratland A, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, Gonzalez Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D",2019-11,2019-Q4,10.1016/S0140-6736(19)32591-7,31679945,Lancet,1,1,1,,,,,,,,,1,,,1,18,,1,,1,1,,,,,,,,,,,Merck Sharp & Dohme,1_Industry
382," Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.","Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS",2019-11,2019-Q4,10.1016/S0140-6736(19)32597-8,31679946,Lancet,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Vertex Pharmaceuticals.,1_Industry
383, Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.,"Fisher BT, Zaoutis T, Dvorak CC, Nieder M, Zerr D, Wingard JR, Callahan C, Villaluna D, Chen L, Dang H, Esbenshade AJ, Alexander S, Wiley JM, Sung L",2019-11,2019-Q4,10.1001/jama.2019.15702,31688884,JAMA,1,1,1,,,,,1,NCTN/NCORP Data Archive,0,0,,,,,,,,,,,,,,,,,,,,,"This study was supported by the following National Cancer Institute grants: NCORP grant UG1CA189955, NCTN Statistics & Data Center grant U10CA 180899, NCTN Operations Center grant U10CA 180886. Caspofungin was supplied by Merck & Company Inc.",2_NonIndustryNIH
384, Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.,"Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, Sirivichayakul C, Watanaveeradej V, Rivera L, Espinoza F, Fernando L, Dietze R, Luz K, Venancio da Cunha R, Jimeno J, Lopez-Medina E, Borkowski A, Brose M, Rauscher M, LeFevre I, Bizjajeva S, Bravo L, Wallace D",2019-11,2019-Q4,10.1056/NEJMoa1903869,31693803,NEJM,1,1,1,,,,1,1,Vivli Center for Global Clinical Research Data,0,0,1,,,,,,,,1,1,,,,,,,,,,,Funded by Takeda Vaccines,1_Industry
385, Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest.,"Francois B, Cariou A, Clere-Jehl R, Dequin PF, Renon-Carron F, Daix T, Guitton C, Deye N, Legriel S, Plantefeve G, Quenot JP, Desachy A, Kamel T, Bedon-Carte S, Diehl JL, Chudeau N, Karam E, Durand-Zaleski I, Giraudeau B, Vignon P, Le Gouge A",2019-11,2019-Q4,10.1056/NEJMoa1812379,31693806,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by the French Ministry of Health,3_NonIndustryNonNIH
386, Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.,"Middleton PG, Mall MA, Drevinek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R",2019-11,2019-Q4,10.1056/NEJMoa1908639,31697873,NEJM,1,1,,,1,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,Funded by Vertex Pharmaceuticals,1_Industry
387, Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.,"Goldberg AC, Leiter LA, Stroes ESG, Baum SJ, Hanselman JC, Bloedon LT, Lalwani ND, Patel PM, Zhao X, Duell PB",2019-11,2019-Q4,10.1001/jama.2019.16585,31714986,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This study was funded by Esperion Therapeutics Inc. Medical writing/editorial support for preparation of this article was also provided to JB Ashtin by Esperion Therapeutics Inc.,1_Industry
388, Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.,"Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, Hornung J, Weidenthaler H, Heery CR, Meyer TPH, Silbernagl G, Maclennan J, Chaplin P",2019-11,2019-Q4,10.1056/NEJMoa1817307,31722150,NEJM,1,1,,,1,,,,,,,1,,,1,6,1,,,,1,,,,,,,,,,,Funded by the Office of the Assistant Secretary for Preparedness and Response Biomedical Advanced Research and Development Authority of the Department of Health and Human Services and Bavarian Nordic,4_Mixed
389, Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.,"Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L, Hung G, Lee J, Kowey P, Talati N, Nag D, Gummidipundi SE, Beatty A, Hills MT, Desai S, Granger CB, Desai M, Turakhia MP",2019-11,2019-Q4,10.1056/NEJMoa1901183,31722151,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Apple,1_Industry
390, Trial of Apremilast for Oral Ulcers in Behcet's Syndrome.,"Hatemi G, Mahr A, Ishigatsubo Y, Song YW, Takeno M, Kim D, Melikoglu M, Cheng S, McCue S, Paris M, Chen M, Yazici Y",2019-11,2019-Q4,10.1056/NEJMoa1816594,31722152,NEJM,1,1,,,1,,,,,,,1,,1,,,,,,,,,,,,,,,,,,Funded by Celgene,1_Industry
391, Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.,"Coleman RL, Spirtos NM, Enserro D, Herzog TJ, Sabbatini P, Armstrong DK, Kim JW, Park SY, Kim BG, Nam JH, Fujiwara K, Walker JL, Casey AC, Alvarez Secord A, Rubin S, Chan JK, DiSilvestro P, Davidson SA, Cohn DE, Tewari KS, Basen-Engquist K, Huang HQ, Brady MF, Mannel RS",2019-11,2019-Q4,10.1056/NEJMoa1902626,31722153,NEJM,1,1,1,,,,,1,NCTN/NCORP Data Archive,0,0,,,,,,,,,,,,,,,,,,,,,"Supported by National Cancer Institute (NCI) grants to the Gynecologic Oncology Group (GOG) Administrative Office (CA 27469), the GOG Statistical Office (CA 37517), NRG Oncology (1U10 CA180822), and the NRG Network Operations Center (U10CA180868) and in part by the National Institutes of Health/NCI under award number P30CA016672 (the investigators used the clinical research shared resource). Roche/Genentech supported the NCI cooperative research and development agreement enabling this trial. Dr. Coleman is supported in part by the Ann Rife Cox Chair in Gynecology and the Judy Reis/Albert Pisani, M.D., Ovarian Cancer Research Fund.",4_Mixed
392," Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.","Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, Taub R, Moussa SE",2019-11,2019-Q4,10.1016/S0140-6736(19)32517-6,31727409,Lancet,1,1,,,1,,,,,,,1,,,1,36,,,1,1,1,,,,,,,,,,,Madrigal Pharmaceuticals,1_Industry
393," Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial.","Kroon FPB, Kortekaas MC, Boonen A, Bohringer S, Reijnierse M, Rosendaal FR, Riyazi N, Starmans M, Turkstra F, van Zeben J, Allaart CF, Kloppenburg M",2019-11,2019-Q4,10.1016/S0140-6736(19)32489-4,31727410,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,Dutch Arthritis Society,3_NonIndustryNonNIH
394," Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.","van der Heijde D, Song IH, Pangan AL, Deodhar A, van den Bosch F, Maksymowych WP, Kim TH, Kishimoto M, Everding A, Sui Y, Wang X, Chu AD, Sieper J",2019-12,2019-Q4,10.1016/S0140-6736(19)32534-6,31732180,Lancet,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,AbbVie,1_Industry
395, Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.,"Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, Yun SC, Hong GR, Song JM, Chung CH, Song JK, Lee JW, Park SW",2020-1,2020-Q1,10.1056/NEJMoa1912846,31733181,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by the Korean Institute of Medicine,3_NonIndustryNonNIH
396," Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.","Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Mace S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC",2019-12,2019-Q4,10.1016/S0140-6736(19)32556-5,31735560,Lancet,1,1,1,,,,1,1,ClinicalStudyDateRequest.com (CSDR),0,0,1,,,,,,,,,,,,,,,,,,,,Sanofi,1_Industry
397, Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants.,"Katheria A, Reister F, Essers J, Mendler M, Hummler H, Subramaniam A, Carlo W, Tita A, Truong G, Davis-Nelson S, Schmolzer G, Chari R, Kaempf J, Tomlinson M, Yanowitz T, Beck S, Simhan H, Dempsey E, ODonoghue K, Bhat S, Hoffman M, Faksh A, Arnell K, Rich W, Finer N, Vaucher Y, Khanna P, Meyers M, Varner M, Allman P, Szychowski J, Cutter G",2019-11,2019-Q4,10.1001/jama.2019.16004,31742630,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,This study was supported by grant 1R01HD088646-01A1 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (awarded to Dr Katheria).,2_NonIndustryNIH
398, Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.,"Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, Trugman JM",2019-11,2019-Q4,10.1001/jama.2019.16711,31742631,JAMA,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,"This trial was sponsored by Allergan plc, Dublin, Ireland. Medical writing and editorial support were provided by Lela Creutz, PhD, and Lisa Feder, PhD, of Peloton Advantage, LLC, an OPEN Health company, Parsippany, New Jersey, and Amy Kuang, PhD, of Allergan plc and funded by Allergan plc.",1_Industry
399," A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.","Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ, Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallee D, Nordwall J",2019-12,2019-Q4,10.1056/NEJMoa1910993,31774950,NEJM,1,1,1,,,,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Supported primarily by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). In-kind support and cosponsorship were provided by the national government of the Democratic Republic of Congo (DRC) and the African Coalition for Epidemic Research, Response, and Training. Logistic support was provided by the World Health Organization (WHO). Some funding for NIAID was provided by the National Cancer Institute through a contract (HHSN261200800001E) with Leidos Biomedical Research and subcontracts to the Mitchell Group. The Biomedical and Advanced Research and Development Authority of the U.S. Department of Health and Human Services provided financial support for the production of ZMapp (contract number, HHSO100201400009C) and REGN-EB3 (contract number, HHSO100201700016C). NIAID and the Defense Advanced Research Projects Agency of the U.S. Department of Defense provided financial support for the production and provision of MAb114. Mapp Biopharmaceutical provided ZMapp, Gilead Sciences provided remdesivir, and NIAID provided MAb114 to the project. Regeneron Pharmaceuticals provided financial support for the provision of REGN-EB3 to the project.",2_NonIndustryNIH
400, Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.,"Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, Veldhuis WB, van Gils CH",2019-11,2019-Q4,10.1056/NEJMoa1903986,31774954,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,"Supported by the University Medical Center Utrecht (project number, UMCU DENSE), the Netherlands Organization for Health Research and Development (project numbers, ZonMW- 200320002-UMCU and ZonMW Preventie 50-53125-98-014), the Dutch Cancer Society (project numbers, DCS-UU-2009-4348, UU-2014-6859, and UU-2014-7151), the Dutch Pink Ribbon–A Sister’s Hope (project number, Pink Ribbon-10074), Bayer Pharmaceuticals (project number, BSP-DENSE), and Stichting Kankerpreventie Midden-West. For research purposes, Volpara Health Technologies provided Volpara Imaging Software, version 1.5, for installation on servers in the screening units.",4_Mixed
401, Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.,"Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, Shinnar S, Conwit R, Meinzer C, Cock H, Fountain N, Connor JT, Silbergleit R",2019-11,2019-Q4,10.1056/NEJMoa1905795,31774955,NEJM,1,1,1,,,,,1,NINDS Archived Clinical Research Datasets,0,0,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the National Institute of Neurological Disorders and Stroke,2_NonIndustryNIH
402, Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.,"Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J",2019-11,2019-Q4,10.1056/NEJMoa1901747,31774956,NEJM,1,1,1,,,,1,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,,,,,,1,1,,,,,,,,,,,Funded by Chugai Pharmaceutical,1_Industry
403," Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.","Clamp AR, James EC, McNeish IA, Dean A, Kim JW, ODonnell DM, Hook J, Coyle C, Blagden S, Brenton JD, Naik R, Perren T, Sundar S, Cook AD, Gopalakrishnan GS, Gabra H, Lord R, Dark G, Earl HM, Hall M, Banerjee S, Glasspool RM, Jones R, Williams S, Swart AM, Stenning S, Parmar M, Kaplan R, Ledermann JA",2019-12,2019-Q4,10.1016/S0140-6736(19)32259-7,31791688,Lancet,1,1,,,1,,1,,,,,,,,1,,,,,,1,,,,,,,,,,,"Cancer Research UK, Medical Research Council, Health Research Board in Ireland, Irish Cancer Society, Cancer Australia.",3_NonIndustryNonNIH
404, Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.,"Hoskin PJ, Hopkins K, Misra V, Holt T, McMenemin R, Dubois D, McKinna F, Foran B, Madhavan K, MacGregor C, Bates A, ORourke N, Lester JF, Sevitt T, Roos D, Dixit S, Brown G, Arnott S, Thomas SS, Forsyth S, Beare S, Reczko K, Hackshaw A, Lopes A",2019-12,2019-Q4,10.1001/jama.2019.17913,31794625,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,The trial was sponsored by University College London (UCL/09/0199) and coordinated by the Cancer Research UK and UCL Cancer Trials Centre. The trial was funded by CRUK Project Grants C2422/7932 and C2422/A11408 (funder reference CRUK/06/034) and by the Cancer Council Queensland for Australian Site Data Management. UK trial centers were supported by the UK National Institute of Health Research.,3_NonIndustryNonNIH
405, Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.,"Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ",2019-12,2019-Q4,10.1056/NEJMoa1905047,31800986,NEJM,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,Funded by the Bill and MelindaGates Foundation,3_NonIndustryNonNIH
406, Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia.,"Werner YB, Hakanson B, Martinek J, Repici A, von Rahden BHA, Bredenoord AJ, Bisschops R, Messmann H, Vollberg MC, Noder T, Kersten JF, Mann O, Izbicki J, Pazdro A, Fumagalli U, Rosati R, Germer CT, Schijven MP, Emmermann A, von Renteln D, Fockens P, Boeckxstaens G, Rosch T",2019-12,2019-Q4,10.1056/NEJMoa1905380,31800987,NEJM,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,"Supported by the European Clinical Research Infrastructure Network (ECRIN); Hamburgische Stiftung für Wissenschaften, Entwicklung und Kultur Helmut und Hannelore Greve (Ham- burg, Germany); by Dr. med. Carl-August Skröder Stiftung (Hamburg, Germany); Dr. Gerhard Büchtemann Stiftung (Ham- burg, Germany); Agnes-Graefe Stiftung (Hamburg, Germany); Georg und Jürgen Rickertsen Stiftung (Hamburg, Germany); Reinhard Frank Stiftung (Hamburg, Germany); Johann Max Böttcher Stiftung (Hamburg, Germany); Richard und Annema- rie Wolf Stiftung (Knittlingen, Germany); Olympus Europa (Hamburg, Germany), which provided funding for the training of personnel at the European centers through POEM Grants 206/7 and 2017/18; the German Society for Gastroenterology and Metabolism and Olympus Europe Foundation (Endoscopy Research Award 2012); a prize awarded at the United European Gastroenterology Week 2010 conference; and the Olympus Euro- NOTES Research Fund Program. The trial was also supported by Harvard Catalyst, the Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, Na- tional Institutes of Health Award UL 1TR002541), and by finan- cial contributions from Harvard University and its affiliated aca- demic health care centers.",3_NonIndustryNonNIH
407, Ubrogepant for the Treatment of Migraine.,"Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A",2019-12,2019-Q4,10.1056/NEJMoa1813049,31800988,NEJM,1,1,1,,,,,,,,,1,,,,,,,,1,1,,,,,,,,,,,Funded by Allergan,1_Industry
408," Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.","Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ",2019-12,2019-Q4,10.1016/S0140-6736(19)33041-7,31813633,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,Intercept Pharmaceuticals,1_Industry
409, External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.,"Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, Olivotto IA",2019-12,2019-Q4,10.1016/S0140-6736(19)32515-2,31813635,Lancet,1,1,1,,,1,,,,,,,,,1,15,,1,,,1,,,,,,,,,,,Canadian Institutes for Health Research and Canadian Breast Cancer Research Alliance,3_NonIndustryNonNIH
410," Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.","Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, Kuske RR, Ganz PA, Parda DS, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, McCormick B, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ Jr, Bryant JL, Wolmark N",2019-12,2019-Q4,10.1016/S0140-6736(19)32514-0,31813636,Lancet,1,1,1,,,,,1,NCTN/NCORP Data Archive,0,0,,,,1,12,1,,,,1,,,,,,,,,,,"National Cancer Institute, US Department of Health and Human Services.",2_NonIndustryNIH
411, Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial.,"Spinella PC, Tucci M, Fergusson DA, Lacroix J, Hebert PC, Leteurtre S, Schechtman KB, Doctor A, Berg RA, Bockelmann T, Caro JJ, Chiusolo F, Clayton L, Cholette JM, Guerra GG, Josephson CD, Menon K, Muszynski JA, Nellis ME, Sarpal A, Schafer S, Steiner ME, Turgeon AF",2019-12,2019-Q4,10.1001/jama.2019.17478,31821429,JAMA,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,"Funding support was provided for the trial by the NIH/NHLBI, Institute of Circulatory and Respiratory Health of the Canadian Institutes Health Research,Washington University in St Louis, the French Ministry of Health Programme Hospitalier de Recherche Clinique, the Quebec Ministry of Health and Social Services, the GFRUP, and the Établissement Français du Sang. The Canadian Critical CareTrials Group (CCCTG) received funding through the Community Development Grant from CIHR's Institute of Circulatory and Respiratory Health. ",4_Mixed
412, Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.,"Hughes TP, Mauro MJ, Cortes JE, Minami H, Rea D, DeAngelo DJ, Breccia M, Goh YT, Talpaz M, Hochhaus A, le Coutre P, Ottmann O, Heinrich MC, Steegmann JL, Deininger MWN, Janssen JJWM, Mahon FX, Minami Y, Yeung D, Ross DM, Tallman MS, Park JH, Druker BJ, Hynds D, Duan Y, Meille C, Hourcade-Potelleret F, Vanasse KG, Lang F, Kim DW",2019-12,2019-Q4,10.1056/NEJMoa1902328,31826340,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Funded by Novartis Pharmaceuticals,1_Industry
413, Effect of Rocuronium vs Succinylcholine on Endotracheal Intubation Success Rate Among Patients Undergoing Out-of-Hospital Rapid Sequence Intubation: A Randomized Clinical Trial.,"Guihard B, Chollet-Xemard C, Lakhnati P, Vivien B, Broche C, Savary D, Ricard-Hibon A, Marianne Dit Cassou PJ, Adnet F, Wiel E, Deutsch J, Tissier C, Loeb T, Bounes V, Rousseau E, Jabre P, Huiart L, Ferdynus C, Combes X",2019-12,2019-Q4,10.1001/jama.2019.18254,31846014,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This study was supported by the Programme Hospitalier de Recherche Clinique 2012 of the French Ministry of Health. The Centre Hospitalier Universitaire de la Réunion is the key sponsor of this study and by delegation the Department of Clinical Research and Development supervises all work in accordance with the French public health code.,3_NonIndustryNonNIH
414, Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial.,"Kozhuharov N, Goudev A, Flores D, Maeder MT, Walter J, Shrestha S, Gualandro DM, de Oliveira Junior MT, Sabti Z, Muller B, Noveanu M, Socrates T, Ziller R, Bayes-Genis A, Sionis A, Simon P, Michou E, Gujer S, Gori T, Wenzel P, Pfister O, Conen D, Kapos I, Kobza R, Rickli H, Breidthardt T, Munzel T, Erne P, Mueller C, Mueller C, Erne P, Muller B, Rickli H, Maeder M, Tavares de Oliveira M Jr, Munzel T, Bayes-Genis A, Sionis A, Goudev A, Dimov B, Hartwiger S, Arenja N, Glatz B, Herr N, Isenrich R, Mosimann T, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Freese M, Vogele J, Meissner K, Martin J, Strebel I, Wussler D, Schumacher C, Osswald S, Vogt F, Hilti J, Barata S, Schneider D, Schwarz J, Fitze B, Hartwiger S, Arenja N, Glatz B, Herr N, Isenrich R, Mosimann T, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Freese M, Vogele J, Meissner K, Martin J, Strebel I, Wussler D, Schumacher C, Osswald S, Vogt F, Hilti J, Barata S, Schneider D, Schwarz J, Fitze B, Arenja N, Rentsch K, Bossa A, Jallad S, Soeiro A, Georgiev D, Jansen T, Gebel G, Bossard M, Christ M",2019-12,2019-Q4,10.1001/jama.2019.18598,31846016,JAMA,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,"This study was supported by the Swiss National Science Foundation, the Swiss Heart Foundation, the University of Basel, the University Hospital Basel, the Foundation for Cardiovascular Research Basel, and the Stanley Thomas Johnson Foundation.",3_NonIndustryNonNIH
415, Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.,"Ray-Coquard I, Pautier P, Pignata S, Perol D, Gonzalez-Martin A, Berger R, Fujiwara K, Vergote I, Colombo N, Maenpaa J, Selle F, Sehouli J, Lorusso D, Guerra Alia EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marme F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P",2019-12,2019-Q4,10.1056/NEJMoa1911361,31851799,NEJM,1,1,1,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,," Supported by Association de Recherche Cancers Gynécologiques (ARCAGY) Research, AstraZeneca, Merck Sharp & Dohme (a subsidiary of Merck), and F. Hoffmann–La Roche.",4_Mixed
416, Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.,"Kozal M, Aberg J, Pialoux G, Cahn P, Thompson M, Molina JM, Grinsztejn B, Diaz R, Castagna A, Kumar P, Latiff G, DeJesus E, Gummel M, Gartland M, Pierce A, Ackerman P, Llamoso C, Lataillade M",2020-3,2020-Q1,10.1056/NEJMoa1902493,32212519,NEJM,1,1,,,1,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,12,1,,,,1,,,,,,,,,,,Bristol-Myers Squibb and GSK/ViiV Healthcare,1_Industry
417, A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia.,"Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A",2020-3,2020-Q1,10.1056/NEJMoa1910182,32212518,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Celgene and Acceleron Pharma,1_Industry
418, Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial.,"Schisterman EF, Sjaarda LA, Clemons T, Carrell DT, Perkins NJ, Johnstone E, Lamb D, Chaney K, Van Voorhis BJ, Ryan G, Summers K, Hotaling J, Robins J, Mills JL, Mendola P, Chen Z, DeVilbiss EA, Peterson CM, Mumford SL",2020-1,2020-Q1,10.1001/jama.2019.18714,32207767,JAMA,1,1,,,1,,,1,NICHD Data and Specimen Hub (DASH),0,0,,,,,,,,,,,,,,,1,,,,,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,2_NonIndustryNIH
419, Surgery versus Conservative Care for Persistent Sciatica Lasting 4 to 12 Months.,"Bailey CS, Rasoulinejad P, Taylor D, Sequeira K, Miller T, Watson J, Rosedale R, Bailey SI, Gurr KR, Siddiqi F, Glennie A, Urquhart JC",2020-3,2020-Q1,10.1056/NEJMoa1912658,32187469,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Physicians’ Services Incorporated Foundation,3_NonIndustryNonNIH
420, Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome.,"Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, Quenot JP, Pili-Floury S, Bouhemad B, Louis G, Souweine B, Collange O, Pottecher J, Levy B, Puyraveau M, Vettoretti L, Constantin JM, Capellier G",2020-3,2020-Q1,10.1056/NEJMoa1916431,32160661,NEJM,1,1,,,1,1,1,,,,,,,,1,12,1,,,,1,,,,,,,,,,,French Ministry of Health,3_NonIndustryNonNIH
421," MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.","Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, Bloom J, Gurram S, Siddiqui M, Pinsky P, Parnes H, Linehan WM, Merino M, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA",2020-3,2020-Q1,10.1056/NEJMoa1910038,32130814,NEJM,1,1,1,,,1,,,,,,,,,1,12,1,,,,1,,,,,,,,,,,National Institutes of Health and others,2_NonIndustryNIH
422, Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.,"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M",2020-3,2020-Q1,10.1056/NEJMoa1901814,32130813,NEJM,1,1,,,1,1,,,,,,,,,1,2,1,,,,1,,,,,,,,,,,TB Alliance (Global Alliance for TB Drug Development) and others,3_NonIndustryNonNIH
423, Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.,"Swindells S, Andrade-Villanueva JF, Richmond GJ, Rizzardini G, Baumgarten A, Masia M, Latiff G, Pokrovsky V, Bredeek F, Smith G, Cahn P, Kim YS, Ford SL, Talarico CL, Patel P, Chounta V, Crauwels H, Parys W, Vanveggel S, Mrus J, Huang J, Harrington CM, Hudson KJ, Margolis DA, Smith KY, Williams PE, Spreen WR",2020-3,2020-Q1,10.1056/NEJMoa1904398,32130809,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,12,1,,,,1,,,,,,,,,,,ViiV Healthcare and Janssen,1_Industry
424, Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.,"Orkin C, Arasteh K, Gorgolas Hernandez-Mora M, Pokrovsky V, Overton ET, Girard PM, Oka S, Walmsley S, Bettacchi C, Brinson C, Philibert P, Lombaard J, St Clair M, Crauwels H, Ford SL, Patel P, Chounta V, DAmico R, Vanveggel S, Dorey D, Cutrell A, Griffith S, Margolis DA, Williams PE, Parys W, Smith KY, Spreen WR",2020-3,2020-Q1,10.1056/NEJMoa1909512,32130806,NEJM,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,12,1,,,,1,,,,,,,,,,,ViiV Healthcare and Janssen,1_Industry
425, Pembrolizumab for Early Triple-Negative Breast Cancer.,"Schmid P, Cortes J, Pusztai L, McArthur H, Kummel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, OShaughnessy J",2020-2,2020-Q1,10.1056/NEJMoa1910549,32101663,NEJM,1,1,1,,,,,,,,,1,,,1,,,,,1,1,,,,,,,,,,,Funded by Merck Sharp & Dohme [a subsidiary of Merck],1_Industry
426, Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.,"Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, Rahbar H, Sung JS, Jacobs C, Harvey JA, Nicholson MH, Ward RC, Holt J, Prather A, Miller KD, Schnall MD, Kuhl CK",2020-2,2020-Q1,10.1001/jama.2020.0572,32096852,JAMA,1,1,1,,,,1,,,,,,,,1,16,,1,,,1,,,,,,,,,,,National Cancer Institute of the National Institutes of Health,2_NonIndustryNIH
427," Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.","Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM, Poppe AY, Buck BH, Field TS, Dowlatshahi D, van Adel BA, Swartz RH, Shah RA, Sauvageau E, Zerna C, Ospel JM, Joshi M, Almekhlafi MA, Ryckborst KJ, Lowerison MW, Heard K, Garman D, Haussen D, Cutting SM, Coutts SB, Roy D, Rempel JL, Rohr AC, Iancu D, Sahlas DJ, Yu AYX, Devlin TG, Hanel RA, Puetz V, Silver FL, Campbell BCV, Chapot R, Teitelbaum J, Mandzia JL, Kleinig TJ, Turkel-Parrella D, Heck D, Kelly ME, Bharatha A, Bang OY, Jadhav A, Gupta R, Frei DF, Tarpley JW, McDougall CG, Holmin S, Rha JH, Puri AS, Camden MC, Thomalla G, Choe H, Phillips SJ, Schindler JL, Thornton J, Nagel S, Heo JH, Sohn SI, Psychogios MN, Budzik RF, Starkman S, Martin CO, Burns PA, Murphy S, Lopez GA, English J, Tymianski M",2020-3,2020-Q1,10.1016/S0140-6736(20)30258-0,32087818,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,"Canadian Institutes for Health Research, Alberta Innovates, and NoNO.",4_Mixed
428," Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.","Fidler S, Stohr W, Pace M, Dorrell L, Lever A, Pett S, Kinloch-de Loes S, Fox J, Clarke A, Nelson M, Thornhill J, Khan M, Fun A, Bandara M, Kelly D, Kopycinski J, Hanke T, Yang H, Bennett R, Johnson M, Howell B, Barnard R, Wu G, Kaye S, Wills M, Babiker A, Frater J",2020-3,2020-Q1,10.1016/S0140-6736(19)32990-3,32085823,Lancet,0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Medical Research Council (MR/L00528X/1).,3_NonIndustryNonNIH
429, A Community-Based Intervention for Managing Hypertension in Rural South Asia.,"Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL, Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L",2020-2,2020-Q1,10.1056/NEJMoa1911965,32074419,NEJM,1,1,1,,,1,,,,,,,,,1,36,,,1,,1,,,,,,,,,,,Joint Global Health Trials scheme,3_NonIndustryNonNIH
430, Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.,"Stander S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, Bieber T, Misery L, Wollenberg A, Reich A, Ahmad F, Piketty C",2020-2,2020-Q1,10.1056/NEJMoa1908316,32074418,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Galderma,1_Industry
431," Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients.","Olsen HT, Nedergaard HK, Strom T, Oxlund J, Wian KA, Ytrebo LM, Kroken BA, Chew M, Korkmaz S, Lauridsen JT, Toft P",2020-3,2020-Q1,10.1056/NEJMoa1906759,32068366,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Danish Medical Research Council, the Danielsens Foundation, and the Scandinavian Society of Anesthesiology and Intensive Care Medicine",3_NonIndustryNonNIH
432, Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.,"Walsh M, Merkel PA, Peh CA, Szpirt WM, Puechal X, Fujimoto S, Hawley CM, Khalidi N, Flossmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suarez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW",2020-2,2020-Q1,10.1056/NEJMoa1803537,32053298,NEJM,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,U.K. National Institute for Health Research and others,3_NonIndustryNonNIH
433," Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial.",HIP ATTACK Investigators.,2020-2,2020-Q1,10.1016/S0140-6736(20)30058-1,32050090,Lancet,1,1,,,1,,1,,,,,,,,1,60,,,1,,1,,,,,,,,,,,Canadian Institutes of Health Research,3_NonIndustryNonNIH
434, Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.,"Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Hudec M, Poliacikova P, Abdul Ghapar AKB, Selvaraj K, Petrov I, Mylotte D, Pinar E, Moreno R, Fabbiocchi F, Pasupati S, Kim HS, Aminian A, Tie C, Wlodarczak A, Hur SH, Marx SO, Jankovic I, Brar S, Bousquette L, Liu M, Stone GW",2020-3,2020-Q1,10.1056/NEJMoa1910021,32050061,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,Medtronic,1_Industry
435," Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal beta-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.","Tong SYC, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J, Archuleta S, Roberts MA, Cass A, Paterson DL, Foo H, Paul M, Guy SD, Tramontana AR, Walls GB, McBride S, Bak N, Ghosh N, Rogers BA, Ralph AP, Davies J, Ferguson PE, Dotel R, McKew GL, Gray TJ, Holmes NE, Smith S, Warner MS, Kalimuddin S, Young BE, Runnegar N, Andresen DN, Anagnostou NA, Johnson SA, Chatfield MD, Cheng AC, Fowler VG Jr, Howden BP, Meagher N, Price DJ, van Hal SJ, OSullivan MVN, Davis JS",2020-2,2020-Q1,10.1001/jama.2020.0103,32044943,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,The study was funded by competitive grants from the Australian National Health and Medical Research Council (grant 1078930) and the Singapore National Medical Research Council (grant 0001-001094) and by seed funding from the Ramiciotti Foundation (grant ES2014/079),3_NonIndustryNonNIH
436, Effect of Incisional Negative Pressure Wound Therapy vs Standard Wound Dressing on Deep Surgical Site Infection After Surgery for Lower Limb Fractures Associated With Major Trauma: The WHIST Randomized Clinical Trial.,"Costa ML, Achten J, Knight R, Bruce J, Dutton SJ, Madan J, Dritsaki M, Parsons N, Fernandez M, Grant R, Nanchahal J",2020-2,2020-Q1,10.1001/jama.2020.0059,32044942,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"UK National Health Service, the National Institute for Health Research, or the Department of Health",3_NonIndustryNonNIH
437, Plaster cast versus functional brace for non-surgical treatment of Achilles tendon rupture (UKSTAR): a multicentre randomised controlled trial and economic evaluation.,"Costa ML, Achten J, Marian IR, Dutton SJ, Lamb SE, Ollivere B, Maredza M, Petrou S, Kearney RS",2020-2,2020-Q1,10.1016/S0140-6736(19)32942-3,32035553,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,UK National Institute for Health Research Health Technology Assessment Programme,3_NonIndustryNonNIH
438," Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.","Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Gottlieb AB, Assudani D, Bedford-Rice K, Coarse J, Ink B, McInnes IB",2020-2,2020-Q1,10.1016/S0140-6736(19)33161-7,32035552,Lancet,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,1,18,,1,,1,1,,,,,,,,,,,UCB Pharma,1_Industry
439," Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial.",Reinforcement of Closure of Stoma Site (ROCSS) Collaborative and West Midlands Research Collaborative.,2020-2,2020-Q1,10.1016/S0140-6736(19)32637-6,32035551,Lancet,1,1,1,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,National Institute for Health Research Research for Patient Benefit and Allergan.,4_Mixed
440, Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.,"Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, Daher M, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, Wierda W, Keating M, Champlin R, Shpall EJ, Rezvani K",2020-2,2020-Q1,10.1056/NEJMoa1910607,32023374,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,M.D. Anderson Cancer Center CLL and Lymphoma Moonshot and the National Institutes of Health,3_NonIndustryNonNIH
441, Lower versus Traditional Treatment Threshold for Neonatal Hypoglycemia.,"van Kempen AAMW, Eskes PF, Nuytemans DHGM, van der Lee JH, Dijksman LM, van Veenendaal NR, van der Hulst FJPCM, Moonen RMJ, Zimmermann LJI, van t Verlaat EP, van Dongen-van Baal M, Semmekrot BA, Stas HG, van Beek RHT, Vlietman JJ, Dijk PH, Termote JUM, de Jonge RCJ, de Mol AC, Huysman MWA, Kok JH, Offringa M, Boluyt N",2020-2,2020-Q1,10.1056/NEJMoa1905593,32023373,NEJM,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,Netherlands Organization for Health Research and Development,3_NonIndustryNonNIH
442, Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction.,"Litonjua AA, Carey VJ, Laranjo N, Stubbs BJ, Mirzakhani H, OConnor GT, Sandel M, Beigelman A, Bacharier LB, Zeiger RS, Schatz M, Hollis BW, Weiss ST",2020-2,2020-Q1,10.1056/NEJMoa1906137,32023372,NEJM,1,1,,,1,,,1,BioLINCC NHLBI Biospecimens and Data,0,0,,,,,,,,,,,,,,,,,,,,,"National Heart, Lung, and Blood Institute",2_NonIndustryNIH
443, Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.,"Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H",2020-2,2020-Q1,10.1001/jama.2019.22450,32016310,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Pharmacosmos A/S,1_Industry
444, Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.,"Stiell IG, Sivilotti MLA, Taljaard M, Birnie D, Vadeboncoeur A, Hohl CM, McRae AD, Rowe BH, Brison RJ, Thiruganasambandamoorthy V, Macle L, Borgundvaag B, Morris J, Mercier E, Clement CM, Brinkhurst J, Sheehan C, Brown E, Nemnom MJ, Wells GA, Perry JJ",2020-2,2020-Q1,10.1016/S0140-6736(19)32994-0,32007169,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research,3_NonIndustryNonNIH
445, Family History of Gastric Cancer and Helicobacter pylori Treatment.,"Choi IJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, Joo J",2020-1,2020-Q1,10.1056/NEJMoa1909666,31995688,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"National Cancer Center, South Korea",3_NonIndustryNonNIH
446, Conservative versus Interventional Treatment for Spontaneous Pneumothorax.,"Brown SGA, Ball EL, Perrin K, Asha SE, Braithwaite I, Egerton-Warburton D, Jones PG, Keijzers G, Kinnear FB, Kwan BCH, Lam KV, Lee YCG, Nowitz M, Read CA, Simpson G, Smith JA, Summers QA, Weatherall M, Beasley R",2020-1,2020-Q1,10.1056/NEJMoa1910775,31995686,NEJM,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,Emergency Medicine Foundation and others,3_NonIndustryNonNIH
447, Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.,"de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van t Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M",2020-2,2020-Q1,10.1056/NEJMoa1911793,31995683,NEJM,1,1,,,1,,1,,,,,,,1,,,,,,,,,,,,,,,,,,Netherlands Organization of Health Research and Development and others,3_NonIndustryNonNIH
448, Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.,"Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, Yoon SH, Trento A, Svensson LG, Herrmann HC, Szeto WY, Miller DC, Satler L, Cohen DJ, Dewey TM, Babaliaros V, Williams MR, Kereiakes DJ, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Brown DL, Fearon WF, Russo MJ, Pibarot P, Hahn RT, Jaber WA, Rogers E, Xu K, Wheeler J, Alu MC, Smith CR, Leon MB",2020-2,2020-Q1,10.1056/NEJMoa1910555,31995682,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Edwards Lifesciences,1_Industry
449," Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.","Lotery A, Sivaprasad S, OConnell A, Harris RA, Culliford L, Ellis L, Cree A, Madhusudhan S, Behar-Cohen F, Chakravarthy U, Peto T, Rogers CA, Reeves BC",2020-1,2020-Q1,10.1016/S0140-6736(19)32981-2,31982075,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Efficacy and Mechanism Evaluation Programme, and National Institute for Health Research and Social Care.",3_NonIndustryNonNIH
450," Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.","Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bose CL, Mwapule A, Mwenechanya M, Chomba E, Carlo WA, Chicuy J, Figueroa L, Garces A, Krebs NF, Jessani S, Zehra F, Saleem S, Goldenberg RL, Kurhe K, Das P, Patel A, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Goco N, Hemingway-Foday J, Moore J, Nolen TL, McClure EM, Koso-Thomas M, Miodovnik M, Silver R, Derman RJ",2020-1,2020-Q1,10.1016/S0140-6736(19)32973-3,31982074,Lancet,1,1,1,,,,,1,NICHD Data and Specimen Hub (DASH),0,0,,,,1,12,1,,,,1,,,,,,,,,,,Eunice Kennedy Shriver National Institute of Child Health and Human Development.,2_NonIndustryNIH
451, Teprotumumab for the Treatment of Active Thyroid Eye Disease.,"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marino M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ",2020-1,2020-Q1,10.1056/NEJMoa1910434,31971679,NEJM,1,1,1,,,,,,,,,1,,,1,11,1,,,,1,,,,,,,,,,,Horizon Therapeutics,1_Industry
452, Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.,"Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG Jr, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O",2020-1,2020-Q1,10.1056/NEJMoa1904351,31971678,NEJM,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,AbbVie,1_Industry
453, Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.,"Marshall HS, McMillan M, Koehler AP, Lawrence A, Sullivan TR, MacLennan JM, Maiden MCJ, Ladhani SN, Ramsay ME, Trotter C, Borrow R, Finn A, Kahler CM, Whelan J, Vadivelu K, Richmond P",2020-1,2020-Q1,10.1056/NEJMoa1900236,31971677,NEJM,1,1,,,1,1,1,,,,,1,,,1,8,1,,,,1,,,,,,,,,,,GlaxoSmithKline,1_Industry
454, Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.,"Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, Polyakov K, Ptaszynski P, Keweloh B, Yao CJ, Pokushalov EA, Romanov AB",2020-1,2020-Q1,10.1001/jama.2019.21187,31961420,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,This trial was supported by local research funds at participating institutions and no funds were provided by industry.,3_NonIndustryNonNIH
455, Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial.,"Issa Y, Kempeneers MA, Bruno MJ, Fockens P, Poley JW, Ahmed Ali U, Bollen TL, Busch OR, Dejong CH, van Duijvendijk P, van Dullemen HM, van Eijck CH, van Goor H, Hadithi M, Haveman JW, Keulemans Y, Nieuwenhuijs VB, Poen AC, Rauws EA, Tan AC, Thijs W, Timmer R, Witteman BJ, Besselink MG, van Hooft JE, van Santvoort HC, Dijkgraaf MG, Boermeester MA",2020-1,2020-Q1,10.1001/jama.2019.20967,31961419,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"The ESCAPE trial was funded by grants from the Netherlands Organization for Health Research and Development (ZonMw; 17110216), and the Dutch Digestive Diseases Foundation (WO10-21, Maag Lever Darm Stichting).",3_NonIndustryNonNIH
456, Effect of Hydroxyethyl Starch vs Saline for Volume Replacement Therapy on Death or Postoperative Complications Among High-Risk Patients Undergoing Major Abdominal Surgery: The FLASH Randomized Clinical Trial.,"Futier E, Garot M, Godet T, Biais M, Verzilli D, Ouattara A, Huet O, Lescot T, Lebuffe G, Dewitte A, Cadic A, Restoux A, Asehnoune K, Paugam-Burtz C, Cuvillon P, Faucher M, Vaisse C, El Amine Y, Beloeil H, Leone M, Noll E, Piriou V, Lasocki S, Bazin JE, Pereira B, Jaber S, Lasocki S, Huet O, Cadic A, Jacob C, Paugam-Burtz C, Restoux A, Ouattara A, Feitita I, Deloge E, Defaye M, Joannes-Boyau O, Carles P, Napolitano G, Monziols S, Futier E, Vignaud M, Paul S, Gahbiche K, Fayon J, Laroche E, Bazin JE, Brandely A, Le Moal C, Lebuffe G, Garot M, Piriou V, Jaber S, Chanques G, Verzilli D, De Jong A, Millot A, Castagnoli A, Leone M, Pastene B, Castelli C, Medam S, Velly L, Vaisse C, Faucher M, Asehnoune K, Samba E, Roquilly A, Le Penndu M, Cuvillon P, Yves Lefrant J, Wira O, Dubout E, Mfam WS, Lescot T, Begneu E, Burey J, Cirilovic T, Beloeil H, Allo G, Pottecher J, Lebas B, Venot C, Rameau JP, Dimache F, Leger PS, El Amine Y",2020-1,2020-Q1,10.1001/jama.2019.20833,31961418,JAMA,1,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,"The study was supported by the Direction de la Recherche Clinique et des Innovations and the Clermont-Ferrand University Hospital, with grants from the Agence National de la Sécurité du Médicament et des Produits de Santé and the Société Française d’Anesthésie et Réanimation.",3_NonIndustryNonNIH
457, Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.,"Matta MK, Florian J, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Yang Y, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong LA, Ganley C, Michele T, Strauss DG",2020-1,2020-Q1,10.1001/jama.2019.20747,31961417,JAMA,1,1,1,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,The study was funded by the US Food and Drug Administration (FDA).,3_NonIndustryNonNIH
458, Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial.,"Schweitzer C, Brezin A, Cochener B, Monnet D, Germain C, Roseng S, Sitta R, Maillard A, Hayes N, Denis P, Pisella PJ, Benard A",2020-1,2020-Q1,10.1016/S0140-6736(19)32481-X,31954466,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,French Ministry of Social Affairs and Health.,3_NonIndustryNonNIH
459, A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.,"Juul SE, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, Robinson T, Ahmad KA, Bendel-Stenzel E, Baserga M, LaGamma EF, Downey LC, Rao R, Fahim N, Lampland A, Frantz Iii ID, Khan JY, Weiss M, Gilmore MM, Ohls RK, Srinivasan N, Perez JE, McKay V, Vu PT, Lowe J, Kuban K, OShea TM, Hartman AL, Heagerty PJ",2020-1,2020-Q1,10.1056/NEJMoa1907423,31940698,NEJM,1,1,1,,,,,1,NINDS Archived Clinical Research Datasets,0,0,,,,1,12,1,,,,1,,,,,,,,,,,National Institute of Neurological Disorders and Stroke,2_NonIndustryNIH
460, Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.,"Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE",2020-1,2020-Q1,10.1001/jama.2019.20687,31935028,JAMA,1,1,1,,,,,1,ClinicalStudyDateRequest.com (CSDR),0,0,,,,,,,,,1,1,,,,,,,,,,,This study was supported by Bayer AG. ,1_Industry
461, Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.,"Parsons JK, Zahrieh D, Mohler JL, Paskett E, Hansel DE, Kibel AS, Liu H, Seisler DK, Natarajan L, White M, Hahn O, Taylor J, Hartman SJ, Stroup SP, Van Veldhuizen P, Hall L, Small EJ, Morris MJ, Pierce JP, Marshall J",2020-1,2020-Q1,10.1001/jama.2019.20207,31935026,JAMA,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"This study was supported by the NCI of the National Institutes of Health under awards UG1CA189823 (Alliance for Clinical Trials in Oncology NCORP grant; https://acknowledgments.alliancefound.org), U24CA196171, U10CA037447, U10CA011789, U10CA041287, U10CA059518, U10CA077651, U10CA077658, U10CA138561, U10CA180791, U10CA180850, U10CA180866, U10CA180830, and U10CA180888 (SWOG); NCI grant 1R01 CA132951-01A1; Department of Defense grant PC073412; the Prostate Cancer Foundation; and William Hamilton Fund.",4_Mixed
462," Health Care Hotspotting - A Randomized, Controlled Trial.","Finkelstein A, Zhou A, Taubman S, Doyle J",2020-1,2020-Q1,10.1056/NEJMsa1906848,31914242,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,1,Supported by the National Institute on Aging of the National Institutes of Health under award number R01AG049897; the Health Care Delivery Initiative of J-PAL North America; and the Sloan School of Management of the Massachusetts Institute of Technology.,4_Mixed
463, Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.,"Fenaux P, Platzbecker U, Mufti GJ, Garcia-Manero G, Buckstein R, Santini V, Diez-Campelo M, Finelli C, Cazzola M, Ilhan O, Sekeres MA, Falantes JF, Arrizabalaga B, Salvi F, Giai V, Vyas P, Bowen D, Selleslag D, DeZern AE, Jurcic JG, Germing U, Gotze KS, Quesnel B, Beyne-Rauzy O, Cluzeau T, Voso MT, Mazure D, Vellenga E, Greenberg PL, Hellstrom-Lindberg E, Zeidan AM, Ades L, Verma A, Savona MR, Laadem A, Benzohra A, Zhang J, Rampersad A, Dunshee DR, Linde PG, Sherman ML, Komrokji RS, List AF",2020-1,2020-Q1,10.1056/NEJMoa1908892,31914241,NEJM,1,1,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,Celgene and Acceleron Pharma,1_Industry
464, Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial.,"Schisterman EF, Sjaarda LA, Clemons T, Carrell DT, Perkins NJ, Johnstone E, Lamb D, Chaney K, Van Voorhis BJ, Ryan G, Summers K, Hotaling J, Robins J, Mills JL, Mendola P, Chen Z, DeVilbiss EA, Peterson CM, Mumford SL",2020-1,2020-Q1,10.1001/jama.2019.18714,31910279,JAMA,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,This research was supported by contracts HHSN275201200007C and HHSN275201300026I from the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.,2_NonIndustryNIH
465, Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.,"Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, Baum SJ, Steinhagen-Thiessen E, Shapiro MD, Stroes ES, Moriarty PM, Nordestgaard BG, Xia S, Guerriero J, Viney NJ, ODea L, Witztum JL",2020-1,2020-Q1,10.1056/NEJMoa1905239,31893580,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Akcea Therapeutics,1_Industry
466, Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.,"Pasi KJ, Rangarajan S, Mitchell N, Lester W, Symington E, Madan B, Laffan M, Russell CB, Li M, Pierce GF, Wong WY",2020-1,2020-Q1,10.1056/NEJMoa1908490,31893514,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,BioMarin Pharmaceutical,1_Industry
467, Alcohol Abstinence in Drinkers with Atrial Fibrillation.,"Voskoboinik A, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S, Prabhu S, Stub D, Azzopardi S, Vizi D, Wong G, Nalliah C, Sugumar H, Wong M, Kotschet E, Kaye D, Taylor AJ, Kistler PM",2020-1,2020-Q1,10.1056/NEJMoa1817591,31893513,NEJM,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,"Supported in part by the Government of Victoria Operational Infrastructure Support Program. Dr. Voskoboinik is the recipient of postgraduate scholarships cofunded by the National Health and Medical Research Council (NHMRC) and National Heart Foundation and Baker Institute Bright Sparks scholarships; Dr. Kalman, a NHMRC practitioner fellowship; and Dr. Stub, a National Heart Foundation Early Career Fellowship and Viertel Foundation Award. Alive Technologies provided a 20% discount for AliveCor Kardia Mobile EKG monitors.",3_NonIndustryNonNIH
468," Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.","Holm NR, Makikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, Trovik T, Kellerth T, Kalinauskas G, Mogensen LJH, Nielsen PH, Niemela M, Lassen JF, Oldroyd K, Berg G, Stradins P, Walsh SJ, Graham ANJ, Endresen PC, Frobert O, Trivedi U, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH",2020-1,2020-Q1,10.1016/S0140-6736(19)32972-1,31879028,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,Biosensors,1_Industry
469," Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.","Lagae L, Sullivan J, Knupp K, Laux L, Polster T, Nikanorova M, Devinsky O, Cross JH, Guerrini R, Talwar D, Miller I, Farfel G, Galer BS, Gammaitoni A, Mistry A, Morrison G, Lock M, Agarwal A, Lai WW, Ceulemans B",2019-12,2019-Q4,10.1016/S0140-6736(19)32500-0,31862249,Lancet,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Zogenix,1_Industry
470, Trial of Anifrolumab in Active Systemic Lupus Erythematosus.,"Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R",2020-1,2020-Q1,10.1056/NEJMoa1912196,31851795,NEJM,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,AstraZeneca,1_Industry
471, Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.,"Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE, Loibl S, Bonanni B, Evans DG, Howell A",2020-1,2020-Q1,10.1016/S0140-6736(19)32955-1,31839281,Lancet,1,1,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,"Cancer Research UK, the National Health and Medical Research Council Australia, Breast Cancer Research Foundation, Sanofi Aventis, and AstraZeneca.",4_Mixed
472," Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.","Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, Francis NA, Lewis RJ, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Seifert B, Sundvall PD, Colliers A, Aabenhus R, Bjerrum L, Jonassen Harbin N, Lindbaek M, Glinz D, Bucher HC, Kovacs B, Radzeviciene Jurgute R, Touboul Lundgren P, Little P, Murphy AW, De Sutter A, Openshaw P, de Jong MD, Connor JT, Matheeussen V, Ieven M, Goossens H, Verheij TJ",2020-1,2020-Q1,10.1016/S0140-6736(19)32982-4,31839279,Lancet,1,1,1,,,1,1,,,,,,,,,,,,,,,1,,,,,,,,,,European Commission's Seventh Framework Programme.,3_NonIndustryNonNIH
473," Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.","Mateos MV, Cavo M, Blade J, Dimopoulos MA, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Krevvata M, Chen Y, Wang J, Kudva A, Ukropec J, Wroblewski S, Qi M, Kobos R, San-Miguel J",2020-1,2020-Q1,10.1016/S0140-6736(19)32956-3,31836199,Lancet,1,1,,,1,,,1,The Yale Open Data Access (YODA) Project,0,0,,,,,,,,,,,,,,,,,,,,,Janssen Research & Development,1_Industry
474," Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.","Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, Gaze D, Kiotsekoglou A, Yuan L, Hu J, Foley C, Van Dyck L, Knight R, Clayton T, Swan L, Thomson JDR, Erdem G, Crossman D, Flather M",2019-12,2019-Q4,10.1016/S0140-6736(19)32518-8,31836196,Lancet,1,1,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,"British Heart Foundation, the UK Marfan Trust, the UK Marfan Association.",3_NonIndustryNonNIH
475, Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.,"Slamon DJ, Neven P, Chia S, Fasching PA, De Laurentiis M, Im SA, Petrakova K, Bianchi GV, Esteva FJ, Martin M, Nusch A, Sonke GS, De la Cruz-Merino L, Beck JT, Pivot X, Sondhi M, Wang Y, Chakravartty A, Rodriguez-Lorenc K, Taran T, Jerusalem G",2020-2,2020-Q1,10.1056/NEJMoa1911149,31826360,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Novartis,1_Industry
476," Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients.","Ginde AA, Brower RG, Caterino JM, Finck L, Banner-Goodspeed VM, Grissom CK, Hayden D, Hough CL, Hyzy RC, Khan A, Levitt JE, Park PK, Ringwood N, Rivers EP, Self WH, Shapiro NI, Thompson BT, Yealy DM, Talmor D",2019-12,2019-Q4,10.1056/NEJMoa1911124,31826336,NEJM,1,1,1,,,,,1,BioLINCC NHLBI Biospecimens and Data,0,0,,,,1,24,,1,,,1,,,,,,,,,,,"National Heart, Lung, and Blood Institute",2_NonIndustryNIH
477," Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.","Murthy RK, Loi S, Okines A, Paplomata E, Hamilton E, Hurvitz SA, Lin NU, Borges V, Abramson V, Anders C, Bedard PL, Oliveira M, Jakobsen E, Bachelot T, Shachar SS, Muller V, Braga S, Duhoux FP, Greil R, Cameron D, Carey LA, Curigliano G, Gelmon K, Hortobagyi G, Krop I, Loibl S, Pegram M, Slamon D, Palanca-Wessels MC, Walker L, Feng W, Winer EP",2020-2,2020-Q1,10.1056/NEJMoa1914609,31825569,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,Seattle Genetics,1_Industry
478, Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.,"Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I",2020-2,2020-Q1,10.1056/NEJMoa1914510,31825192,NEJM,1,1,1,,,,,1,Vivli Center for Global Clinical Research Data,0,0,,,,,,,,,,,,,,,,,,,,,Daiichi Sankyo and AstraZeneca,1_Industry
479," Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.","Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Ostergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J",2020-1,2020-Q1,10.1016/S0140-6736(19)32971-X,31813637,Lancet,1,1,1,,,,1,1,Vivli Center for Global Clinical Research Data,0,0,,,,1,6,1,,,1,1,,,,,,,,,,,Eli Lilly and Company,1_Industry
480," Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.","Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C, Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P, Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M, Rukazenkov Y, Soria JC",2020-1,2020-Q1,10.1056/NEJMoa1913662,31751012,NEJM,1,1,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,AstraZeneca,1_Industry
481, A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.,"Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Bejot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallee PC, Lee BC, Lee KB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I, Steg PG, Sung SM, Touboul PJ, Touze E, Varenne O, Vicaut E, Yelles N, Bruckert E",2020-1,2020-Q1,10.1056/NEJMoa1910355,31738483,NEJM,1,1,1,,,1,,,,,,,,,1,6,1,,,,1,,,,,,,,,,,"Supported by a grant (AOM09002) from the French Ministry of Health, by SOS–Attaque Cérébrale Association, and by grants from Pfizer, AstraZeneca, and Merck for the French sites and from Pfizer for the South Korean sites.",4_Mixed
482, Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.,"De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, Kini AS, Veien KT, Abdel-Wahab M, Kim WK, Balan P, Van Mieghem N, Mathiassen ON, Jeger RV, Arnold M, Mehran R, Guimaraes AHC, Norgaard BL, Kofoed KF, Blanke P, Windecker S, Sondergaard L",2020-1,2020-Q1,10.1056/NEJMoa1911426,31733182,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Bayer,1_Industry
483, A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.,"Dangas GD, Tijssen JGP, Wohrle J, Sondergaard L, Gilard M, Mollmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimaraes AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schafer U, Seeger J, Tchetche D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S",2020-1,2020-Q1,10.1056/NEJMoa1911425,31733180,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Bayer and Janssen Pharmaceuticals,1_Industry
484, Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.,"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, Lopez-Sendon J, Ostadal P, Koenig W, Angoulvant D, Gregoire JC, Lavoie MA, Dube MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, LAllier PL, Guertin MC, Roubille F",2019-12,2019-Q4,10.1056/NEJMoa1912388,31733140,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,"Supported by the Government of Quebec, the Canadian Institutes of Health Research, and philanthropic foundations, with the funds administered by the Montreal Heart Institute. The Montreal Health Innovations Coordinating Center managed the trial and is a division of the Montreal Heart Institute.",3_NonIndustryNonNIH
485, A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.,"Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F",2020-1,2020-Q1,10.1056/NEJMoa1912770,31702883,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cara Therapeutics,1_Industry
486, Conservative Oxygen Therapy during Mechanical Ventilation in the ICU.,"Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, Finfer S, Freebairn R, King V, Linke N, Litton E, McArthur C, McGuinness S, Panwar R, Young P",2020-3,2020-Q1,10.1056/NEJMoa1903297,31613432,NEJM,1,1,1,,,1,1,,,,,,,,1,24,,1,,,1,,,,,,,,,,,Funded by the Health Research Council of New Zealand,3_NonIndustryNonNIH
487, Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.,"de Wit R, de Bono J, Sternberg CN, Fizazi K, Tombal B, Wulfing C, Kramer G, Eymard JC, Bamias A, Carles J, Iacovelli R, Melichar B, Sverrisdottir A, Theodore C, Feyerabend S, Helissey C, Ozatilgan A, Geffriaud-Ricouard C, Castellano D",2019-12,2019-Q4,10.1056/NEJMoa1911206,31566937,NEJM,1,0,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,Sanofi,1_Industry